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ABSTRACT 
Increased vascular reactivity is a common observation in human 
and experirr. ental hypertension. In this study, reactivity of the per- 
fused mesenteric arteriaVarteriolar vascular bed was examined during 
the development of renal and renal/salt hypertension in the rat. 
Increased reactivity to noradrenaline was observed in tissues 
from rats 1-12 weeks after the induction of renal/salt hypertension. In 
the early (1-2 week) stages, preparations were supersensitive to nor- 
adrenaline but not to KCl. In the later (4- 6 week)stages, the increase 
in noradrenaline reactivity was due to supersensitivity and another factor 
which increased KCl reactivity and was characterized by an elevated r:: a. x- 
imum response. The noradrenaline response potentiating effects of 
exogenous angiotensin II were attenuated in the early but not the later 
stages of hypertension. Vascular reactivity to noradrenaline in tissues 
from renal hypertensive rats was similar to that in renal/salt hyper- 
tensive rats, but with a slower time course. 
The decay of noradrenaline responses in calcium-f res conditions 
was slower in tissues from early renal/salt hypertensive rats, indicating 
that an increased availability of activator calcium was the mechanism of 
supersensitivity. 
The characteristics of the a-adrenoceptor did not appear to 
differ in the renal/salt hypertensive rat as the pA2 value for phentol- 
amine did not change. Differences in the pA2 value for indorarin were 
observed in tissues from hypertensive rats but probably resulted from 
the unusual properties of this drug. 
The early supersensitivity to noradrenaline was partially 
attributable to the effects of a positive sodium balance. Endogenous 
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CHAPTER 1 
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INTRODUCTION 
The haemodynamic characteristic of hypertension in humans 
and in experimental animals is a raised peripheral resistance to the 
flow of blood (Freis, 1960). Several influences on the peripheral 
vasculature have been implicated as causes of increased resistance. 
Nervous and humoral influences on the blood vessels may increase 
resistance, however the evidence for hyper-activity of these systems 
is equivocal. There is a large body of evidence (Doyle, 1968) that 
the blood vessels of hypertensive patients respond more powerfully 
than normal to humoral and nervous activation. Increased "vascular 
reactivity" appears to be a more common finding in hypertension than 
a hyper-activity of the nervous or humoral control systems. 
The aim of the present study is to examine the changes in 
reactivity of perfused resistance vessels from rats, during the 
development of hypertension. The perfused mesenteric vasculature 
preparation is used since it avoids the complications of a capillary 
and post-capillary resistance section. Increased reactivity in this 
preparation has been previously demonstrated but its nature has not 
been elucidated since full dose-response curve data during the develop- 
ment of hypertension was not obtained (McGregor and smirk, 1968,1970., 
Haeusler and Haefely, 1970., Armstrong, 1972., Haeusler and Finch, 1972 
a, b). The important unanswered question is whether increased reactivity 
is a cause or a consequence of hypertension. 
The experimental model used is the renal hypertensive rat, 
with and without salt-loading, since the development of hypertension and 
changes in reactivity can be accurately followed from a defined, operative 
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starting point. Renal hypertension was thought to be the best model 
for this type of study since hypertension induced by salt and desoxy- 
corticosterone involves administration of an exogenous steroid which 
might influence vascular reactivity per se, while the spontaneously 
hypertensive rat develops hypertension rather slowly a%i lacks a 
suitable control animal. 
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LITERATURE REVIEW 
Richard Bright (1836) first drew attention to the 
association of proteinuria and dropsy, with cardiac hypertrophy. He 
speculated that the cardiac hypertrophy might be due to some altered 
quality of the blood which led to either direct stimulation of the 
heart or to some alteration in the peripheral vessels resulting in 
a greater action being necessary to force the blood through them. 
The concept of blood pressure in clinical medicine was ill-defined at 
this time, but, Bright's suggestions laid the foundations of modern 
concepts of the pathogenesis of hyperVension. 
THE HAEPIODYNAMICS OF HYPERTENSION IN HUMANS 
The factors that determine the arterial blood pressure are, 
i) the cardiac output, ii) the peripheral resistance to the flow of 
blood and iii) the blood viscosity. 
The blood viscosity is normal in hypertension (Pickering, 
1936). Tibblin, Bergentz, -Bjure and Wilhelmsen (1966) reported 
increased blood viscosity in hypertensive patients, but used an 
in vitro technique which may be an unreliable indicator of viscosity 
in vivo (Djojosugito, Folkow, Öberg and White, 1970). 
When reliable methods for measuring cardiac output became 
available, no difference was found between normal and hypertensive 
subjects (Goldring and Chasis, 1944.1 Hickam and Cargill, 1948., 
Bolomey, Michie, Michie, Breed, Schreiner and Lavson, 1949., `Werko 
and Lagerlof, 1949., Lewis, Houssay, Haynes and Dexter, 1953", 
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Varnauskas, 1955., Judson, Hollander and Wilkins, 1957., Taylor, 
Donald and Bishop, 1957., Brod, 1960., Rowe., Castillo, Maxwell and 
Crumpton, 1961., Yurchak, Hood, Rolett, Hickler and Gorlin, 1964). 
It was concluded that increased vascular resistance to flow was the 
haemodynamic hallmark of hypertension (Freia, 1960., Page and" 
McCubbin, 1966). 
A recent clinical study by Frohlich, Tarazi and Dustan 
(1969) has confirmed that peripheral resistance and not cardiac output 
is raised in stable hypertension. However, patients with variable, 
but above average blood pressure, designated "labile hypertensives", 
were an exception, since they had increased cardiac output but no 
change in peripheral resistance. 
THE EXPERIMENTAL INDUCTION OF HYPERTENSION IN ANIMALS 
Experimental animal models of various high blood pressure 
conditions are required in order to examine the haemodynamics of the 
development of hypertension. 
The earliest experimental studies were designed to 
determine the effect of nephrectomy and other manipulations of the 
kidney on the blood pressure. Grasritz and Israel (1879) induced 
hypertrophy of the heart, by partial nephrectomy of rabbits, which 
they attributed to the development of hypertension. Katzenstein 
(1905) made the first observations on the effects of partial 
constriction of the main renal arteries on the blood pressure, but 
his period of observation was short and the results were either 
negative or equivocal. There were numerous other attempts to 
induce hypertension by manipulation of the kidney or its circulation, 
the most successful being those of Chanutin and Ferris (1932), who 
induced chronic hypertension in rats by partial nephrectomy. 
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The great impetus to the modern study of hypertension was 
the demonstration by Goldblatt, Lynch, Hanzal and Summerville (1934) 
that the application of a clamp to the renal artery of a dog, with 
subsequent removal of the opposite kidney, resulted in chronic 
elevation of the blood pressure. Numerous procedures are now- 
available which elevate the blood pressure in experimental animals. 
Most techniques involve some manipulation of the kidney or renal 
artery. Instead of"a "Goldblatt" clamp, the kidney function can 
be impaired by a ligature (Grollman, 1944) or a cellophane capsule 
(Page, 1939). The removal of one kidney and the administration of 
desoxycorticosterone (D. O. C. ) or other steroids (Grollman, Harrison 
and Williams, 1940), enucleation of the adrenals with unilateral 
nephrectomy (Skelton, 1955), the use of choline or potassium-free 
diets (Grollman and White, 1958) and infarction of the kidney 
(Loomis, 1946), all induce hypertension. 
The spontaneously hypertensive rat (S. H. R. ) has been 
developed by selective inbreeding (Smirk and Hall, 1958., Okamoto 
and Aoki, 1963) as a model of human essential hypertension. Dahl 
(1961) has developed a strain of pure bred salt-sensitive rats, which 
become hypertensive when salt loaded. 
THE HAEM, ODYNAMICS OF ýXPERIMENTAL HYPERTENSION 
Renal hypertension has been commonly used for continuous 
haemodynamic studies, since the operative procedures provide an 
accurately defined starting point. Ledingham and Pelling (1967) 
and Ferrario, Page and McCubbin (1970), using rats and dogs, 
respectively, have shown that renal hypertension is characterized by 
an initial transient rise in cardiac output, followed by an increase 
in peripheral resistance, which sustains the hypertension. The 
transient rise in cardiac output is probably stimulated by an increased 
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plasma volume, due to impaired renal function, which would cause 
increased cardiac filling (Ledingham, 1971). However, prostaglandin 
Fla may also play a role in stimulating venoconstriction and 
therefore in increasing venous return (McGiff, Crowshaw and Itskovitz, 
1974). 
The sustained rise in peripheral resistance which 
characterizes and maintains the high blood pressure in all stable 
hypertensive states, has attracted much research effort. Peripheral 
resistance, at a constant cardiac output, is determined by the 
diameter of the resistance vessels. The state of contraction, or 
tone, of these vessels is influenced by a complex interaction of 
neural and humoral influences, the effect of which is determined by 
the sensitivity of the vascular smooth muscle and the structure of 
the vessel. All these factors have been implicated as causes of 
increased peripheral resistance in hypertension. 
POSSIBLE CAUSES OF INCREASED PERIPHERAL RESISTANCE IN HYPERTENSION 
A. NERVOUS MECHANISMS 
1. THE CENTRAL COMPONENT 
The brain is the most oxygen sensitive organ served by the 
cardiovascular system. Teleologically, the brain should possess 
the dominant blood pressure regulating mechanism as protection 
against reduced blood flow and consequent ischaemia. Dickinson 
(1965), has suggested that vertebral artery disease, which causes 
increased cerebrovascular resistance to flow, could be the cause of 
human essential hypertension. This hypothesis has been extended to 
renal hypertension, in which levels of the vasoconstrictor agent 
angiotensin II may be increased (Gross, 1971). An infusion of 
angiotensin II into the vertebral artery produces hypertension, 
while the same dose, administered systemically is without a pressor 
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effect (Dickinson and Lawrence, 1963., Yu and Dickinson, 1965). 
However, Marshall (1966) found no tendency for patients with brain 
stem vasomotor centre ischaemia having higher blood pressures than 
those with ischaemia of the cerebral hemisphere. 
Observations made with centrally acting antihypertensive 
agents such as a methyldopa support the hypothesis that the brain 
is involved in hypertension. a-Tlethy]noradrenaline, probably the 
active metabolite of a-methyldopa, is thought to stimulate the 
a-adrenoceptors in the brain-stem which mediate the reflex withdrawal 
of sympathetic drive (Henning and Rubenson, 1971). Catecholamine 
turnover is reduced in the brain-stem and hypothalamus of D. O. C. - 
saline hypertensive rats (Nakamura, Gerold and Thoenen, 1971 a) and 
this deficiency of catecholamines may be involved in the pathogenesis 
of this model of experimental hypertension. Conflicting results 
have been obtained for the S. H. R. since Louis, Krauss, Kopin and 
Sjoerdsma (1970) reported a deficiency of catecholamines but 
Nakamura, Gerold and Thoenen (1971 b) found no change in central 
catecholamine turnover. 
2. THE PERIPHERAL COMPONENT 
If the increased peripheral resistance in hypertension is 
due to excessive sympathetic vasomotor discharge, then sympathectomy 
should provide a cure. The extensive excision of the paravertebral 
sympathetic ganglia has been widely practised (Pickering, 1968) but 
the benefit of such an operation is still not clear since a properly 
controlled clinical trial has never been organized. Immediately 
after the operation, there is a considerable fall in arterial 
pressure, but in most patients the fall is not sustained (Platt and 
Stanbury, 1950). 
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Pharmacological sympathectomy, by the administration of 
large doses of the ganglion blocking agent hexamethonium, lowers 
the blood pressure of hypertensive patients more than in normotensive 
subjects (Doyle and Smirk, 1955). This would suggest an increased 
neurogenic component in the control of the blood pressure in the 
hypertensive subject. However, renal hypertension in rats can 
develop in the absence of a functional sympathetic nervous system, 
although a neurogenic component seems likely in the chronic renal 
hypertensive state (Dorr and Brody, 1966., Finch and Leach, 1970). 
The development of hypertension in the New Zealand strain of S. H. R 
is prevented by immunosympathectomy (Clark, 1969), while catecholamine 
depletion by 6-hydroxy dopamine may or may not prevent the development 
of hypertension in the Japanese S. H. R. (Haeusler, Finch and Thoenen, 
1972., Yamori, Yamabe, De Jong, Lovenberg and Sjoerdsma, 1972., 
Vapaatala, Hackman, Anttila, VainionpaA and Neuvonen, 1974). 
Direct recording from or direct stimulation of sympathetic 
nerves in the Japanese S. H. R. has indicated that an increased 
vasoconstrictor discharge occurs in these animals (Okamoto, Nosaka, 
Yamori and Matsumoto, 1967., Iriuchijima, 1973). However, the levels 
of regulatory enzymes for catecholamine biosynthesis are decreased 
in the mesenteric arteries of the animals (Tarver, Berkowitz and 
Spector, 1971) and this would contra-indicate increased sympathetic 
activity. 
Rates of excretion of noradrenaline and its metabolites, 
which may indicate sympathetic nervous activity, are usually normal 
in hypertensive patients (Brunjes, 1964). Gitlow, Mendlowitz, Wilk, 
Wolf and Naftchi (1964) suggest that essential hypertensives have an 
enhanced plasma noradrenaline clearance rate, whereas, De Quattro 
and Miura (1973) could find no evidence of abnormal noradrenaline 
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turnover in patients with primary hypertension. Patients with renal 
or renovascular hypertension have normal plasma noradrenaline clear- 
ance rates (Gitlow, Mendlowitz, Bertani, Wilk and Glabman,, 1969). 
Louis, Doyle and Anavekar (1973) have demonstrated an increased 
catecholamine concentration in the plasma of hypertensive patients. 
Such an increase is unlikely to be the cause of hypertension, since 
plasma catecholamines can be increased without an elevation of the 
blood pressure (Engelman and Portnoy, 1970). 
In experimental hypertension, the evidence for changes in 
catecholamine metabolism is equivocal. De Champlain has suggested 
that a reduction in noradrenaline storage, with a consequent increase 
in turnover rate, may be important in the pathogenesis of D. O. C. -salt 
hypertension in rats (De Champlain, Krakoff and Axelrod, 1968., 
De Champlain, Mueller and Axelrod, 1969). However, Louis (1970) 
has reported experiments on noradrenaline turnover in D. O. C. -salt 
and spontaneously hypertensive rats, indicating that noradrenaline 
plays only a contributory rather than a primary role in both forms 
of hypertension. 
The second to second feedback control of vasomotor 
discharge is provided by the baroreceptors. Disturbances of the 
function of these pressure receptors can lead to hypertension in 
experimental animals (Krieger, 1964., Ferrario, McCubbin and Page, 
1969., Cowley, Liard and Guyton, 1973), McCubbin, Green and Page 
(1956) have shown that the baroreceptors "reset" a few days after 
renal hypertension is induced, so that they tend to maintain rather 
than to suppress the elevated blood pressure. Disturbances of 
baroreceptor function are unlikely to maintain a stable hypertensive 
state alone, since resetting at normotensive levels could easily 
occur in the absence of stressful hypertensive stimuli. However, 
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secondary resetting of the baroreceptors may account for the 
inconclusive data which has been obtained on sympathetic function 
in hypertension. A sympathetic function in a hypertensive state, 
which is indistinguishable from the normotensive reference, may be 
abnormal in relation to the elevated blood pressure. 
The first effective antihypertensive drugs were the ganglion 
blocking agents (Paton and Zaimis, 1949). The present day 
antihypertensive agents, guanethidine and a-methyl dopa have 
their major effects on the sympathetic nervous system, whether 
peripheral or central in action. It is likely, therefore that 
there is a neurogenic component involved, at least in the maintenance 
of hypertension. 
B. HUMORAL 2. IECHANISMS 
1. RENIN AND ANGIOTENSIN 
Goldblatt, Lynch, Hanzal and Summerville (1934) demonstrated 
that persistent hypertension could be produced by constricting the 
renal arteries. It seemed obvious that the pressor substance, renin, 
which had been isolated from the kidney by Tigerstedt and Bergman 
(1898) was responsible. Benin itself is not pressor, but is a 
proteolytic enzyme (Helmer, 1971) produced mainly by the 
juxtaglomerular cells, which reacts with a substrate, present in the 
a globulin fraction of the plasma, to form the decapeptide angiotensin 
I. Angiotensin I is converted enzymically, in the lungs (Ng and Vane, 
1968), to the octapeptide angiotensin II, which is the most potent 
natural pressor substance known (Gross and Bock, 1962). 
It was assumed that increased plasma angiotensin II was the 
cause of experimental renal hypertension in animals, and its various 
naturally occuring counterparts in man. However, numerous studies 
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have failed to confirm this assumption, as both plasma renin and 
angiotensin II levels are often normal in. chronic renal hypertension 
in various species, including man (Brown, Davies, Lever and Robertson, 
1964). 
Patients with renal artery stenosis and malignant 
hypertension have raised plasma renin levels (Brown, Davies, Lever 
and Robertson, 1966). However, normal levels are found in patients 
with chronic renal failure (Gutkin, Levinson, King and Masker, 1969) 
and renal parenchymal disease (Brown, Davies, Lever and Robertson, 
1965). Plasma angiotensin II concentratiors are elevated in malignant 
hypertension (Catt, Cran, Zimmet, Best, Cain and Coghlan, 1971) and 
in patients with cirrhosis with as cites or juxtaglomerular cell 
hyperplasia, but this may be unrelated to the level of the blood 
pressure (Gocke, Gerten, Sherwood and Laragh, 1969). 
If we consider non-renal forms of hypertension, plasma 
renin is suppressed in most hypertensive patients with aldosterone- 
secreting adenomas (Conn, Cohen and Rovner, 1964). Essential 
hypertensives have been divided into three sub-groups of low, high 
and normal plasma renin activities (Brunner, Laragh, Baer, Newton, 
Goodwin, Krakoff, Bard and Bühler, 1972). 
In experimental animals, plasma renin activity is elevated 
in hypertension by clamping one renal artery with the contralateral 
kidney intact. If the contralateral kidney is removed, only an 
acute rise in plasma renin activity is observed (Gross, 1971) and 
subsequently the levels return to normal. Hypertension can be 
induced by overdosage with sodium retaining corticoids and dietary 
salt, even though renin has effectively disappeared from the blood 
(Gross and Sulser, 1957., Gross, 1960., Rosenthal and Hollander, 1973). 
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In the S. H. R. plasma renin activity increases after the 
development of hypertension suggesting that no direct relationship 
exists between the two parameters (De Jong, Lovenberg and Sjoerdsma, 
1972). Conversely, Sen, Smeby and Bumpus (1972) found elevated 
plasma renin activities in the pre-hypertensive and early hypertensive 
stages and normal or subnormal activities during the established 
hypertensive phase in S. H. R. Koletsky, Shook and Rivera- 
Velez (1970) reported an abnormally low juxtaglomerular cell 
granulation, indicative of a suppressed renin synthesis, in kidneys 
from S. H. R. of 6 weeks to 12 months age. These contradictory 
findings may be due to the lack of a valid control animal. 
Plasma renin and presumably angiotensin II levels are 
increased in some forms of hypertension, but the rise is often 
moderate, and the direct vasoconstrictor action alone probably 
insufficient to account for the elevated blood pressure (Peart, 
Robertson and Grahame-Smith, 1961). However, angiotensin II also 
has indirect pressor actions mediated by the sympathetic nervous 
system and adrenal glands. Angiotensin II stimulates the release 
of catecholamines from the adrenal medulla (Braun-Menendez, Fasciolo, 
Leloir and Munoz, 1939) and sensitizes the neurovascular effectors 
so that the effects of sympathetic vasomotor discharge are augumented 
(McCubbin and Page, 1963). Angiotensin II will also facilitate 
ganglionic transmission (Lewis and Reit, 1966). 
The cross-perfusion experiments of Bickerton and Buckley 
(1961) first demonstrated that'angiotensin II has cardiovascular 
effects which are mediated via the central nervous system. These 
effects are primarily due to an increased sympathetic discharge 
(Severs, Daniels, Smookler, Kinnard and Buckley, 1966., Ueda, Uchida, 
Ueda, Gondaria and Katayama, 1969). The central hypertensive effects 
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of a vertebral artery infusion of angiotensin II persist over 7 day 
infusion periods (Fukiyama, McCubbin and Page, 1971), indicating 
that this facet of the many actions of angiotensin could cause a 
stable hypertension. 
Circulating angiotensin II appears to act on the brain in 
the area postrema, where there is no effective blood-brain barrier 
(Ueda, 1968). Endogenous non-circulatory, renin and angiotensin 
have also been demonstrated in brain tissue, and their distribution 
correlates with noradrenaline concentrations in different areas of 
the brain (Fischer-Ferraro, Nahetod, Goldstein and Finkielman, 19? 1). 
The conceptual division between neural and humoral influences on 
peripheral resistance vessels would therefore appear to be an over- 
simplification. 
Recently, a new enzyme termed "tonin" has been found in 
rat submaxillary glands and many other tissues. This enzyme not 
only converts angiotensin I to angiotensin II but also cleaves 
angiotensin II directly from renin substrate (Boucher, Asselin and 
Genest, 1974). If this enzyme is of physiological significance, 
then previous studies using renin measurements as an index of 
angiotensin II levels may prove to be of limited value. 
The role of angiotensin II in the pathogenesis of 
hypertension has been clarified by the recent development of specific 
angiotensin blocking agents (Marshall, Vine and Needleman, 1970). 
This direct approach to the angiotensin receptor, obviates many of 
the problems involved in the interpretation of results based on renin 
measurements. Results using these agents indicate that levels of 
angiotensin are elevated during acute renal artery constriction, and 
that angiotensin is involved in the pathogenesis of both acute one 
kidney and acute two kidney renal hypertension in rats (Davis, 
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Freeman, Johnson and Spielman, 1974). Increased levels of 
angiotensin iI appear to contribute to the. maintenance of the 
high blood pressure in chronic two kidney, but not chronic one 
kidney hypertensive rats (Davis, Freeman, Johnson and Spielman, 
1974). Angiotensin antagonists have no effect on the blood pressure 
of normal, D. O. C. hypertensive or spontaneously hypertensive rats 
(Pals, Masucci, Denning, Sipos and Fessler, 1971). 
In human hypertensives, the angiotensin antagonist, I-Sar-8- 
Ala angiotensin II, lowers the blood pressure in high renin essential, 
renal and malignant hypertension (Brunner, Gavr gis, Laragh and 
Keenan, 1973). Further studies using these specific antagonists 
should provide answers to many questions about the renin-angiotensin 
system, particularly with reference to hypertension. 
2. RENTAL ANTIHYPERTENSIVE AGENTS 
An alternative hypothesis to that of excessive blood levels 
of pressor agents, is a deficiency of a humoral depressor agent in 
hypertension. These antihypertensive factors are linked with the 
non-excretory function of the kidney, for the following reasons. 
Renoprival hypertension, caused by total nephrectomy, can be 
promptly relieved by a renal transplant (Muirhead, Stirman, Lesch 
and Jones, 1956). In renoprival hypertension, the blood pressure 
is significantly reduced when intact renal tissue without excretory 
function is present (Muirhead, Stirman and Jones, 1960). Implantation 
of kidney tissue into the peritoneal cavity attenuates renal 
hypertension (Lauwers & Gomez, 1964), and renal homo transplantation in 
hypertensive patients usually reduces the blood pressure to normal 
(Kolff, Nakamoto, Poutasse, Straffon and Figueroa, 1964). 
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Attempts have been made to extract the antihypertensive 
factor from the kidney, and to identify it. Extracts of whole 
kidney contain some material that lowers the blood pressure in 
hypertensive animals (Grollman, Williams and Harrison, 1940). A 
neutral lipid from the renal medulla, with antihypertensive but no 
vasodepressor properties, was isolated by Muirhead, Daniels, Booth, 
Freyburger and Hinman (1965). The acidic fraction from the renal 
medulla contains potent vasodepressors including P. G. E. 2 
(Daniels, 
Hinman, Leach and Muirhead, 1967). McGiff, Crowshaw and Itskovitz 
(1974) have suggested that pressor hormones constrict the blood 
vessels and release P. Gwithin the vascular bed, and in the 
kidney, which reducesor terminatesthe vasoconstrictor response. 
Finally, a phospholipid has been extracted from whole kidneys 
which inhibits the reaction between renin and its substrate (Sen, 
Smeby and Bumpus, 1968). These antihypertensive factors are of 
great interest, but there is, as yet, no substantial evidence to 
link them pathogenically with hypertension. 
3. ADRENAL HORMONES 
Adrenal cortical hormones may be involved in high blood 
pressure, since patients with Addison's disease are hypotensive 
while those with Cushing's syndrome are hypertensive (Cushing, 1932). 
A specific relationship between steroids and the production of 
hypertension was not established until Loeb, Atchley, Ferrebee and 
Ragan (1939) demonstrated the hypertensive effects of 11-deoxy- 
corticosterone when administered to patients with Addison's disease. 
Conn (1955) made a major contribution to the study of 
steroid induced hypertension by describing a new hypertensive 
syndrome, caused by overproduction of aldosterone by an adenoma. 
Hypertension can also be caused by congenital adrenal hyperplasia 
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due to a deficiency of 11-hydroxylase or 17-hydroxylase, enzymes 
which are involved in the synthesis of cortisol (Kaplan, 1974). 
In renal hypertensive patients, aldosterone levels are 
usually normal (Laragh, Sealey and Sommers, 1966), while excretion 
levels of aldosterone are elevated in malignant hypertension (Genest, 
Lemieux, Davignon, Koiw, Nowaczynski and Steyermark, 1956). 
Currently, the work of Melby, Dale and Wilson (1971) has 
aroused interest in the possible participation of another 
mineralocorticoid, which might be secreted in patients with low renin 
essential hypertension. This mineralocorticoid, 18-OH 
deoxycorticosterone, has been found in elevated concentrations in 
about one third of low renin essential hypertensives (Brown, Ferriss, 
Fraser, Lever, Love, Robertson and Wilson, 1972). 
The experimental model of steroid induced hypertension is 
the D. O. C. -salt hypertensive rat (Grollman, Harrison and Williams, 
1940). Aldosterone secretion is stimulated in experimental renal 
hypertension where one renal artery is clamped and the other kidney 
left intact. However, if the contralateral kidney is removed, 
aldosterone levels are normal (Singer, Losito and Salmon, 1963). 
The adrenals are not necessary for the production of hypertension 
by experimental aortic co-arctation (Carretero, Erzmann, Polomski, 
Piwonska, Oza and Schork, 1973). However, the adrenal cortex is 
essential for the development of hypertension in the Japanese S. H. R. 
(Aoki, Takikawa and Hotta, 1973). 
The mineralocorticoids do not raise the blood pressure by 
a direct constrictor action on the blood vessels. Water and sodium 
retention, stimulated by these steroids, probably increase blood 
volume which, in turn, would increase cardiac output (Borst and Borst 
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de Geus, 1963). Sodium retention and potassium excretion produce 
hypernatremia and hypokalemia, and these might also raise cardiac 
output by increasing myocardial strength (Haddy, 1974). The 
increased cardiac output would raise the arterial pressure, and the 
effect would be subsequently augmented by an increase in peripheral 
resistance. Sodium retaining steroids may have more direct effects 
on peripheral resistance, since alkalosis increases the resistance to 
flow through vascular beds (Haddy and Scott, 1965), and hypernatremia 
increases the sodium and perhaps water content of the aorta (Redleaf 
and Tobian, 1958a). An increased water content of the blood vessels 
would limit their distensibility and might also reduce their luminal 
diameter (Tobian, 1960). There is also evidence that U. O. C. 
potentiates the pressor effects of noradrenaline, (Raab, Humphreys 
and Lepeschkin, 1950) which could promote hypertension in the presence 
of a normal sympathetic discharge rate. 
A chromaffin cell tumor, phaeochromocytoma, usually 
located in the adrenal medulla can cause hypertension by releasing 
excessive quantities of catecholamines into the blood stream (Beer, 
King and Prinzmetal, 1937). Phaeochronocytoma is perhaps the only 
example of hypertension in which we are fairly sure of the causative 
factor. The excessive plasma catecholanines cause vasoconstriction 
and, hence, an increase in peripheral resistance. 
4. THE RENIN-ANGIOTENSIN-ALDOSTERONE-SODIUM SYSTEM 
The humoral factors which may increase peripheral resistance 
in hypertension have been considered separately. A recurrent 
dilemma in work on the pathogenesis of hypertension is the difficulty 
of identifying single causative agents. This is particularly 
evident in the high, normal and sometimes low values found for such 
factors as renin and aldosterone. One possible explanation is that 
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they are not causative agents. Another, is that because of their 
interrelation and influence on sodium balance, a primary disturbance 
of one is followed by compensatory adjustment in the other. 
It is very probable that sodium, renin and aldosterone are 
related in some way, although the exact nature of their interrelation 
is not established (Fraser, Brown, Chinn, Lever and Robertson, 1969). 
Brown, Fraser, Lever and Robertson (1971) have suggested that, sodium 
loss in some way stimulates the release of renin, and consequently 
elevates levels of angiotensin II (Fig. 1: 1). Angiotensin II may 
raise the blood pressure by direct action on the blood vessels and/or 
stimulate aldosterone secretion. Elevation of the blood pressure 
would promote sodium loss by. pressure diuresis, while aldosterone 
would stimulate sodium retention. Sodium retention, as previously 
discussed, would expand the plasma volume and increase the blood- 
pressure. However, if renin was released in excess to the sodium 
balance, or the elevated blood pressure failed to promote sodium loss, 
then hypertension would result. 
The action of angiotensin II, either in raising the blood 
pressure by increased peripheral resistance or by stimulating the 
secretion of aldosterone, may be regulated by sodium. In states of 
sodium depletion, the pressor effects of angiotensin II are diminished 
while the aldosterone effect is enhanced, but in sodium excess, the 
pressor response is enhanced and the aldosterone effect diminished 
(Fraser, Brown, Chinn, Lever and Robertson, 1969., Brown, Fraser, 
Lever, Robertson, James, McCusker and Wynn, 1968., Blair-West, Coghlan, 
Denton, Goding, Wintour and Wright, 1965). Therefore, a constant 
level of angiotensin II in the plasma could produce a progressively 
increasing stimulus to aldosterone secretion if there was progressive 
sodium depletion. Conversely, a normal or subnormal concentration of 
- 19 - 
BLOOD SODIUM 
PRESSURE 
N 
STATUS 
oolý 
4 
RENIN 
®` 
ANGIOTENSIN I 
ANGIOTENSIN 11 
HIGH SODIUM 
RESISTANCE 
LOW SODIUM 
ALDOSTERONE 
VESSELS 
Fig. 1: 1 
0 
A proposed scheme for the interrelationship of blood 
pressure the renin-angiotens_n -aldosterone system and sodium 
balance. 
Continuous arrows indicate stimulation, discontinuous 
arrows indicate inhibition. Both renin mediated pathways are 
hypertensive. See text for further explanation. 
- 20 - 
angiotensin could raise the blood pressure in a state of sodium 
retention. 
C. BLOOD VESSEL STRUCTURE AND FUNCTION - 
1. AUTOREGULATION 
Ledingham and Cohen (1964) have promoted the concept that 
the increased peripheral resistance of hypertension is due to 
autoregulation. This myogenic response to stretch by the resistance 
vessels could be stimulated by an early increase in cardiac output. 
Autoregulation is a protective mechanism against excessive tissue 
blood flow at high perfusion pressures. Evidence for this theory 
comes from patients with co-arctation of the aorta. The mean 
arterial pressure in the lower half of the body is normal, whereas, 
rostral to the co-arctation, it is raised. However, tissue blood 
flow in the upper and lower limbs remain normal, despite the marked 
disparity in perfusion pressure (Patterson, Shepherd and Whelan, 
1957). Functional autoregulation is also suggested to be caused by 
structural changes in the vessel wall (Folkow, Hallback, Lundgren 
and Weiss, 1910 c)or by a reduction in the number of small arterioles 
supplying an organ (Hutchins and Darnell, 1974). 
Olmsted and Page (1965), however, found that renal 
hypertension in dogs was associated with an early rise in peripheral 
resistance, associated with a fall in cardiac output. Their results 
were therefore not compatible with the autoregulation theory. 
2. VASCULAR REACTIVITY 
Attempts to demonstrate increased autonomic nervous activity 
or increased amounts of circulating pressor substances in all types 
of hypertension have not been generally successful. An alternative 
possibility is, that in hypertension the resistance vessels might 
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respond to stimuli of a normal magnitude by an excessive constriction, 
either as a primary defect, or as a secondary sustaining mechanism. 
In order to examine this possibility it is important to know whether 
the resistance vessels contract more powerfully in hypertensive 
subjects than in normal people, whether this phenomenon is specific 
to certain agonists or generalized, and whether it precedes or 
follows the hypertension. 
Two types of test have been used to examine this hypothesis 
in humans, i) systemic pressor responses to various stimuli, 
"cardiovascular reactivity", and ii) studies of constriction in 
regional vascular beds, "vascular reactivity". 
i) Cardiovascular reactivity in humans 
Cardiovascular reactivity is defined as the degree with 
which the heart and peripheral vascular system respond to quantitated 
stimuli. 
a) Reflex stimuli 
Early studies on cardiovascular reactivity involved the 
use of reflex stimuli with the measurement of the evoked pressor 
response. Hines and Brown (1933) found enhanced pressor responses 
to cold in hypertensive patients, but Pickering and Kissin (1936) 
did not confirm these results. Later investigations by Alam and 
Smirk (1938) and Russek and Zohman (1945) showed that although larger 
pressor responses to cold frequently occurred in hypertensive patients, 
some had responses in the normal range. 
F cercise, emotional or pain stimuli produced rises in blood 
pressure which were often greater in hypertensive patients (Barath, 
1928., Alam and Smirk, 1938., 'olff, 1951). 
r 
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It was generally assumed that the rise in blood pressure 
to reflex pressor stimuli was due to vasoconstriction. However, 
Boyer, Fraser and Doyle (1960) have shown that cold immersion of the 
foot causes a pressor response in normal subjects which is mainly 
due to a rise in cardiac output, whereas, in the hypertensive subject, 
the response is largely due to vasoconstriction. Evidence for 
cardiovascular hyperreactivity from experiments using reflex pressor 
stimuli is therefore probably not a reliable indication of the degree 
of vasoconstriction. 
b) Chemical stimuli 
Systemic pressor responses to adrenaline and noradrenaline 
were found to be normal in hypertensive patients (Pickering and Kissin, 
1936; and Gombos, Hulet, Bopp, Goldring, Baldwin and Chasis 1962). 
Conversely, Goldenberg, Hines, Baldwin, Greeneand Roh (1948), Judson, 
Epstein and Wilkins (1950) and Staquet, Demanet and Bastenie (1965) 
found that hypertensive subjects were more sensitive to injected 
noradrenaline than normotensive volunteers. 
The first comparison of the effects of angiotensin in 
hypertensive and normal subjects was made by Doyle and Black (1955)" 
They found that a slightly larger pressor response occurred in 
hypertensive patients, and that this was greatly augmented by ganglion 
blockade. 
Kaplan and Silah (1964) have studied pressor responses to 
angiotensin in a variety of hypertensive states. Patients with 
essential hypertension exhibited hyperreactivity to angiotensin 
whereas, those with renovascular and malignant hypertension were 
hypo-reactive. This specific lack of sensitivity was attributed to 
high endogenous levels of angiotensin. Roguska, Simon and Del Greco 
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(1968) have suggested that this lack of sensitivity to angiotensin 
may also be partly due to non-specific hyporeactivity of the 
vasculature. 
L'i! idence for the effects of chemical vasoconstrictor 
stimuli in inducing pressor responses is obviously conflicting. 
The differences in results are probably due to the different starting 
blood pressures and baroreceptor sensitivities of normotensive and 
hypertensive subjects. The use of intra-arterial infusions of 
vasoconstrictor agents has permitted examination of the responses of 
the blood vessels without the complications introduced by the general 
circulation. 
ii) Vascular reactivity in the peripheral circulation of 
hypertensive patients 
Vascular reactivity is defined as the degree with which 
the vasculature responds to quantitated stimuli. 
Duff (1957) demonstrated increased reactivity to intra-arterial 
adrenaline, using the hand blood flow of hypertensive and normotensive 
individuals. Adrenaline constricts blood vessels in the skin and 
dilates those in the muscles and is therefore not the ideal agonist 
for studies of vascular reactivity. 
Doyle, Fraser and Marshall (1959) studied the response of 
the forearm circulation and found increased reactivity to intra-arterial 
noradrenaline, 5-hydroxytryptamine and angiotensin in hypertensive 
subjects. When the results were corrected for the initial state of 
resistance in the forearm, responses to noradrenaline and 5-hydroxy- 
tryptamine were still significantly greater in the hypertensive group, 
but responses to angiotensin were no different from the normotensive 
control. 
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Increased vascular reactivity to noradrenaline in essential 
hypertensive patients has been demonstrated in the skin (E r5ny, 1963), 
striated muscle (Moulton, Spencer and Willoughby, 1958), the digit 
(Mendlowitz, Naftchi, Wolf and Gitlow, 1965) and in the conjunctiva 
(Lee and Holze, 1951). Scroop and Whelan (1968), in contrast, could 
find no difference in hand blood vessel reactivity to angiotensin or 
noradrenaline in essential hypertensives. 
Folkow, Grimby and Thulesius (1958) and Sivertoson(1970) 
have studied resistance to flow in the forearm and hand vascular beds 
of normotensive and essential hypertensive subjects. They found 
that resistance to flow at maximal vasodilation, due to heating and 
ischaemia of the beds, was greater in hypertensive than normoter ivc 
patients. These results were confirmed by Conway (1963). 
Dose-response curves of resistance responses to intra- 
arterial noradrenaline exhibited a steeper slope than control but 
with no change in the vasoconstrictor threshold dose. Folkow, 
Hallbäck, Lundgren, Sivertsson and Weiss (1973) have claimed that 
such changes in the noradrenaline dose-response curve, together with 
an increase in basal resistance to flow, are caused by an increase in 
vascular wall/lumen ratio, due to medial hypertrophy. Folkow and 
his group have suggested that essential hypertension is triggered 
by intermittent bouts of hypothalamic neurohumoral stimulation which 
increase cardiac output in genetically predisposed persons. The 
increased blood flow so produced is reduced by increased peripheral 
resistance due to structural changes in the resistance vessels. 
This theory does not explain why hypertension and medial 
hypertrophy do not occur in many patients with increased cardiac 
output due to a hyperdynamic circulation, marked nutritional anaemia, 
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hyperthyroidism, and Pagets' disease (Page, 1974). It is also 
partly contradicted by evidence from studies on intact in vivo 
arterioles in human hypertensives, which indicate. that the increased 
wall/lumen ratio is due to a persistent shortening of the smooth 
muscle and not to hypertrophy or hyperplasia of the media (Short, 
1966). 
Studies in patients with renal or renovascular hypertension 
have indicated that vascular reactivity to noradrenaline is at the 
upper limit of the normal range, as assessed in digital and hand 
blood vessels (Mendlowitz, Naftchi, Wolf and Gitlow, 1965., Scroop 
and Whelan, 1968). 
Perhaps the most interesting studies of regional vascular 
reactivity have been those in the healthy offspring of hypertensive 
parents. Doyle and Fraser (1961 a, b) found that an infusion of 
noradrenaline into the brachial artery induced greater vasoconstriction 
in the forearm of the normotensi: ve offspring of hypertensive patients 
than in a group of students whose parents were normotensive. Davis 
and Landau (1966) found that hypertensive patients were more sensitive 
to adrenaline applied to the conjunctiva than normotensive individuals, 
and that 70% of normotensive first degree relations of hypertensive 
patients also had enhanced sensitivity. 
It is therefore probable that in inherited hypertension, 
vascular hyperresponsiveness may precede the rise in blood pressure 
and may therefore be of importance in the pathogenesis of the disease. 
The use of isolated vascular preparations from human 
hypertensives would provide the most detailed evidence on vascular 
reactivity. Because of the lack of fresh blood vessels from patients 
who are not receiving antihypertensive therapy, vessels from 
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experimental animals have been widely used. 
There are, however, two recent studies on isolated vessels 
from human hypertensives. Horwitz, Clineschmidt, Van Buren and 
Ommaya (1974) have studied the responses of temporal artery strips 
from hypertensive patients whose antihypertensive medication had 
been withdrawn for 2 weeks. Responses to noradrenaline or 
phenylephrine were identical in vessels from hypertensive and 
normotensive subjects, over the full dose range used. The 
a-adrenoceptors in the "hypertensive" and "normotensive" arteries 
were also identical, as judged by the pA2 and Kb values for 
phentolamine. Ettinger, Seibel and Riecker (1970) perfused small 
arteries from patients with essential hypertension. In contrast to 
the work using arterial strips, they found larger than normal responses 
to noracdrenaline in vessels from hypertensive subjects. 
iii) Cardiovascular reactivity in animals with exper. imental 
hypertension 
a) Renal hypertension 
The first demonstration of increased cardiovascular 
reactivity in experimental hypertension was the report by Ogden, 
Brown and Page (1944) of increased sensitivity in the renal 
hypertensive rabbit to the pressor effects of vasopressin. Phelan, 
Eryetishir and Smirk (1962) and Phelan (1966) showed that the renal 
hypertensive rat (R. H. R. ) exhibited exaggerated cardiovascular 
responses to adrenaline and vasopressin, but, like Conway (1955), 
could only demonstrate hyperreactivity to noradrenaline in the ganglion 
blocked animal. In contrast, Page and Taylor (1949) and Page, Kaneko 
and McCubbin (1966) found little or no change in cardiovascular 
reactivity to a variety of pressor agents in chronic renal hypertensive 
dogs, with the exception that tyramine induced responses were increased. 
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In acute renal hypertensive dogs, they found increased cardiovascular 
reactivity to adrenaline, noradrenaline and 5-hydroxytryptarnine, but 
responses to angioterisin were subnormal. 
Recent studies have not clarified the situation. Shibayama, 
Mizogami and Sokabe (1971) using pithed, decerebrate, vagotomized 
R. H. R. found no changes in reactivity to noradrenaline, whereas 
Finch (1971), reported increased blood pressure responses to 
noradrenaline and tyramine in the pithed R. H. R. 
b) D. O. C. hypertension 
Evidence for cardiovascular hyperreactivity in the D. O. C. 
hypertensive animal is also contradictory. Masson, Page and 
Corcoran (1950) using dogs and rats, and Shibayama, Mizogami and 
Sokabe (1971) using rats, found no changes in cardiovascular responses 
to adrenaline, noradrenaline and angiotensin. However, increased 
cardiovascular reactivity to noradrenaline in D. O. C. hypertensive 
rats has been demonstrated by Sturtevant (1956) and Finch (1971). 
c) The spontaneously hypertensive rat 
In the New Zealand strain of S. H. R., Smirk and Hall (1958) 
and Phelan (1968) have demonstrated increased pressor responses to 
adrenaline and vasopressin. Like the R. H. R., hyperreactivity to 
noradrenaline could be unmasked by ganglion blockade. 
In the Japanese strain of S. H. R., the study by Shibayama, 
Mizogami and Sokabe (1971) indicated no changes in noradrenaline 
pressor responses but increased reactivity to angiotensin. Dupont 
and Sassard (1974), in contrast, demonstrated exaggerated responses 
to noradrenaline and normal responses to angiotensin, in ganglion 
blocked S. H. R. 
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d) Adrenal regeneration and salt induced hypertension 
Rats with adrenal-regeneration hypertension (Gardner and 
Honore, 1964 a, b ) show enhanced pressor responses to vasopressin 
but not to angiotensin, noradrenaline and adrenaline. Conversely, 
rats with hypertension induced by chronic salt ingestion exhibit increased 
reactivity to angiotensin, noradrenaline, adrenaline and 
vasopressin (Honore and Gardner, 1966 a, b ). Dahl, Heine and 
Tassinari(1964) found increased cardiovascular reactivity to 
noradrenaline and angiotensin in a strain of rats that were prone 
to the development of hypertension on salt ingestion. This increased 
reactivity occurred even when the rats . were maintained 
in a 
norinotensive state by a low salt diet, indicating that the increased 
reactivity preceded the development of hypertension. 
Studies involving the measurement of the response to 
various drugs as a change in the blood pressure of the whole animal, 
have their limitations. Reflex and direct effects of sympathomimetic 
substances on cardiac output and hormonal influences on the blood 
vessels will affect the reactivity. Interpretation of such results 
is complicated because the cardiovascular reactivity is dependant on 
the stage and type of hypertension, on the pressor drug used, on the 
level of anaesthesia, if used, and on the starting blood pressure. 
In order to determine vascular reactivity without the complications 
of the intact cardiovascular system, investigations on isolated blood 
vessels have been made. 
iv) Vascular reactivity in isolated arerarations from experimental 
hypertensive animals 
The use of isolated vascular preparations to examine the 
phenomenon of increased vascular reactivity in hypertension, obviates 
many of the problems of the in vivo approach. 
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Two methods have been used; arterial strips or rings and 
perfused vascular beds. Both have advantages and disadvantages; 
the arterial strip or ring can provide a direct tension record 
uncomplicated by anatomical changes in the vascular structure. The 
technique is, however, limited to fairly large arteries in the rat. 
Perfusion techniques are usually necessary to examine the behaviour 
of the arterioles, which are the major site of peripheral resistance 
(Freis, 1960), but changes in the structure of these vessels can 
complicate interpretation of the results. 
The stimulating agent usually employed is exogenous 
noradrenaline. Sympathetic nerve stimulation to release endogenous 
noradrenaline, would be a more physiological stimulus. Few 
investigations have attempted this approach since excision of the 
required vascular tissue often damaged the nerve supply, making 
comparisons between the "hypertensive" and "normotensive" preparation 
diffi. cult. 
v) The determinants of vascular reactivity 
The term, "vascular reactivity" in its widest sense, means 
"the ability of the vessel to respond". To understand and sub-divide 
this rather nebulous term, a consideration of the events which link 
the application of a vasoactive stimulant to the haemodynamic response 
is required (see Fig. 1: 2). 
a) The drug-receptor interaction 
It is widely accepted that the interaction between a drug 
and a specific receptor follows the law of mass action (Clark, 1933)" 
The receptor occupancy (Ariens, 1964) or the rate of receptor occupancy 
(Paton, 1961) determines the degree of the stimulus to respond. A 
modification of the receptors could cause a change in the reactivity, 
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which will be defined as "true specific supersensitivity". This 
phenomenon would be experimentally characterized by a shift of the 
dose-response curve to the left, for agonists stimulating a 
single receptor type. The maximum response of the vascular tissue 
would be normal but the threshold dose for stimulation would be 
lowered. Such a true specific supersensitivity could, however, 
also be caused by changes in the neuronal uptake or enzymatic 
decomposition of the agonist in the tissue. 
b) The supply of ATP And calcium to the contractile proteins 
The possibility that the supply of ATP to the contractile 
filaments may cause changes in reactivity is unlikely. Evidence 
suggests that the intracellular calcium concentration is the rate- 
limiting step for contraction (Waugh, 1962., Bohr, 1964., Hinke, 
Wilson and Burnham, 1964). The intracellular [Ca++] may be increased 
to a level that will activate the contractile proteins, either by 
increasing the rates of accumulation, or by decreasing the rates of 
elimination or sequestration of Ca 
++ 
. 
Activator Ca++ may come from either intracellular or 
extracellular sources (Hinke, 1965). In the resting smooth muscle 
the concentration of activator Ca 
++ is less than 10-7 M, although the 
concentration of Ca++ in the extracellular pool is greater than 10-3M 
(Bohr, 1973). The plasma membrane of the cell must therefore 
maintain a 10,000 fold concentration difference if the vascular 
smooth muscle is to remain relaxed. Three sites have been implicated 
as the intracellular bound Ca 
++ 
pool, the sarcoplasmic reticulum 
(Devine, Somlyo and Somlyo, 1972), the mitochondria and the plasma 
membrane with its surface vesicles (Fitzpatrick, Landon, Debbas and 
Hurwitz, 1972., Baudouin, Meyer, Fermandjain, and Morgat, 1972). 
An increase in the permeability of the plasma membrane, or 
a reduction in the calcium binding ability of the intracellular Ca 
++ 
pool could cause an increase in reactivity. Such a change would be 
characterized by a shift to the left of the dose=response curve to 
all agonists utilizing the affected calcium pool. Such a change, 
without an increase in maximal tension development will be termed 
"true non-specific supersensitivity". 
c)' The contractile proteins 
An increase in actomyosin synthesis could lead to 
hypertrophy of the vascular smooth muscle. This would be evidenced 
by an increase in the absolute contractile force exerted by the 
vessel, without any change in the degree of muscle shortening. 
Such a change in "contractility" would be characterized by a greater 
maximum tension development, to all agonists, without any shift in 
the dose % maximum response curve. 
d) The passive elastic elements 
To exert tension, or shorten, the contractile filaments of 
the smooth muscle cell must "take up the slack" in its passive 
elastic elements. The amount of "slack" will be determined by the 
resting length and tension of the muscle under investigation. Changes 
in the passive elastic elements can affect the dose-response curve to 
any agonist. An increase in the elastic component of a vascular 
tissue would tend to shift the dose-response curve to the right. 
e) Mechanical factors in intact blood vessels 
In the intact vessel, there are additional mechanical 
factors which complicate the analysis of the contractile response. 
One factor which can have a marked influence on vascular reactivity 
is-the wall/lumen ratio. For a given degree of shortening of the 
smooth muscle in the outer media, the lumen will be reduced more in a 
- X5 
thick walled vessel than in a thin walled vessel. Consequently, 
if hypertensive disease is associated with an increase in wall/lumen 
ratio due to hypertrophy (Folkow, Hallbäck, Lundgren and Weiss, 
1970c) or swelling (Tobian, 1960) of the vascular wall, this 
structural change will lead to augmented responses in the intact 
vessel. A structurally based "apparent hyperreactivity" would be 
characterized by a steeper dose-response curve with no change in 
the vasoconstrictor threshold dose. If the increase in wall/lumen 
ratio was due to medial hypertrophy, an elevation of the maximum 
response would occur. A greater resistance to flow at maximum 
vasodilation would indicate that the increase in wall thickness had 
narrowed the luminal diameter (Folkow, Hallbäck, Lundgren & Weis 1970c) 
It would be ideal if all studies on vascular reactivity 
used the same criteria and definitions of the phenomenon. This is 
not the case, for a variety of reasons. Early investigators did not 
realize the importance of analysing full dose-response data and 
concepts of the factors determining the vascular response were, in 
retrospect, primitive. Studies on responses from arterial strips 
cannot directly determine whether apparent hyperreactivity is present. 
Studies in perfused intact vessels cannot distinguish between 
contractility or viscoelastic changes when a change in the wall/lumen 
ratio has occurred. Also, there often appears to be a complex of 
these various influences which summate to cause increased vascular 
reactivity. The participation of individual influences is therefore 
extremely difficult to ascertain. 
If the factors which can increase vascular reactivity are 
divided into two groups comprising a) specific and non specific 
supersensitivity, and b) contractility, viscoelastic influences and 
structural changes, the significance of early work on vascular 
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reactivity is clearer. A change in the sensitivity of the vascular 
smooth muscle preceding the development of hypertension could be the 
primary event in increasing peripheral resistance and blood pressure. 
A change in the structure of the vessel wall would probably be a 
defensive reaction against the effects of high blood pressure and 
therefore secondary to hypertension. 
(vi) Vascular reactivity in arterial strips and rings from renal 
hypertensive rats 
a) Aortic preparations 
Redleaf and Tobian (1958a)used helically cut aortic strips 
from R. H. R. and found that they responded tc noradrenaline with 
weaker contractions than normal. Mallov (1959,1961) improved the 
methodology by cutting matched saw-tooth strips of aortae from renal 
hypertensive and normotensive rats. He found that the aortae from 
R. H. R. exerted less tension than normal to noradrenaline stimulation, 
even though the strips from hypertensive animals contained more 
alkali-soluble nitrogen, thought to be of muscular origin. 
Gordon and Nogueira (1962), related the noradrenaline induced 
contractile tension of aortic strips from renal hypertensive and normo- 
tensive rats to the width and length of the strips. Strips from R. H. R. 
produced more tension than those from control animals. This contradic- 
tion of the previous studies was explained on the grounds that "hyper- 
tensive" aortae had a greater optimum resting tension than the "normo- 
tensive" strip. The low resting tensions used by the previous 
investigations could therefore have masked the increased reactivity. 
Gordon (1962) suggested that increased aortic reactivity preceded the 
development- of hypertension. Gordon did not prove that aortic 
reactivity was increased in pre-hypertensive animals, but defined 
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(1973) also suggested that an increase in available calcium was the 
mechanism of increased reactivity. Nephrotensin, a pressor agent 
which is present in the blood of acute but not chronic R. H. R. 
(Grollman, 1970., Grollman and Krishnamurty, 1971) was proposed 
as the cause of this change in calcium regulation. 
b) Preparations from carotid and femoral arteries 
Moerman, Herman, Bogaert and De Schaepdryver (1969) used 
carotid artery strips from renal hypertensive dogs to investigate 
vascular reactivity. Strips from renal hypertensive dogs were more 
sensitive than normal to noradrenaline, as assessed by the ED50% 
dose.. 
Studies using femoral artery strips (Bandick and Sparks, 
1970., Holloway and Bohr, 1973) from acute renal hypertensive rats 
have also demonstrated increased reactivity to noradrenaline, 
adrenaline and potassium chloride. Both groups of investigators 
found a greater degree of spontaneous activity in arteries from 
hypertensive than from normotensive rats. Bandick and Sparks (1970) 
found that the "hypertensive" strips were less extensible than normal, 
whereas, Holloway and Bohr (1973) could demonstrate no difference in 
passive'stiffness. Both groups suggested that the increased reactivity 
and spontaneous activity in femoral arteries from acute R. H. R. was 
due to an increase in membrane permeability, probably involving calcium. 
Co Preparations from arterioles 
Bohr (1961) reported studies on strips of small resistance 
vessels from R. H. R. These arteriolar strips were more sensitive than 
normal to adrenaline, noradrenaline and angiotension. This technique 
of direct. tension recording from strips of arterioles is ideal for 
studies of vascular reactivity, since the resistance vessels 
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contribute the major proportion of peripheral resistance. Technical 
difficulties have apparently inhibited further investigations 
using arteriolar strips. 
vii) Reactivity in arterial strips from D. O. C. hypertensive rats 
a) Aortic preparations 
Studies by Redleaf and Tobian (1958a) Mallov (1959,1961) 
and Massingham and Shevde (1971) have demonstrated reduced reactivity 
to noradrenaline in aortic strips from D. O. C. hypertensive rats. 
Tension development to KC1 and the resting potential of the vascular 
smooth muscle were found to be normal (Massingham and Shevde, 1971). 
b) Preparations from femoral and carotid arteries 
Extensive investigations of femoral artery reactivity in 
D. O. C. hypertension have been made by Bohr's group (Bohr and Sitrin, 
1970, Holloway, Sitrin and Bohr, 1972., Holloway and Bohr, 1973)" 
They have shown that the femoral artery strips from D. O. C. hypertensive 
rats respond to lower concentrations of adrenaline and KC1 than do 
normal preparations. Preparations from hypertensive rats exhibited 
a greater tendency to develop spontaneous activity and this was 
exaggerated by high sodium bathing solutions. This, together with 
evidence that a higher than normal concentration of calcium was 
required, to stabilize the "hypertensive" artery, led to the 
suggestion that a change in membrane permeability had occurred. 
Hansen, Abrams and Bohr (1974) investigated the paradox 
that strips from D. O. C. hypertensive rats were more sensitive than 
normal to agonists, as assessed by threshold and ED5 dose, but 
produced less tension at high doses of agonist. Partial occlusion 
of one iliac artery was used to protect one femoral artery from the 
high blood pressure. The ability to develop tension, however, was 
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equally reduced in strips of femoral arteries from occluded and non- 
occluded limbs. Iliac occlusion per se seemed to have weakened the 
vascular smooth muscle. Responses at different initial tension 
showed that "hypertensive" strips developed less tension than normal 
at any level of passive tension. Contradicting the suggestion of 
Gordon and Nogueira (1962), that arteries from hypertensive rats 
might adapt to the higher pressure so that a greater passive tension 
would be required for their complete activation. The decrease in 
the ability to develop tension was suggested by Hansen, Abrams and 
Bohr (1974) to be a functional result of ultrastructural disruption 
of the muscle filaments (Gardner and Matthews, 1969). 
Since previous studies had indicated that ion permeability of 
the vascular smooth muscle membrane might be altered in hypertension, 
Bohr (1974) examined the effects of various ions on carotid artery 
strips from D. O. C. hypertensive rats. Reactivity to barium was less 
than normal, while responses to strontium exceeded the controls. 
These differences were attributed to an altered ability to bind 
calcium in the artery cell wall. 
viii) Reactivity in arterial strips from spontaneously 
hypertensive rats 
a) Aortic preparations 
Studies on aortic strips and rings from the Japanese and 
New Zealand strains of S. H. R. have demonstrated a reduced ability 
to develop tension when stimulated with noradrenaline (Spector, 
Fleisch, Maling and Brodie, 1969., Levy, 1973, Massingham and 
Shevde, 1971). The reduction in contractility may precede the 
development of hypertension(Shibata, Kurahashi and Kuchii, 1973). 
Field, Janis and Triggle (1972) and Janis and Triggle 
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(1972) demonstrated increased tension development to low doses of 
noradrenaline; however, responses to high doses of the atonist were 
less than normal. In contrast, Hallbäck, Lundgren and Weiss (1971) 
reported that tension developmer.. t in the aorta of the S. H. R. was 
normal over the full noradrenaline dose-response curve. Clineschmid. t, 
Geller, Govier and Sjoerdsma (1970) have shown that the choice of 
control animals greatly influences the interpretation of results from 
aortae of S. H. R. Aortic 
reactivity to noradrenaline in the S. H. R. was 
identical with results from aortae of one strain of control rats, but 
less than the reactivity in another strain. 
An impairment of the a-adrenoceptor3 cannot account for the 
generally low contractility reported for noradrenaline responses. The 
affinity and the number of a-adrenoceptors in the aortae from S. H. R. 
have been reported as normal 
(Clineschmidt, Geller, Govier and 
Sjoerdsma, 1970., Janis and Triggle, 1972). 
Responses to KC1, like those to noradrenaline, are reduced 
in the aorta of the S. H. R. 
(Spector, Fleisch, Maling and Brodie, 1969., 
Massingham and Shevde, 1971., Grollman and Krishnamurty, 1973., Levy, 
1973., Shibata, Kurahashi and Kuchii, 1973)" Field, Janis and Triggle 
(1972) however, suggested that a greater tension is developed at low 
dose levels. Responses to 5-hydroxytryptamine (Spector, Fleisch, 
Alaling and Brodie, 1969) angiotensin, ouabain (Shibata, Kurahashi 
and Kuchii, 1973) and prostaglandin E2 (Levy, 1973) are also reduced in. 
the aortae from the S. H. R. 
Spector, Fleisch, Maling and Brodie (1969) have reported 
that aortae from S. H. R. relax more than normal when stimulated with 
isoprenaline. Relaxation induced by papaverine and nitroglycerin 
were, however, found to be of normal magnitude (Shibata, Kurahashi 
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and Kuchii, 1973). 
The rate of decay of aortic responses, on washing nor- 
adrenaline or KC1 from the tissues, was found to be slower than 
normal in preparations from S.. H. R. (Field, Janis and Triggle, 1972., 
Grollman and Krishnamurty, 1973). However, the rate of decay of 
responses in calcium-free conditions was found to be normal by Field, 
Janis and Triggle, 1972) but faster than normal by Shibata, Kurahashi 
and Kuchii (1973)" 
Shibata, Kurahashi and Kuchii (1973) demonstrated differences 
between the profile of the noradrenaline induced response of the 
aortae from the S. H. R. and the normotensive rat. The normal response 
to noradrenaline comprised a fast and a slow phase, but, in 
aortae from the S. H. R., the slow phase was reduced or absent. The 
S. H. R. aorta was found to contract when exposed to rin++, CO 
++ 
and 
La+++ ions which were without contractile effects in control 
tissues. 
The majority of investigators suggest that there is a change 
in the musculature of the S. H. R. aorta, which impairs contraction 
(Spector, Fleisch, Maling and Brodie, 1969., Levy, 1973). This defect 
may be due to a change in the calcium permeability of the cell membrane 
(Shibata, Kurahashi and Kuchii, 1973., Tenner, 1973). 
b) Preparations from femoral and carotid arteries 
Holloway and Bohr (1973), using femoral artery strips, have 
confirmed that La 
+++ 
contracts vascular smooth muscle from 
the S. H. R. 
This result was also reported by Bohr (1974) using the 
carotid artery. Holloway and Bohr (1973) found that femoral arteries 
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from S. H. R. had a greater tendency to develop spontaneous activity than 
control tissues, but exhibited no change in threshold or tension 
development to KC1 or adrenaline. 
ix) Vascular reactivity in intact perfused blood vessels 
from renal hypertensive rats 
a) Perfused hind-quarters or hind-limb preparations 
McQueen (1956) demonstrated that responses to noradrenaline 
of the perfused hind-quarters preparation were increased 2 or 3 days 
after the induction of renal or renoprival hypertension in rats. The 
reactivity to 5-hydroxytryptamine and pitressin was also increased 
(McQueen, 1957). The increased reactivity of renoprival hypertension was 
dependent on the adrenal glands or an adequate salt intake, while the 
ischaemic kidney was implicated in the increased reactivity of renal 
hypertension (McQueen, 1956). 
McQueen (1961) suggested that an increase in vascular wall 
thickness had occurred, since the noradrenaline"response of the 
isolated preparation, at a constant flow rate, was related to the 
initial perfusion pressure. Water-logging of the vascular wall was 
suggested to be the mechanism involved (Tobian and Binion, 1954) since 
medial hypertrophy was unlikely to cause such a rapid increase in 
reactivity. 
Reserpine treatment lowered the blood pressure of the R. H. R. 
to normal, but did not completely reverse the changes in reactivity 
of the perfused hind-quarters preparation (McQueen, 1961). The 
increased reactivity was therefore probably not solely a consequence 
of the increased blood pressure. 
Laverty (1961), using the perfused hind-limb preparation, 
also demonstrated increased reactivity to noradrenaline in the R. H. R. 
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Oono (1966) and Baum and Shropshire (1967a)confirmed this result but 
only in tissues from the chronic R. H. R. Reactivity in preparations from 
the acute R. H. R. was not significantly different from normal. Baum 
and Shropshire (1967a)demonstratad that responses to lumbo-sympathetic 
nerve stimulation were only increased in the early stages of hyper- 
tension. In contrast, Tripod and Bein (1960) found a reduction in 
reactivity to noradrenaline in perfused hind-limb preparations from 
chronic renal hypertensive rats, but responses to adrenaline, histamine 
and angiotensin were elevated. 
Nolla-Panades (1963) examined the effect of high blood 
pressure on reactivity, by co-arctation of the rat aorta anterior to 
the origins of the renal arteries. Blood pressure rostral to the 
co-arctation was elevated, but, caudal to the co-arctation the pressure 
was normal. Reactivity to noradrenaline in the perfused hind-quarters 
was increased, even though this area was normotensive. The basal 
perfusion pressure of the isolated preparation and noradrenaline 
response amplitude were correlated. The study showed that although 
a change in the vessel wall probably had occurred, 'it could not be 
a consequence of the high blood pressure. 
Demura, Fukuchi, Takahashi and Goto (1965) related increased 
reactivity in the perfused hind-quarters preparation from renal 
hypertensive rats, to the ionic composition of the aorta. Reactivity 
to noradrenaline and angiotensin was increased in the R. H. R., and in 
rats treated with D. O. C., angiotensin and NaCl, aldosterone, angio- 
tensin and NaCl, and angiotensin alone. All animals with increased 
reactivity also exhibited increased aortic contents of Na+ and K+ ions. 
Rats with aminonucleoside induced nephrosis or carbon tetrachloride 
induced liver cirrhosis exhibited reduced reactivity ana reduced 
aortic K+ ion content. Increased reactivity therefore appeared to be 
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associated with an increased ion content of the vasculature. The 
pathogenic implications of. changes in vascular K+ content were unclear, 
since changes in reactivity did not always parallel changes in the 
blood pressure. 
Lundgren, Hailbäck, Weiss and Folkow (1974) studied the 
changes in the noradrenaline dose-response curve of the perfused hind- 
quarters preparations, during the development of renal hypertension 
in the rat. Hypertension was induced by clipping one renal artery 
with the contralateral kidney left untouched. The blood pressure of 
the rats stabilized at hypertensive levels two weeks after the 
application of the "Goldblatt" clip. Changes in the dose-response 
curve, i. e. increased slope, maximum response and the basal resistance 
to flow stabilized after 2-3 weeks. The first signs of increased reac- 
tivity, as evidenced by changes in the noradrenaline dose-response 
curve, occurred 7 days after the operation, but the blood pressure 
was elevated after 3 days. These results indicated that apparent 
hyperreactivity in renal hypertension was a consequence and not a 
primary cause of the high blood pressure. 
Removal of the constricting clip from the renal artery 
reduced the blood pressure of the rats to normal levels in one day 
(Lundgren, 1974 a). Reversion of the noradrenaline dose response 
curve and basal resistance to flow took 3 weeks. This result would 
suggest that medial hypertrophy in the vasculature has no significant 
role in the maintenance of hypertension. 
Lundgren (1974 a) argued that the removal of the renal artery 
clip would cause a reduction in cardiac output, which would lower the 
blood pressure (Ledingham, 1971). This explanation is erroneous since 
Ledingham, (1971) was discussing the one kidney R. H. R. while Lundgren 
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(197+ a) used the two kidney model. 
Lundgren (1974 b) investigated the effects of propranolol on 
the development of renal hypertension and changes in vascular design. 
Neither pretreatment nor treatment in established hypertension with 
propranolol had any effect on blood pressure or changes in reactivity. 
If a rise in cardiac output was responsible for the structural 
adaptation of the blood vessels (Folkow, 1971), then this could not 
have been mediated by i adrenoceptors. 
Haeusler and Finch (1972 a) and Armstrong (1972) have demon- 
strated that reactivity to 5-hydroxytryptamine is increased in the 
perfused hind-quarter preparation from the R. H. R. Dose-response 
curves to 5-hydroxytryptamine in "hypertensive" preparations, were 
steeper and had a greater maximum response than normal. Reactivity 
to noradrenaline was also increased, but to a lesser degree. Hyper- 
reactivity could not be solely due to a structural change in the 
vasculature, even though there was an increase in basal resistance 
to flow (Haeusler and Finch, 1972 b). 
An equal degree of hyperreactivity to all agonists would 
have resulted if a structural vascular adaptation was the only cause 
of the increased reactivity. However, the differences in reactivity 
of the hind-quarters vascular bed may have been because noradrenaline 
and 5-hydroxytryptamine constrict the precapillary vessels while 
5-hydroxytryptamine also dilates the post-capillary vessels (Folkow, 
Hallback, Lundgren, Sivertsson and Weiss, 1973)- 
b) The perfused mesenteric vasculature preparation 
McGregor and Smirk (1968,1970), Armstrong (1972) and Haeusler 
and Finch (1972 a) demonstrated hyperreactivity to noradrenaline and 
5-hydroxytryptamine but not Ca 
++ 
using the perfused mesenteric 
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vasculature preparation from the R. H. R. The increase in response 
amplitude to 5-hydroxytryptamine was much greater than the increase 
in noradrenaline reactivity. 
The dose-response curves of the "hypertensive" tissues were 
steeper and achieved greater maximum responses than the control 
curves (Armstrong, 1972., Haeusler and Finch, 1972. a). The threshold 
vasoconstrictor dose of 5-hydroxytryptamine was lower in "hyper- 
tensive" tissues, which would suggest that some change in vascular 
sensitivity to this agonist had occurred. Since the mesenteric 
vasculature preparation consists of precapillary vessels only, the 
difference in hyperreactivity between noradrenaline and 5"-hydroxy- 
tryptamine could not be explained by the post-capillary vasodilator 
action of the latter. 
Despite the greatly increased reactivity to 5-hydroxytrypt- 
amine, studies using 5-hydroxytryptamine antagonists have shown no 
causal relationship between this agonist and the high. b: '. ood pressure 
(Armstrong, 1972., Haeusler and Finch, 1972 a). 
x) Vascular reactivity in intact nerfused blood vessels 
from D. O. C. hvnertensive rats 
a) Perfused hind-quarters or hind-limb nrenarations 
Demura, Fukuchi, Takahashi and Goto (1965) and Baum and 
Shropshire (1967b)have demonstrated increased reactivity to nor- 
adrenaline and angiotensin in perfused hind-limb and hind-quarters 
preparations from U. O. C. hypertensive rats. In contrast, Oono (1966) 
could find no change in reactivity to these agonists. 
Haeusler and Finch (1972 b) and Armstrong (1972) also 
demonstrated increased reactivity to noradrenaline and to 5-hydroxy- 
tryptamine in perfused hind-quarters preparations from D. O. C. 
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hypertensive rats. Response curves to both agonists were steeper 
than normal with a greater maximum response. The basal resistance 
to flow was increased in "hypertensive" preparations (Baum and 
Shropshire, 1967. b), Haeus]. er and Finch, (1972. b) which could have 
been due to a medal hypertrophy. Haeusler and Finch (1972 b), 
but not Armstrong (1972), reported a lowered threshold to noradrenaline 
and 5-hydroxytryptamine in "hypertensive" preparations, which could 
indicate supersensitivity of the blood vessels. 
b) The perfused rat tail preparation 
Beilin and Wade (1970) studied the perfused rat tail 
preparation from D. O. C. hypertensive rats and found increased reactivity 
to noradrenaline but not to angiotensin. The basal resistance to flow 
of the "hypertensive" preparations was less than that of the control 
preparation. Perfused tails from rats with hypertension that persisted 
after withdrawal of D. O. C. behaved somewhat differently (Beilin and 
Ziakus, 1971). Basal resistance to flow was increased and response 
curves to both noradrenaline and to 5-hydroxytryptamine were steeper 
than normal with a greater maximum response. 
Beilin and Wade (1970) and Beilin and Ziakus (19? 1) suggested 
that in D. O. C. hypertension, the D. O. C. had some specific effect on 
the a-adrenoceptor or on noradrenaline metabolism, while in the post- 
D. O. C. hypertensive phase, a structural change had occurred in the 
blood vessels. 
c) The perfused rat caudal artery preparation 
Hinke (1965) made a rigorous study of the changes in the 
structure and reactivity of the isolated, perfused caudal artery 
preparation from the D. O. C. hypertensive rat. 
r 
Histological examination of the arteries revealed fragmentation 
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of the internal elastic lamina, degeneration of the inner half of 
the tunica media and an increase in artery wall mucopolysaccharides. 
Wall hypertrophy was demonstrated, particularly in arteries from 
rats in the early stages of hypertension. "Hypertensive" arteries 
also exhibited an increased resistance to flow and a reduced internal 
diameter, indicating that the wall hypertrophy had reduced lumen 
diameter. 
The work performed by the arteries was assessed by the 
variation of wall tension with radius, at a constant pressure. 
Arteries from hypertensive rats, constricted with noradrenaline 
and vasopressin, performed more work than normal. This increase in 
the amount of work performed could not have been due to a simple 
increase in vascular wall/lumen ratio. Muscle fibre hypertrophy 
could have increased the work output, but the histological evidence 
indicated an expansion of the extracellular space as the mechanism 
of wall hypertrophy. Hinke (1965) suggested that a change in cell 
membrane permeability could have caused the increase in sensitivity 
of the "hypertensive" vessel. 
Hinke (1966) further investigated the caudal 
artery by abolishing and re-establishing contractions to noradrenaline 
or potassium by manipulation of the [Ca++] in the perfusion fluid. 
Responses in "hypertensive" arteries were more difficult to abolish in 
zero [Ca++] perfusion fluid than in normal vessels. Less Ca++, than 
normal, was required to re-establish contractions in "hypertensive" 
arteries. The caudal arteries from hypertensive rats contained more 
Na+, K+, Mg + and Ca++ than normal. These results indicated that the 
"hypertensive" artery was more sensitive to noradrenaline than normal 
because of an increase in the efficiency of Ca++ utilization. 
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d) The perfused mesenteric vasculature preparation 
Dose-response curves to 5-hydroxytryptamine and to noradrenaline 
are steeper than normal, with a greater maximum response, in perfused 
mesenteric vasculature preparations from D. O. C. hypertensive rats 
(Armstrong, 1972., Haeiisler and Finch, 1972 b). These results 
suggest an increase in vascular wall/lumen ratio. However, the 
inequality of the increases in reactivity to the two agonists and the 
normal resistance to flow at maximum vasodilation did not support 
this mechanism (Haeusler and Haefely, 1970., Haeusler and Finch, 
1972 b). 
The normal reactivity of depolarized "hypertensive" preparation 
to Ca provided further evidence against a structural vascular change 
as the sole cause of hyperreactivity. In addition, vasoconstrictor 
threshold doses to 5-hydroxytryptamine (Armstrong, 1972) or to both 
5-hydroxytryptamine and noradrenaline (Haeusler and Finch, 1972, b), 
were lowered in the "hypertensive" preparation, indicating that some 
degree of supersensitivity was also present. 
Finch (1974) has shown that reduction of the blood pressure 
of D. O. C. salt hypertensive rats, by 4 weeks of antihypertensive 
therapy, does not alter the increased reactivity of the mesenteric 
vasculature preparation to noradrenaline and 5-hydroxytryptamine. 
Finch (1974) suggested that these results seriously questioned the 
role of increased vascular reactivity in the maintenance of hyper- 
tension. However, the vasodilator hydrallazine was included in the 
anti-hypertensive treatment. This drug would counteract the haemo- 
dynamic effects of increased reactivity in vivo but this effect would 
not be apparent in the isolated mesenteric vasculature preparation. 
e) The perfused renal artery preparation 
Perfused renal arteries from D. O. C. hypertensive rats 
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responded normally to noradrenaline or 5-hydroxytryptamine (Haeusler 
and Finch, (1972 b). The basal resistance to flow was less than 
normal, probably because of compensatory dilation in response to 
the unilateral nephrectomy procedure used by Haeusler and Finch 
(1972. b). 
xi) Vascular reactivity in intact perfused blood vessels from 
spontaneously h2pertensive rats a"s 
a) Perfused hind-quarters or hind-limb preparations 
Folkow's group have reported that vascular hyperreactivity 
occurs in the perfused hind-quarters preparation as well as in the 
systemic vascular bed of the Japanese S. H. R. (Folkow, Hallbäck, 
Lundgren and Weiss, 1970 a, b, c). The increased reactivity was 
characterized by an increase in the slope and maximum response of 
the noradrenaline dose-response curve, with an increase in basal 
resistance to flow, but, with no change in vasoconstrictor threshold 
dose (Folkow, Hallbäck, Lundgren and Weiss, 1970 b, c). 
Folkow, Hallbäck, Lundgren and Weiss (1970 c) have suggested 
that these changes were caused by medial hypertrophy in the blood 
vessels leading to an increase in the wall/lumen ratio. The major 
site of this change in wall/lumen ratio was the precapillary 
resistance section of the hind-quarters vascular bed (Folkow, 
Hallbäck, Lundgren, Weiss, Albrecht and Julius, 1974). Further 
evidence supporting an increase in vascular wall thickness was 
demonstrated by the resistance vessels of the S. H. R. being less 
distensible than normal (Hallbäck, Lundgren and Weiss, 1974). 
Hallbäck and Folkow (1974) have suggested that the S. H. R. 
responds to environmental stimuli with exaggerated pressor responses. 
Elimination of the pressure load prevents the development of 
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vascular hyperreactivity in the S. H. R. (Folkow, Gurevich, Hallbäck, 
Lundgren and Weiss, 1971). It was therefore suggested that the 
exaggerated pressor responses trigger the gradual structural 
adaptation of the resistance vessels (Folkow, Hallbäck, Lundgren, 
Sivertsson and Weiss, 1973). If such a mechanism is of primary 
importance in the pathogenesis of high blood pressure in the S. H. R., 
then the time course of the structural vascular adaptation should 
be rapid. Regional hypotension, caused by aortic ligation in the 
young S. H. R. stimulated regression of the structural vascular 
adaptation within 3-7 days and was complete in 3 weeks (Folkow, 
Hallback, Lundgren and Weiss, 1973). In the old S. H. R., regression 
of vascular changes had a similar time course, but was less complete, 
probably because of increased collagen and elastin in the vessels 
(Weiss and Hallbauck, 1974). Vascular hypertrophic changes in the 
S. H. R. appear to regress rapidly; }] there is no evidence to date 
on the speed of development of these changes. 
Evidence suggests that the S. H. R. may have a genetic 
disposition towards hypertrophic changes in response to load, since 
immunosympathectomy or anti-hypertensive drug treatment reduced the 
blood pressure to normal without complete regression of the vascular 
changes (Folkow, Hallback, Lundgren and Weiss, 1971., 1972., Weiss, 
1974). The resistance vessels of the S. H. R. hypertrophy to a greater 
extent than those from normal rats, in response to the same pressure 
rt load (Folkow, Hallback, Lundgren, Sivertsson and Weiss, 1973). 
Laverty (1961) has demonstrated that increased reactivity to 
noradrenaline also occurs in the perfused hind-limb preparation from 
the New Zealand strain of S. H. R. Increased peripheral resistance 
in the S. H. R. hind-limb was initially suggested to be wholly of 
neurogenic origin (Laverty and Smirk, 1961). However, later 
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studies (Laverty, McGregor and McQueen, 1968) indicated that a 
structural change in the vascular wall was also involved. 
Haeusler and Finch (1972 b) have shown that the increased 
resistance to flow, in the systemic or hind-quarters circulation of 
Japanese S. H. R., develops with age. Dose-response curves of the 
perfused hind-quarters to noradrenaline were steeper than normal, 
with an elevated maximum response, but, with no change in vaso- 
constrictor threshold dose, Armstrong (1972) reported similar results 
for the New Zealand strain of S. H. R. 
Haeusler and Finch (1972 b) found that there was no change 
in the 5-hydroxytryptamine dose-response curve in the perfused hind-quarter 
preparation from the Japanese S. H. R. Armstrong (1972), in contrast, 
reported an increase in reactivity to this agonist which exceeded 
that for noradrenaline responses, using the New Zealand S. H. R. 
b) The perfused mesenteric vasculature preparation 
Reactivity to noradrenaline, angiotensin, 5-hydroxytrypt- 
amine, KC1 but not to Ca 
++ is increased in the perfused mesenteric 
vasculature preparation from the S. H. R. (McGregor and Smirk, 1968, 
1970; Haeusler and Haefely, 1970; Armstrong, 1972; Haeusler and 
Finch, 1972 a, b). Resistance to flow was increased in preparations 
from the New Zealand strain (McGregor and Smirk, 1968) but not from 
the Japanese strain of S. H. R. (Haeusler and Finch, 1972 b). The 
dose-response curves to noradrenaline and 5-hydroxytryptamine exhibited 
the characteristics of an increased vascular wall/lumen ratio (Haeusler 
and Finch, 1972, -b., Armstrong, 1972). 
Some aspects of the hyperreactivity did not fit the hypothesis 
of an increased wall/lumen ratio. The vasoconstrictor threshold to 
5-hydroxytryptamine was lower in preparations from the S. H. R. (Armstrong, 
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1972; Haeusler and Finch, 1972. a) and the increase in reactivity to 
this agonist greatly exceeded that to norad. renaline (McGregor and 
Smirk, 1970.,, Haeusler and Haefely, 1972 a., Armstrong, 1972). 
Finch (1974) has shown that 4 weeks of anti-hypertensive 
treatment lowers the blood pressure of the S. H. R. but does not affect 
reactivity to noradrenaline. Similarly, Wood and Clark (1974) have 
shown that sympathectomy by 6-OH-dopamine lowers the blood pressure of 
S. H. R. but does not abolish the increased mesenteric vasculature 
reactivity to noradrenaline and 5-hydroxytryptamine. These results 
contradict a similar study (Weiss, 1974) in which some regression of 
the vascular changes in the perfused hind-quarters preparation were 
found. 
c) The perfused renal artery and renal vascular bed 
In the perfused renal vascular bed of the S. H. R. resistance 
to flow was found to be lower than normal (Folkow, Hallback, Lundgren, 
Sivertsson and Weiss, 1973) while it was normal in the perfused renal 
artery (Haeusler and Finch, 1972 a). Folkow, Hallbäck, Lundgren, 
Sivertsson and Weiss, (1973) have suggested that the renal vascular 
bed of the S. H. R. resembles the hind-quarters preparation in its 
response to agonists, while Haeusler and Finch (1972 a, b) have reported 
normal or below normal reactivity to noradrenaline and 5-hydroxytrypt- 
amine in the perfused renal artery. 
A SUMMARY OF THE EVIDENCE FOR INCREASED VASCULAR REACTIVITY IN HYPERTENSION 
Studies on human hypertensive patients have shown that increased 
reactivity to noradrenaline is a more common observation, especially 
in essential hypertension, than are changes in the humoral and neurogenic 
influences on the peripheral resistance. 
Evidence for increased reactivity in experimental hypertension is 
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dependant on the type of preparation employed. 
Investigations using large artery strips have shown that a 
true non-specific supersensitivity may occur in acute renal and D. O. C. 
hypertension. As these hypertensive states progress, the vascular 
changes converge with those in the S. H. R., as impaired arterial 
contractility becomes the dominant factor. 
In the perfused preparation, involving true resistance vessels, 
the evidence is different. Increased reactivity is a common observation and 
the controversy is whether it is caused by changes in the vessel 
structure or sensitivity. The degree of structural change may depend 
on the segment of the vascular tree which is studied. In complete 
vascular beds, such as the hind-quarters, some narrowing of the vessel 
lumen seems to occur. In the arterial-arteriolar bed, such as the 
mesenteric vasculature preparation, luminal narrowing is apparently 
absent. Contractility of the resistance vessels is increased, in 
direct contrast to the reduction in contractile strength observed in 
the larger arteries. 
The opposite directions of the contractility changes in the 
aorta and in smaller arteries and arterioles, during hypertension, can 
be explained from the results of studies with tritiated thymidine. 
True hypertrophy of smooth muscle cells, as evidenced by the increased 
incorporation of tritiated thymidine has been demonstrated in arterial 
and arteriolar smooth muscle, but not in the aorta 
(Crane and Dutta, 
1963). Increases in vascular smooth muscle mass have been detected in 
the mesenteric and coronary arteries, but not in the aorta of experimental 
hypertensive animals (Fischer and Llaurado, 1967). It is likely, there- 
fore, that medial hypertrophy and consequently increased contractility 
do not occur in the aorta of hypertensive animals. Degenerative changes 
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in the smooth muscle cells (Gardner and Matthews, 1969) with reduced 
contractility are therefore more prominent in the aorta than in 
smaller arteries. 
CHAPTER 2 
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GENERAL METHODS 
In this study, blood pressure was recorded from conscious 
normotensive and renal. hypertensive (Grolinan, 1944) rats and re- 
activity to agonists was examined in the perfused mesenteric vasculature 
preparation. This chapter describes these methods. 
1. THE RAT PERFUSED ISOLATED MESENTERIC VASCULATURE PREPARATION 
a) INTRODUCTION 
The perfused preparations commonly used for the evaluation 
of vascular reactivity are the hind-quarters (McQueen, 1956., Folkow, 
Hallbäck, Lundgren and Weiss, 1970 a, b, c), the hind-limb (Laverty, 
1961), the tail (Beilin and Wade, 1970) and the mesenteric vasculature 
of the rat (McGregor and Smirk, 1968,1970). The mesenteric vasculature 
was chosen for the present study since it contains true resistance 
vessels without the complications of a capillary and post-capillary 
vascular section. 
b) METHODS 
The technique for the perfusion of the mesenteric vasculature 
is a modification of that described by McGregor (1965). 
Female Charles River rats (150-300 g) were anaesthetized by 
intraperitoneal injection of pentobarbitone sodium (60 mg/kg). The 
abdomen was opened by midline incision and the ileum and colon were 
exposed. The superior mesenteric artery, which accompanies the vein 
in adipose tissue, was identified and cannulated. The perfusion pump 
was in operation during the cannulation process. The perfused area 
was identified by blanching, and included an area of ileum and caecum. 
Since the ileal mesentery was the only area to be used, the other 
branches of the artery (caecal, ileo-colic, colic and pancreatico- 
duodenal) were tied off. The perfused mesentery with the ileum still 
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attached was removed from the rat. The mesentery was severed close to 
the ileum so that only arteries and arterioles were perfused, obviating 
possible interference from the activity of the intestinal smooth muscle. 
The mesenteric vessels were placed in a water-jacketed glass 
cup, and perfused with Kreb's solution for 1h to equilibrate. 
Kreb's perfusion solution of the following composition (mM): 
Na Cl, 118.4; KC1,4.7; NaHCO3,25.0; KH2PO4,1.2; Ca Cl21 2.5; 
Mg SO 4' 1.2; Glucose, 11.0; bubbled with 5% CO2 in 02, was normally 
used. Mesenteric vasculature preparations were perfused at a rate of 
2 ml/min except when otherwise stated. 
The perfusion apparatus consisted of a heating coil maintained 
at 37°C, a Watson-Marlow H. R. flow inducer pump and 'Y' junction poly- 
ethylene tube, one arm of which led to a Bell and Howell L-327-L221 
pressure transducer and the other via a short length of rubber tubing 
(for injection of drugs) to a portex cannula O. D. 0.75 mm (Fig. 2: 1). 
Under conditions of constant flow, constrictor responses 
caused increases in perfusion pressure which were recorded on a Devices 
M. 2. recorder (Fig. 2: 2). Constrictor responses were measured from 
the perfusion pressure baseline preceding each response. 
Agonist drugs were injected at 2 min intervals for nor- 
adrenaline or 4 min intervals for 5-hydroxytryptamine and KC1. 
Preparations were dosed with one of these agonists until there was 
no further increase in responses to a standard dose. Do. se-response 
data was then obtained by increasing doses of the agonist from the 
threshold to near the maximum dose and then reducing the doses down 
to the threshold. The two responses obtained for each dose level were 
averaged, minimizing the influence of the previous agonist dose. 
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Fig. 2: 1 
A diagram of the apparatus for the rat perfused mesenteric 
vasculature preparation. 
Thick arrows indicate the flow of water at 37°C. The Krebs 
solution is pumped from the reservoir via a heating coil to a Y- 
junction. One arm, including an injection port of rubber tubing, 
supplies the perfused tissue, the other connects to a pressure trans- 
ducer. Increased resistance to flow in the mesentery causes an 
increased back-pressure which is recorded by the transducer. 
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Figure 2: 2 
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Noradrenaline induced constrictor responses (mm Hg) of the 
rat isolated perfused mesenteric vasculature. The hc -; zontal axis 
represents minute intervals. Note the initial injection artifact 
followed by a rapid constrictor response which returns to a stable 
baseline. 
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Bipolar platinum electrodes, placed around the superior 
mesenteric artery were occasionally used to stimulate peri-arterial 
sympathetic nerves. Square wave stimuli of 40 V, 0.5 ms width at a 
frequency of 40 Hz were applied for periods of 10 s. 
Antagonist drugs and angiotensin II amide we:, c added to the 
Kreb's solution and perfused for periods of 15 min to 1.5 h. 
i) Histology 
Sections of terminal vessels of the mesenteric vasculature 
preparation, i. e. at the point of entry into the ileum, were examined 
histologically to identify the nature of the vessels involved. The 
sections were stained with haomatoxylin and eosin or with Gomori 
aldehyde fuchsin. 
ii) Drugs used 
The drugs used throughout this study were: - angiotensin II 
amide (Hypertensin, Ciba), Sari Ile8 angiotensin II (Beckman), desi- 
pramine hydrochloride (Geigy), disodium ethylenediaminetetra-acetic 
acid (Na2E. D. T. A., B. D. H. ), ethylene bis-(aminoethyl)-tetraacetic acid 
(E. G. T. A., Koch-Light), guanethidine sulphate (Ciba), indoramin hydro- 
chloride (Wyeth), (±) isoprenaline sulphate (Burroughs Wellcome), (-) 
noradrenaline bitartrate (Koch-Light), papaverine sulphate. (B. D. H. ), 
phentolamine mesylate (Ciba), potassium chloride (B. D. H. ), 5-hydroxy- 
tryptamine (serotonin creatinine sulphate, Koch-Light). Doses refer 
to base. 
iii) Statistical Analysis 
Significant differences were assessed using the Student's t 
test. Significant differences are indicated on'figures, throughout 
this study, by stars: - 
p<0.05 is indicated by 
©p <0.02 is indicated by 
00 
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p <0.01 is indicated by p <0.001 is indicated by -* 
* 
Unless stated otherwise, mean values 
1 S. E. M. are given throughout 
this study. 
c) RESULTS 
i) The baseline perfusion pressure k 
The mean minimum perfusion pressures recorded before and 
after cannulation of the tissue were 21.2 
1 0.5 (due to the cannula, 
n= 6) 38.8 1 1.1 (cannula and tissue, n= 6) respectively. 
Isoprenaline (0.5-1.0 fig) and papaverine (1 fig) reduced the 
baseline perfusion pressure by 2-4 mm Hg, indicating that the tissue 
was virtually atonic. The resistance to flow was due to the calibre and 
elasticity of the mesenteric arterioles. 
ii) The stability of the preparation 
The baseline perfusion pressure remained constant for at 
least six h. The tissue showed full sensitivity to noradrenaline 
after about 1h of dosing with this agonist and remained stable for 
4-5 h. 
iii) The sensitivity of the preparation 
Tissues usually gave recordable constrictor responses at 
0.02 ug of noradrenaline (n = 15. ), 0.1 ug of 5-hydroXrtryptamine 
(n = 6) and 200 v. g of KCl (n = 10 Figs. 2: 3,4,5)" 
Maximum responses were evoked by 8.0 - 16.0 ug of nor- 
adrenaline, 3.0 - 12.0 g of 5-hydroxytryptamine and 2.0 - 8.0 mg. 
of KC1 (Figs. 2: 3,4,5). 
Typical constrictor responses to noradrenaline are shown in 
Fig. 2: 2. 
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Fig. 2: 
The mean noradrenaline dose-response curve for mesenteric 
vasculature preparations (n = 9-19). The threshold for stimulation 
was 0.02 jig and the maximum response was evoked by 8- 16 jig of 
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pg Noradrenaline. 
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The mean 5-hydroxytryptamine dose-response curve of 6 
mesenteric vasculature preparations. The threshold for stimulation 
was 0.1 jig and the maximum response occurred at 3- 12.0 ug of 
5-hydroxytryptamine. Note the shallow gradient of the dose-response 
line. 
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The mean KC1 dose-response curve of 10 mesenteric vasculature 
preparations. Doses of 2x 10-4 g KC1 to 4x 10-3 g evoked dose- 
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iv) The specificity of the preparation 
Tachyphylaxis to 5-hydroxytryptamine (continuous infusion 
of 0.57 x 10-5M) had no effect on responses to noradrenaline. 
v) Adrenergic neurone stimulation br potassium chloride 
Potassium chloride is a depolarizing agent which will 
stimulate adrenergic nerves. The a-adrenoceptor blocking agent 
indoramin (10 
6M) 
had no effect on KC1 induced responses (n = 2), 
indicating that under the conditions of these experiments, there 
was no indirect adrenergic component. of the mesenteric vasculature 
response. 
vi) The dimensions and structure of the terminal mesenteric vessels 
Arterial/arteriolar vessels were identified in sections of 
the mesenteric vasculature preparation (Figs. 2: 6,7). The external 
diameter of these vessels ranged from 20 - 300 pm. The smallest 
vessels had 2-3 layers of medial smooth muscle cells. All the 
vessels had internal elastic laminae,. indicating that they were not 
precapillary metarterioles. 
vii) The innervation of the preparation 
Peri-arterial nerve stimulation evoked responses of 25 - 80 
mm Hg (n = 4). Guanethidine (5 x 10 
6M) 
abolished these 
responses but had no effect on responses to exogenous noradrenaline 
(n = 2). 
d) DISCUSSION 
A perfused mesenteric vasculature preparation from the rat 
has been described. The preparation consists of arteries and arterioles 
which are innervated by sympathetic nerves and constrict in response 
to'noradrenaline, 5-hydroxytryptamine and KC1. 
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Fig. 2: 6 
Section of a terminal arteriole from the rat mesenteric 
vasculature preparation, stained with haematoxylin and eosin (x 100). 
Note, there are two to three layers of medial muscle cells. 
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Fig. 2: 7 
Section of a terminal arteriole from the rat mesenteric 
vasculature preparation, stained with Gomori aldehyde fuchsin for 
elastic tissue (x 100). Note, the heavily stained internal elastic 
lamina. 
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Since the preparation was intended for use in studies on 
vascular reactivity, it was important to know which elements of the 
vascular tree were present. Severing of the mesentery from the 
ileum ensured that only the afferent vessels were perfused. 
The distinction between a small artery and 1. arteriole 
is vague. Furness and Marshall (1974) sub-divided the afferent 
mesenteric vessels of the rat on the basis of their internal diameters. 
Principal arteries had internal diameters of 80 - 350i1m, small arteries 
ranged from 30 - '-+0µm and terminal arterioles had internal diameters 
of 18 - 30Pun. Maximov and Bloom (1957) classified arterioles as having 
a maximum diameter of 300Im, whereas Ham (1957) drew a dividing line 
between arteries and arterioles at 100ýYndiameter. A classification 
of arteries and arterioles based on the diameter of the fixed pre- 
paration is further complicated by the influence of the method of 
preservation (Cowdry, 1938). Benninghoff (1930) classified arterioles 
into three groups on a structural basis. The smallest, group 1 
arterioles, had no elastic lamina and one layer of muscle cells. 
Group 2 arterioles had an elastic lamina, and group 3 arterioles had 
an elastic lamina and several layers of muscle cells. 
The results of the present study indicate that the mesenteric 
vasculature preparation contains arterioles whether they are classified 
on size or structure. The mesenteric arterioles are probably of the 
group 3 type (Benninghoff, 1930). Histological evidence, and the lack 
of basal tone in the preparation indicate that the preparation does 
not contain precapillary metarterioles since these vessels exhibit 
spontaneous tone (Folkow and Neil, 1971), and have no internal elastic 
lamina (Ham, 1957). 
The mesenteric vasculature preparation is innervated by 
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sympathetic adrenergic nerves, which are sensitive to blockade with 
guanethidine. The sympathetic innervation of this tissue has also been 
demonstrated pharmacologically by McGregor (1965) and Malik and Ling 
(1969) and histologically by Furness and Marshall (1974). 
The dose-response curves of the mesenteric vasculature pre- 
paration to noradrenaline, 5-hydroxytryptamine and KC1 were similar to 
those reported for this preparation by Haeusler and Haefely (1970) and 
Haeusler and Finch (1972a). Slight quantitative differences between the 
present results and those previously reported may be due to the higher 
perfusion rates used by Haeusler and Haefely (1970) and Haeusler and 
Finch (1972a). 
Mesenteric vasculature responses to noradrenaline were rapid 
and stable over long periods. The absence of cross-t&chyphylaxis 
between noradrenaline and 5-hydroxytryptamine responses demonstrated 
that noradrenaline wasstimulating a-adrenoceptors and not a combination 
of a-and 5-hydroxytryptamine receptors (Innes, 1962). 
Dose-response curves to KCl were steeper than those to nor- 
adrenaline. At high doses of KCl the responses were depressed, probably 
because of impaired repolarization of the smooth muscle cells. 
The dose-response curves to 5-hydroxytryptamine had very 
shallow slopes. A rather flat dose-response curve for 5-hydroxytrypt- 
amine has also been demonstrated by Haeusler and Finch (1972 a). 
2. THE INDIRECT RECORDING OF SYSTOLIC BLOOD PRESSURE IN 
UNANAESTHETIZED RATS 
a) INTRODUCTION 
The recording of the blood pressure of conscious experimental 
animals is a pre-requisite of any study of hypertension. The implantation 
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of an indwelling arterial catheter to enable the direct measurement of 
systolic and diastolic blood pressure is ideal (Weeks and Jones, 1960., 
Popovic, Sybers and Popovic, 1968) but untenable when the blood 
pressures of a large number of animals is to be followed over long 
periods. 
The tail cuff method of Gerold and Tschirky (1968) was used 
in the present study to measure the systolic blood pressure of the rats. 
b) M ; THOD 
Rats were pre-heated in perspex water jackets or restrained 
in perspex holders in a heating box (39°C) prior to blood pressure 
recording. 
The pressure applied by an occluding cuff around the rats tail 
was measured using a Bell and Howell 4-327-L221 pressure transducer, 
and recorded using a Devices M2 recorder. Pulsations of the tail 
artery were recorded by a pneumatic pulse-transducer (E. ard M. Instruments). 
The pressure applied by the cuff, which just occluded the tail artery, 
was taken as the systolic blood pressure. The sensitivity of the pulse 
transducer was constant throughout the study, so that the pulse would 
re-appear at the same tail artery blood flow in each animal. 
c) RESULTS 
A typical experimental record is shown in Fig. 2: 8. The 
pressure in the tail-cuff is raised until pulsations of the tail artery 
cease. The occluding pressure is then slowly released through a valve. 
The cuff pressure at which the tail artery pulsations re-appear is taken 
as the systolic blood pressure. Three readings were taken for each 
animal and averaged. These readings were usually constant over the 2-3 
min recording period indicating that reactive hyperaemia was not inter- 
fering with the measurements. 
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Tail cuff pressure 
250 ,, 
mm Hg. 
Systolic pressure 
/I\ 
i 
1 
Pulse from 
pneumatic sensor. 
Fig. 2: 8 
A typical indirect blood pressure measurement record. The 
pulsations of the tail artery of the preheated rat are shown in the 
lower trace, and the occlusion cuff pressure in the upper trace. The 
cuff pressure is increased until the tail artery is occluded (pulsations 
cease) and then decreased via a slow release valve until pulsations 
re-commence. The occlusion cuff pressure (175 mmHg) at which 
pulsations re-commence is taken as the systolic blood pressure. Note, 
this rat had a systolic blood pressure of 175 mmHg i. e. was hyper- 
tensive. 
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In order to examine whether the procedure was stressful, and 
whether the stress affected the blood pressure, mean results from 7 
rats obtained on their first and third exposure to the technique were 
compared. The average blood pressure at the first measurement was 
116.0 ± 4.5. The third mean blood pressure reading (three weeks 
after the first) was 114.9 
1 4.3. There was no significant difference 
between these mean values. 
d) DISCUSSION 
The method described provides a rapid non-invasive technique 
for the measurement of systolic blood pressure in unanaesthetized rats. 
A previous investigation of this method in which simultaneous 
recordings of blood pressure were made directly from an indwelling 
carotid cannula (Staniforth, 1970., personal communication) has shown 
that pre-heating of the rats causes a small (5 mm Hg) fall in the 
systolic blood pressure. This was unavoidable since pre-heating was 
necessary to obtain a measurable tail artery pulse. 
The major problem involved in recording the blood pressure 
of conscious animals is that the stress of the procedure may cause 
temporary hypertension. The procedure used in this study did not raise 
the blood pressure of the rats. Mean pressures were no higher when 
the rats were first introduced to the technique than when they had 
become accustomed to it. 
Staniforth (1970, personal communication) found that a constant 
correction factor of 23 mmHg should be added to the indirect reading to 
achieve parity with the direct measurement. This correction factor was 
omitted from the present study, since changes in blood pressure rather 
")t-fr LI b/ 
than absolute values are important in hypeDtensior4PickeriTog, -1968). 
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3. THE PRODUCTION OF RENAL HYPERTENSION BY THE METHOD OF 
GROLLMAN (1944) 
a) INTRODUCTION 
Renal hypertension in experimental animals can be produced 
by a variety of methods: - 
1. Partial ablation of the kidney, (Chanutin and Ferris, 1932). 
2. Constriction of the renal artery, (Goldblatt, Lynch, Hanzal 
and Summerville, 1934)" 
3. Encapsulation of the kidney in silk or cellophane causing 
an inflammatory invasion of the renal cortex, (Page, 1939). 
4. Compression of the kidney by a figure-of-eight ligature, 
(Grollman, 1944). 
All of these methods have advantages and disadvantages, the 
common difficulty being to impair renal function sufficiently to produce 
hypertension but not so much as to cause death by renal insufficiency. 
The "Goldblatt - clip" method is the most commonly used, but the 
Grollman method was judged to be technically simpler. The 
Grollman method is an established technique in this institute for 
the evaluation of novel antihypertensive agents. Further information 
on the characteristics of this type of renal hypertension would there- 
fore be advantageous. 
b) METHOD 
Female Charles River rats, 130-180 g were anaesthetized with 
a fluothane-oxygen mixture. The right kidney was exposed retroperiton- 
eally by lumbar incision, and the adrenal gland pushed away from its 
attachment to the kidney. A silk ligature was passed under both poles 
of the kidney in a figure-of-eight fashion to compress the parenchyma 
(Fig. 2: 9). 
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One week after the application of the ligature, contralateral 
nephrectomy was performed. After the removal of the contralateral kidney, 
some of the rats were given 0.9% saline to drink ad libitum. These rats 
were termed "renal/salt hypertensive rats". Some animals were given 
tap-water to drink ad libitum and were termed "renal hypertensive rats". 
i) Sham 2. ptrations 
These were identical to the operative procedure outlined above 
except that a) the constricting ligature was not applied to the kidney, 
b) the contralateral kidney was not removed. 
c) RESULTS 
The tightness of the figure-of-eight ligature was found to be 
the dominant factor in the "Grollrnan" renal hypertension. If the ligature 
was too loose, the rats did not become hypertensive. If the ligature was 
too tight the rats died of renal insufficiency 1-2 weeks after 
nephrectomy. The optimum tightness of the ligature was found, by trial 
and error, to be that which compressed the kidney without distorting 
the organ. 
The mean systolic blood pressures of the successfully operated 
rats with or without salt-loading are shown in Fig. 2: 10. The application 
of the "figure-of-eight" ligature caused a significant rise in systolic 
blood pressure which continued after removal of the contralateral kidney. 
Salt-loading with 0.9% saline had no effect on the rise in blood pressure 
during the first week after contralateral nephrectomy. From 2-4 
weeks after nephrectomy the salt-loading exacerbated the hypertension. 
The blood pressure of the renal/salt hypertensive rats reached a plateau betw 
170 and 180 mmHg 2 weeks after nephrectomy, but it took 3-4 weeks for 
the blood pressures of the renal hypertensive rats to stabilize. 
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Fib. 2: 10 
The development of hypertension in "Grollman" hypertensive 
rats, numbers of animals in parentheses. F8, indicates application 
of the figure-of-eight ligature, N, indicates contralateral nephrectomy. 
The application of the figure-of-eight ligature increases the blood 
pressure, and the removal of the contralateral kidney further elevates 
the blood pressure. The blood pressure of renal/salt rats stabilizes 
between 170 and 180 mmIig 2 weeks after contralateral nephrectomy. 
Renal hypertensive rats had stable blood pressures between 160 and 170 
mmHg after 3-4 weeks. Significant differences between the mean blood 
pressures of renal/salt and renal hypertensive rats are indicated by 
stars. 
The blood pressures of the sham operated control animals fell 
after the first operation but then stabilized around 120 mmHg. 
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From 2 to 6 weeks following contralatera1 nephrectomy, 
the blood pressures of the renal/salt rats were higher than those for 
the renal rats, although this difference was not always statistically 
significant. Twelve weeks after contralateral nephrectomy there was 
no difference in mean blood pressure between the renal/salt and the 
renal hypertensive rats, (Fig. 2: 10). 
The mean blood pressure of the sham-operated rats decreased 
after the first but not after the second operation. 
Salt-loading caused a greater mortality rate (10%) than in 
renal hypertensive rats (4-59W. Animals whose blood pressure exceeded 
200 mmHg often died. 
d) " DISCUSSION 
A simple, effective method for inducing renal hypertension 
in rats has been described. The blood pressures of the operated rats 
rose rapidly during the 2 (renal/salt) or 4 (renal) weeks following 
nephrectomy and remained at hypertensive levels for the duration of 
the study (12 weeks). 
The maximum blood pressures achieved by the hypertensive rats 
were similar to those reported by Grollman and Harrison (1945) and by 
Laramore and Grollman (1950). However, Vapaatalo, Lahovaara and Hackman 
(1970) and Handler and Bernheim (1950) have reported lower blood pressure 
levels for this method. The variation in the maximum blood pressure 
produced by this method is probably due to the different tensions with 
which the various investigators applied the "figure-of-eight" ligature. 
Salt-loading accelerated the development of hypertension and 
increased the mortality rate, but did not influence the final peak blood 
pressure of the rats. Salt-loaded renal hypertensive rats were found to 
- 80 - 
have more consistent blood pressures than the renal hypertensive 
animals and were therefore a more useful model for the study of 
vascular reactivity. 
A high salt intake has previously been shown to exacerbate 
this type of renal hypertension and to increase the mc, ^1ity rate 
(Handler and Bernheim, 1950., Vapaatalo, Lahovaara and Hackman, 1970). 
Grollman and Harrison (1945) have demonstrated that drastic salt 
restriction lowers the blood pressure and prolongs the life of this 
type of hypertensive rat. Salt-loading also has a hypertensive effect 
in dogs which have had 70% of their renal mass removed (Douglas, Guyton, 
Langston and Bishop, 1964) and accelerates the development of hyper- 
tension with increased mortality in the Japanese S. H. B. (Dahl and 
Tuthill, 1974). However, renal hypertension induced by a "Goldblatt" 
clip on the renal artery, is unaffected by salt-loading (Redleaf*and 
Tobian, 1958b., AMiksche, Miksche and Gross, 1970). The absence of 
salt-sensitivity in "Goldblatt" renal hypertension is probably because 
kidney function is not impaired, but operates at a higher systemic 
blood pressure. Renal hypertension induced by a reduced kidney mass 
or a "figure-of-eight" ligature, in which there is variable damage 
to the nephrons is salt-sensitive because the increased load tends to 
overstress the remaining kidney tissue and elevates the blood pressure. 
The haemodynamic events leading to hypertension after the 
application of the "figure-of-eight" ligature and contralateral 
nephrectomy are unknown. However, it is reasonable to assume that 
the haemodynamic changes correspond to some degree with the sequence 
outlined in chapter 1. 
CHAPTER ý 
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VASCULAR REACTIVITY TO NOR&DRENALINE, POTASSIUM CHLORIDE AND 
ANGIOTENSIN II IN THE RAT PERFUSED MESENTERIC VASCULATURE 
PREPARATION, DURING THE DEVELOPMENT OF RENAL/SALT HYPEt<TENSION 
a) INTRODUCTION 
Considerable evidence has been amassed from human studies 
demonstrating an increase in cardiovascular reactivity to various 
physiological and pharmacological stimuli in hypertensive patients. 
The possibility of a link between increased vascular reactivity and 
elevated peripheral resistance in hypertension has led to many 
investigations of vascular reactivity in a variety of experimental 
hypertensive states. 
Two major explanations have been proposed for this increase 
in vascular reactivity. 1. A true supersensitivity occurs when the 
same sub-maximal dose of agonist evokes a greater than normal degree 
of shortening in the vascular smooth muscle cell. In isolated 
arterial tissues, true supersensitivity is evidenced by a displace- 
ment of the dose-response curve to the left of the control with a 
lower vasoconstrictor threshold (Haeusler and Finch, 1972a). 
2. An apparent hyperreactivity, occurs when the degree of smooth 
muscle cell shortening is normal, but, owing to an increased wall/ 
lumen ratio, works at a greater mechanical advantage than in the 
normal vessel. In perfused arterial tissues, this is evidenced by 
a steeper dose-response curve with an elevated maximum response 
(Folkow, Hallbäck, Lundgren and Weiss, 1970c). 
Previous investigations on reactivity in perfused vascular 
preparations from renal hypertensive rats have not confirmed either 
of these explanations, since full dose-response data at a variety 
of time points during the development of hypertension have not been 
obtained (McQueen, 1956., 1957., 1961., Tripod and Bein, 1960., 
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Laverty, 1961., Nolla-Panades, 1963., Demura, Fukuchi, Takahashi and 
Goto, 1965., Oono, 1966., Baum and Shropshire, 1967a., McGregor and 
Smirk, 1968., Haeusler and Haefely, 1970., Armstrong, 1972., Haeusler 
and Finch, 1972b., Lundgren, 1974 a, b). 
This chapter describes the changes in vascular 
reactivity to noradrenaline, potassium chloride and angiotensin which 
accompany the rise of blood pressure in experimental renal/salt 
hypertension. The interaction of angiotensin and noradrenaline in 
tissues from normotensive and hypertensive rats was also investigated, 
in-an attempt to elucidate the cause of true vascular supersensitivity 
to noradrenaline. 
Since the completion of the present study, Lundgren, Hallback, 
Weiss and Folkow (1974) have published a similar investigation, using 
the perfused hind-quarters preparation from the renal hypertensive 
rat. 
b) METHODS 
The induction of renal/salt hypertension, the perfused 
mesenteric vasculature preparation and the measurement of systolic 
blood pressure, have been described (Chap. 2). 
i) Selection of hypertensive animals 
Hypertensive rats with blood pressures close to the mean 
values given in Fig. 2: 10 were used in the experiments. Rats whose 
blood pressures had exceeded 200 mm Hg were evaluated separately 
since they were judged to be in the malignant phase of hypertension, 
with muscular weakness, labile blood pressure, and lesions in the 
mesenteric vasculature typical of periarteritis nodosa. 
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ii) Experimental Procedure 
Renal/salt hypertensive and sham operated rats were 
sacrificed and their mesenteric vasculatures perfused at 1,2,4 and 
6 weeks post-operatively for the determination of reactivity to 
noradrenaline and angiotensin. Another group of hypertensive rats 
were sacrificed at 2,4 and 6 weeks after contralateral nephrectomy 
for the determination of reactivity to potassium chloride. Normo- 
tensive, unoperated rats were used to provide the control potassium 
chloride dose-response curve. Three hypertensive rats were sacrificed 
12 weeks after contralateral nephrectomy and their mesenteric 
vasculatures stimulated with all three agonists. 
In some experiments, the potentiating actions of angiotensin 
II amide on noradrenaline- and potassium chloride- evoked responses 
were investigated. After the initial agonist dose-response curve, 
the tissue was perfused with angiotensin II amide Krebs solution. An 
equilibration period of 15 min was allowed, during which the direct 
constrictor response to angiotensin occurred and subsequently tachy- 
phylaxed. The noradrenaline or potassium chloride dose-response curve 
was repeated in the presence of angiotensin II amide. 
The results of experiments designed to investigate the 
interaction of angiotensin II amide and noradrenaline in tissues from 
renal/salt hypertensive rats (1-2 weeks after contralateral nephrectomy), 
indicated that early supersensitivity to noradrenaline could have been 
caused by supranormal levels of endogenous angiotensin II in these 
animals. A series of dummy experiments were made, to test whether 
the noradrenaline potentiating effects of a high level of endogenous 
angiotensin would be detectable in the perfused mesenteric vasculature 
from renal/salt hypertensive rats, and whether this potentiation would 
attenuate the additional noradrenaline potentiating action of an infusion 
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of exogenous angiotensin. 
iii)- "" Dummy" experiments 
Dose-response curves (a) to noradrenaline were made on the 
perfused mesenteric vasculature preparation from normotensive rats. 
Angiotensin II amide (10-7M) was infused as previously described and 
the noradrenaline dose-response curves (b) repeated. If it is assumed 
that the vasculature in the acute hypertensive rat is exposed to an 
abnormally high concentration of endogenous angiotensin II, then the 
perfused mesenteric vasculature preparation, when tachyphylaxed to 
exogenous angiotensin II amide, would be in a similar state. The 
tachyphylactic tissue was then perfused with normal Krebs solution 
for 1j -2h, simulating the equilibration and preliminary dosing 
time which would normally elapse before noradrenaline dose-response 
curves were obtained. The noradrenaline dose-response curve (c) was 
then repeated, angiotensin II amide (10-7M) infused again and a final 
noradrenaline dose-response curve (d) made (See Fig. 3: 10, dose-response 
curves a to d). 
iv) Analysis of results 
The mean dose-response curves to noradrenaline and potassium 
chloride were plotted in absolute values (Figs 3: 1-4,11-13) to 
evaluate changes in reactivity, and as a% of the maximum response 
(Figs 3: 5-8,14-16) to evaluate changes in sensitivity, independent 
of differences in contractility. 
The following analyses of the dose-response data were made: - 
The threshold dose 
The threshold dose of noradrenaline for each group of pre- 
parations was taken as the mean of the smallest dose which evoked a 
'response greater than 1 mm Hg. The threshold response on Figs 3: 1-9 
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Reactivity shift = 
Dose which evokes response 
amplitude x in control 
preparation. 
Dose which evokes response 
amplitude x in "hypertensive" 
preparation. 
(each "hypertensive"preparation was compared with all the "control" pre- 
parations). 
The mean 50% maximal responses (x) of the hypertensive dose- 
response data are given in Tables 3: 3 and 3: 9. 
c) RESULTS 
i) Vascular reactivity to noradrenaline 
The mean body weights and systolic blood pressures of the 
renal/salt and sham operated rats are given in Table 3: 1. 
Temporal changes in vascular reactivity 
The noradrenaline dose-response curves in preparations from 
renal/salt hypertensive rats were shifted to the left of the control at 
all the time points investigated (Fig. 3: 1-4). At the 1 and 2 week 
stages, the threshold dose was decreased with no change in the maximum 
response. At the 4 and 6 week stages, the maximum responses were increased 
with no significant reduction in threshold dose (Table 3: 2). The regression 
line gradients were greater at the 4 and 6 week stages than at the 1 and 
2 week stages. However, the 4 and 6 week regression line gradients were 
not significantly different from the gradients of the control regression 
lines (Table 3: 2). 1 
The reactivity shifts of the "hypertensive" dose-response curves 
were calculated as described and are given in Table 3: 3. 
Temporal changes in vascular sensitivity 
Figs 3: 5-8, show the noradrenaline dose-response curve data 
expressed as a% of the maximum response. This negates the 
_87_ 
Table 3: 1 
Weeks aft 
Sham Control Renal/Salt Hypertensive 
second Body Wt. B. P. n Body Wt. B. P. n 
operation g mmHg g mmHg 
1 210.6 ± 5.7 111.4 5.2 5 168. o ± 6.4* 142.3 2.3* 5 
2 . 218.4 
4.0 117.0 6.2 5 194.5 ±18.1 182.6 7.8* 6 
4 263.0 ± 8.1 114.5 5.2 7 226.8 ± 9.5 182.5 3.0* 6 
6 263.0 8.1 114.5 5.2 7 238.6 121.3 165.1 1 5.3* 7 
The'mean body weights and systolic blood pressuresof renal salt 
hypertensive and sham operated rats, used for the determination 
of noradrenaline reactivity. (* Significantly different from 
sham control). 
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Table 3: 3 
Weeks after 50% "hypertensive" Sham Rena salt 
second response Mean dose Mean dose Reactivity 
operation amplitude mmHg 119 ILg Shift 
1 66.7 1.49 ± 0.39 0.21 1 0.05* 8.70 ± 1.13* 
2 68.0 0.94 ± 0.04 0.15 ± 0.03* 7.99 ± 0.77* 
4 83.1 1.08 ± 0.14 0.19 ± 0.02* 6.13 0.37* 
6 94.8 1.87 t 0.33 0.27 t 0.04* 7.76 ± 0.74* 
The mean noradrenaline reactivity shifts of mesenteric vasculature 
preparations from renal/salt hypertensive rats (* Significantly 
different from sham control, mean dose indicates the dose to evoke a 50% 
"hypertensive" response amplitude in individual sham control tissues). 
Table 3: 4 
Weeks after 
second 
operation 
Sham Control 
ED5 dose 
119 
Renal salt 
ED5 , dose Sensitivity 
IT Shift 
1 1.28 ± 0.26 0.21 0.05* 7.45 0.82* 
2 0.95 0.07 0.15 0.03* 7.90 ± 0.81* 
4 0.74 0.09 0.19 0.02* 4.18 0.26* 
6 0.74 ± 0.09 0.27 ± 0.04* 3.10 0.20* 
Mean noradrenaline ED 06 doses for mesenteric vasculature preparations 
from sham operated and renal/salt hypertensive rats, and noradrenaline 
sensitivity shifts. ('Significantly different from sham control). 
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response) of mesenteric vasculature preparations from sham control 
(n=7) and renal/salt hypertensive rats (n=7), 6 weeks post-operatively. 
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effect of an increased contractility and a consequently greater maximum 
response, allowing changes in the sensitivity of the blood vessels to 
be quantified. All the "hypertensive" dose-response curves are shifted 
to the left of the control, but in contrast to the reactivity shift 
(Figs 3: 1-4, Table 3: 3) the sensitivity shift decreasod in the later 
4-6 week stages of hypertension (Table 3: 4). 
ii) Vascular reactivity to angiotensin 
The potentiation of noradrenaline responses by angiotensin II 
amide in mesenteric vasculature preparations from the normotensive 
rat 
The noradrenaline sensitivity shifts, induced by perfusion 
with angiotensin II amide at 1Ö 
10 
, 10 
9,1Ö-8 
and 10r7M, and the 
angiotensin evoked constrictor response are given in Table 3: 5. 
The potentiation of noradrenaline responses by angiotensin 
was only significant at all noradrenaline dose levels at a concentration 
of 10-7M (Fig. 3: 9). Since this was also the only concentration which 
evoked a direct constrictor response, it was used in experiments on 
preparations from renal/salt hypertensive rats. 
Angiotensin (10-7M) caused a true noradrenaline super- 
sensitivity with a lower threshold dose (control threshold = 0.027 
0.005, angiotensin treated threshold = 0.014 
± 0.001 'g, p<0.05) and 
no elevation of the maximum response (control maximum = 107.0 - 5.3 fig, 
angiotensin treated maximum = 109.9 
± 4.0 mmHg). 
The direct angiotensin II induced constrictor response and the 
potentiation of noradrenaline induced responses by angiotensin II 
amide in mesenteric vessels from renal/salt and sham operated rats 
The mean constrictor response and mean angiotensin induced 
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Table 3: 5 
Angiotensin II 
amide concentration 
Noradrenaline 
sensitivity shift 
Angioterisin 
constrictor 
response 
n 
1Ö-10 M 1.26 ± 0.16 0 mmHg 6 
10^9 M 1.82 0.27* 0 mmHg 5 
10^8 M 2.15 0.25* 0 mmHg 6 
16-7 M 2.74 0.19* 14.8 t 2.4 mmHg 11 
Angiotensin induced constrictor responses and angiotensin induced 
noradrenaline sensitivity shifts in mesenteric vasculature 
preparations from normotensive rats. ' (* Significantly different 
from angiotensin untreated control). 
Table 3: 6 
Weeks after 
second 
operation 
Angiotensin 
constrictor 
response mmHg 
Control 
noradrenaline 
EDS i dose 
Angiotensin 
treated nor- 
adrenaline 
ED 
w/6 dose 
Angiotensin 
induced nor- 
adrenaline 
sensitivity 
shift 
Sham 
1 48.8 ± 8.3 1.28 ± 0.26 0.40 ± 0.09 3.34 0.27 
2 57.8 11.1 0.95 ± 0.07 0.23 ± 0.03 4.26 ± 0.46 
4-6 4,0.7 ± 9.5 0.74 ± 0.09 0.31 ± 0.07 2.85 ± 0.47 
Rena salt 
1 36.1 ± 8.8 0.21 0.05* 0.11 0.02* 2.1 0.340 
2 68.2 ± 10.9 0.15 ± 0.03* 0.09 0.01* 1.46 ± 0.15* 
4 65.2 9.6 0.19 0.02* 0.08 ± 0.01* 2.58 ± 0.41 
6 30.1 ± 5.4 0.27 ± 0.04* 0.14 ± 0.02* 2.30 ± 0.30 
Angiotensin induced constrictor responses and angiotensin induced 
noradrenaline sensitivity shift in tissues from renal/salt and sham 
operated rats. (*Significantly different from sham control) 
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Mean % responses (n=11) to noradrenaline, injected into 
the perfused isolated mesenteric vasculature of normotensive rats, 
in the absence and presence (E ý) of angiotensin II 
amide (1Ö 
7M). Mean responses to noradrenaline were significantly 
greater (indicated by asterisks) in the presence of angiotensin, 
than in its absence. 
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sensitivity shift for preparations from renal/salt hypertensive and 
sham operated rats are given in Table 3: 6. 
Direct constrictor response amplitudes to angiotensin were 
not significantly different from the sham control in preparations from 
renal/salt hypertensive rats. However, the noradrenaline sensitivity 
shift induced by angiotensin II amide was significantly reduced in 
tissues from 1 and 2 week hypertensive rats whose reactivity shifts 
were predominantly due to increased sensitivity to noradrenaline 
(compare Tables 3: 3 and 3: 4). 
IIDu mmy". Experiments; The duration of the potentiating action 
of angiotensin and its influence on a further infusion of angio- 
tensin in tissues from normotensive rats 
Mean noradrenaline dose-response curves (a), (b), (c) and 
(d) (n = 8, see methods) are shown in Fig. 3: 10. The dose-response 
curves demonstrated that the noradrenaline potentiating effects of 
an infusion of 10 
?M 
angiotensin II amide did not wash out during 
1-2h perfusion with normal Krebs solution (compare lines b and 
c), and that a further exposure of the tissue to angiotensin II did 
not cause any further potentiation of noradrenaline induced responses 
(compare lines c and d). The tachyphylaxis to the direct constrictor 
effects of angiotensin II amide (10-7M) did wash out during the 1-2 
h normal Krebs perfusion. The mean constrictor response to the first 
" 
angiotensin infusion was 21.3 
± 6.8 mm Hg while the second infusion 
evoked a mean response of 40.6 
± 2.9 mm Hg (n = 6). 
iii) Vascular reactivity to potassium chloride 
The mean body weights and systolic blood pressuresof the 
renal/salt and normotensive unoperated rats are given in Table 3: 7. 
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Table 
Group Body Wt. g. B. P. mmHg n 
Norniotensive Control 238.4 27.2 113.2 2.3 10 
Renal/salt hypertensive, 
Weeks after nephrectomy 
2 201.0 20.0 179.5 ± 3.3* 8 
4 231.7 11.7 182.9 8.9* 7 
6 243.5 ± 25.2 158.0 ± 4.1* 5 
Mean body weights and systolic blood pressures of normotensive and 
renal/salt hypertensive rats, used for the determination of KC1 
reactivity. (' Significantly different from control) 
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Temporal changes in vascular reactivity 
In contrast to noradrenaline responses, there was no 
deviation in potassium chloride responses from the control, at 2 
weeks after nephrectomy (Fig. 3: 11). At the 4 and 6 week stages 
(Fig. 3: 12,13) there was a displacement of the dose-response line 
to the left, the maximum responses were elevated (Table 3: 8) but, 
as with the noradrenaline data, there was no significant increase in 
the'dose response curve gradient. The reactivity shifts of the 
"hypertensive" dose-response curves were calculated and are given in 
Table 3: 9" 
Temporal changes in vascular sensitivity 
In contrast to the noradrenaline sensitivity changes in 
tissues from hypertensive rats, there was no change in sensitivity to 
potassium chloride (Table 3: 10, Fig. 3: 14-16). 
The potentiation of potassium chloride responses by angiotensin 
II amide (1Ö 
7M) 
Angiotensin II amide (10 -? 1-1) appeared to potentiate potassium 
chloride responses slightly, but this potentiation was not statistically 
significant at any dose level (n = 6, Fig. 3: 17). 
iv) 1eactivity to _ 
noradrenaline, potassium chloride and anti= tensin 
II amide in perfused mesenteric vasculature preparations from 
12 week renal/salt hypertensive rats 
In order to determine whether the reactivity shifts to 
noradrenaline and potassium chloride reached equivalence at a later 
stage in hypertension, three rats were studied 12 weeks post- 
operatively (blood pressure = 175 
± 13.4 mm Hg, body weight = 
323.6 ± 8.7 g). Data from these preliminary experiments indicated 
that the reactivity shift to KC1 was less than that to noradrenaline, 
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Mean constrictor responses (mmHg) to KC1 of mesenteric 
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Table 3: 9 
Weeks after 50% maximal hyper- Control Rena salt 
nephrectomy tensive response Mean dose Mean dose Reactivity 
amplitude mmHg gx 10-4 gx 10-4 Shift 
2 36.0 7.9 1.3 6.8 0.5 0.97 0.06 
4 42.0 9.7 1.8 10.2 1.9 1.12 0.10 
6 57.0 16.9 4.7 6.5 2.1* 3.5 ± 0.47* 
The mean KC1 reactivity shift of mesenteric vasculature preparations 
from renal/salt rats. (* Indicates significantly different from 
normotensive control, mean dose indicates the dose to evoke a 50% "hyper- 
tensive" response amplitude in individual sham control tissues). 
Table 3: 10 
Control ED 0. dose-4 
KCI x 10 
Renal/salt. 
Weeks after 
EDSý/ dose 
4 
g KC1 gx 10 
nephrectomy 
Normotensive 8.0 ± 1.1 2 6.8 0.5 
4 10.2 1.9 
6 6.5 2. 
KCl mean ED5 doses for tissues from renal/salt hypertensive and 
normotensive rats 
Table 3: 11 
Group Body wt. B. P. Angiotensin Angiotensin n 
g mmHg Response induced nor- 
mmHg adrenaline 
sensitivity 
shift 
4-6 week Sham 263,0 8.1 114,5 ± 5.2 40.7 ± 9.5 2.85 ± 0,47 7 
4-6 week malig- 194,0 13.5* 221,5 ± 3,6* 23.5 ± 12.3 2.48 ± 0.30 6 
nant 
Mean body weight, blood pressure, angiotensin response and angiotensin 
induced noradrenaline sensitivity shift in tissues from sham operated 
and malignant hypertensive rats 
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Fig. : 14 
Mean constrictor responses to KCl (; ö of the maximum 
response) of mesenteric vasculature preparations from normotensive 
(n=10) and renal/salt hypertensive (n=8) rats, 2 weeks post- 
operatively. Compare with Fig. 3: 11. 
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Fig. 3: 1 
Mean constrictor responses to KC1 (% of the maximum 
response) of mesenteric vasculature preparations from normotensive 
(n=10) and renal/salt hypertensive (n=7) hypertensive rats, 4 
weeks post-operatively. Compare with Fig. 3: 12. 
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/ 
j 
o---o Normotensive. 
ý- -a Hypertensive. 
6 Weeks. 
10 
Mean constrictor responses to KC1 (expressed as % of 
the maximum response) of mesenteric vasculature preparations from 
normotensive (n=10) and renal/salt hypertensive (n=5) rats, 6 weeks 
post-operatively. Compare with Fig. 3: 13. 
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while angiotensin induced responses and the angiotensin induced 
noradrenaline reactivity shift did not differ from the control. 
v) Vascular resistance in the perfused mesenteric vasculature 
preparation from normotensive and "6 week" hypertensive rats 
Perfusion pressure-flow characteristics of mesenteric 
vasculature preparations from normotensive rats (n = 6) and "6 week" 
hypertensive rats (n = 6, mean systolic blood pressure = 194.3 
1 7.8 
mmHg) were examined. Flow rates of 2,4 and 8 ml/min in "normotensive" 
tissues caused respective mean - S. E. M. maximum pressures of 65.5 
0.9,112.1 ± 1.1,211.0 ± 2.4 mmHg, and in "hypertensive" tissues 
caused significantly greater pressures of 70.8 
* 1.3,120.8 ± 3.0, 
and 222.5 2.6 mmHg. Although an increase in vascular resistance 
was detected, the amplitude of this change was very small. 
vi) Vascular reacti. vit to noradrenaline otassiun chloride and 
an otensi_n II in mesenteric vasculature preparations from 
renal/salt hyyrertensive rats with blood pressures exceeding 
200 mmHg, 4-6 weeks post-operatively. 
Reactivity to noradrenaline and angiotensin 
The mean systolic blood pressure, body weight, angiotensin 
evoked response amplitude and angiotensin induced noradrenaline 
sensitivity shift are given in Table 3: 11. (p 109). 
Both reactivity and sensitivity to noradrenaline were not 
significantly different from control, except that there was a 
significant depression of the maximum response (Fig. 3: 18,19). 
Reactivity to potassium chloride 
Mesenteric vasculature preparations from three rats (4-6 
weeks after contralateral nephrectomy, mean body weight = 201.0 
1 
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Fig. 3: 18 
Mean constrictor responses (mmiig) to noradrenaline of 
mesenteric vasculature preparations from sham operated (n=7) and 
renal/salt hypertensive rats with blood pressures. exceeding 200 mmHg 
(n=6), 4-6 weeks post-operatively. Note the absence of shift of 
the "hypertensive" dose-response curve and the depression of the 
maximum response. 
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Share. 
: Hypertensive. 
ks. 
Mean constrictor responses to noradrenaline (expressed 
as a% of the maximum response) of mesenteric vasculature preparations 
from sham operated (n=7) and renal/salt hypertensive rats whose 
blood pressure had exceeded 200 mmHg, 4-6 weeks post-operatively. 
Note the absence of a significant shift of the "hypertensive" dose- 
response curve. 
001 0.1 " 1.0 10 
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18.7 g, mean systolic blood pressure = 211.7 
± 2.4 mmHg) were hypo- 
reactive to potassium chloride, with depressed maximum responses 
(Fig. 3: 20). 
d) DISCUSSION 
Previous investigations have demonstrated increased reactivity 
to noradrenaline in perfused preparations from renal hypertensive 
rats (Chap. 1). The results of the present study elucidate this 
phenomenon in detail and separate the true supersensitivity component 
from the increased reactivity. 
During the 1 and 2 week stages of hypertension, the nor- 
adrenaline dose-response curve shift was caused by an increase in 
vascular sensitivity to the agonist (Fig. 3: 21). The supersensitivity 
was' characterized by a lower vasoconstrictor threshold dose with no 
elevation of the maximum response. Haeusler and Haefely (1970) have 
demonstrated a similar supersensitivity in the pharmacologically or 
surgically denervated mesenteric vascular bed, and the angiotensin 
II potentiation of noradrenaline responses, described in the present 
study (Fig. 3: 9) also shows similar characteristics. 
During the 4 to 6 week stages of hypertension the super- 
sensitivity of the mesenteric vasculature declined and the noradrenaline 
dose-response curves (Fig. 3: 3,4) exhibited some of the characteristics 
i1 
ascribed to an increased wall/lumen ratio (Folkow, Hallback, Lundgren 
and Weiss, 1970c). The maximum noradrenaline evoked constrictor 
responses were elevated but the dose-response curves were not significantly 
steeper than control. The "6 week hypertensive" dose-response curve was 
significantly steeper than the "1 week hypertensive" curve indicating 
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Fig. 3: 20 
Control. 
Hypertensive. 
4- 6 Weeks. 
lo- I 
Mean constrictor responses to KC1 (mmHg) of perfused 
mesenteric vasculature preparations from normotensive (n=10) and 
renal/salt hypertensive (n=3) rats whose blood pressure had 
exceeded 200 mmIig, 4-6 weeks post-operatively. Note 
the markedly reduced maximum response of the hypertensive tissues. 
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Fig. 3: 21 
Summary Figure 
Upper trace; mean systolic blood pressure of rats used. 
Middle trace; angiotensin induced sensitivity shift of noradrenaline 
dose-response curves made on tissues from sham operated and renal/salt 
hypertensive rats. 
Lower trace; histogram comparing noradrenaline reactivity shift 
VCM 
noradrenaline sensitivity shift 
Q, 
KCl reactivity shift 
and calculated noradrenaline non-supersensitive slo. ft remainder 
Note 1). The reactivity shift reaches a maximum before the blood 
pressure. 
2). In the early (1 and 2 week) stages of renal/salt hypertension 
the noradrenaline reactivity shift is caused by a change in sensitivity 
which corresponds with a reduction in the noradrenaline potentiating 
actions of exogenous angiotensin II. 
3). Reactivity to KC1 increases in the later (4 and 6 week) stages 
of renal/salt hypertension and corresponds to the non-supersensitivity 
induced noradrenaline reactivity shift remainder. The potentiating 
action of exogenous angiotensin II are normal in the later stages of 
hypertension. 
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that although a structural vascular change may have occurred, some 
degree of supersensitivity was still present. The increased resistance 
to flow in "6 week' hypertensive" tissues was minimal, and it is 
possible that medial hypertrophy in this vascular bed does not involve 
any luminal narrowing. Other investigators of-vascular reactivity in 
this preparation from hypertensive rats (Haeusler and iIaefely, 1970., 
Haeusler and Finch, 1972b., McGregor and Smirk, 1970) have failed to 
find any increase in vascular resistance, although a small increase 
was demonstrated by McGregor and Smirk (1968) by using large numbers 
of rats. 
In a recent study (Lundgren, Hallbäck, Weiss and Folkow, 
1974) vascular reactivity to noradrenaline was investigated during 
the development of renal hypertension, using the rat perfused hind- 
quarters preparation. It was concluded that medial hypertrophy and 
an increased wall/lumen ratio occurred 2 weeks after the induction of 
hypertension and that there was no component of vascular super- 
sensitivity. Dose-response curve shift data was not reported, therefore 
any supersensitivity present would have been ignored in the analysis of 
the results. An increase in the resistance to flow, the noradrenaline 
dose-response curve gradient and in the maximum response at the 2 week 
hypertensive stage indicated apparent hyperreactivity. However, the 
paired "t" test used is not as rigorous as the unpaired test used in the 
present study. Further analysis of the results of Lundgren, Hallba'cx, 
Weiss and Folkow (1974), using an unpaired "t" test, shows that the 
increased dose-response curve gradient was not significant at the 2 week 
hypertensive sage. The slope analysis used in this study involved measure- 
ment of the tangent of the angle rather than the fitting of regression 
lines to the dose-response data. 
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The results of the present study indicate that true vascular 
supersensitivity to noradrenaline does occur in renal hypertensive 
rats, and that this supersensitivity reaches a maximum before the 
blood pressure (Fig. 3: 21). The later apparent hyperreactivity is 
probably a consequence of the high blood pressure since it was related 
to the duration of the hypertension. 
Reactivity to noradrenaline in tissues from malignant 
hypertensive rats (blood pressure : 200 mmHg) was normal (Fig. 3: 18,19) 
but with a reduced maximum response. The dose-response curves to 
potassium chloride (Fig. 3: 20) also exhibited a reduced maximum, but 
with abypo-reactivity over the dose-range used. The reduction in 
contractility may have been due to degenerative changes in the vessels 
(Gardner and Matthews, 1969) caused by the extremely high blood 
pressure and poor state of health of these animals. 
The normal reactivity to potassium chloride at 
the 2 week hypertensive stage provides evidence that the early true 
noradrenaline supersensitivity was specific. Haeusler and Haefely 
(1970) found that denervation of the mesenteric vasculature preparation 
caused a pre-junctional supersensitivity to noradrenaline, but had no 
effect on potassium chloride induced responses. 
The dose-response relations for potassium chloride at the 
4 and 6 week hypertensive stages were in agreement with the nor- 
adrenaline results at these time points, i. e. an elevation of the 
maximum response with no significant increase in gradient over control. 
However the 6 week potassium chloride reactivity shift was only about 
0.5 of the noradrenaline reactivity shift. An increase in wall/lumen 
ratio of the vessels should cause the same degree of shift to all 
agonists. In contrast to noradrenaline, a structural vascular change 
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may therefore be the sole factor involved in apparent KC1 hyper- 
reactivity.. 
The inequality of the dose-response curve shifts to nor- 
adrenaline and KC1 at the 12 week hypertensive stage indicates that 
a component of true supersensitivity to noradrenaline was still 
present at this stage. The shift of the noradrenaline dose-response 
curve due to factors other than supersensitivity was calculated by 
dividing the sensitivity shift into the reactivity shift (Fig. 3: 21). 
It is interesting that the KC1 apparent hyperreactivity shift at the 
6 week hypertensive stage was-of a similar magnitude to the non- 
supersensitive shift rcrlainder for noradrenaline responses. 
Direct constrictor responses to angiotensin were not 
significantly greater in tissues from hypertensive rats than from 
sham controls, but were significantly greater than responses obtained 
in tissues from normotensive unoperated rats. Direct constrictor 
responses to angiotensin II have been shown to be greater than normal 
in rats with. adrenal regeneration hypertension (Gardner and Honore, 
1964a), renal hypertension or spontaneous hypertension (McGregor and 
Smirk, 1968). The results of the present study are inconclusive, 
since only one dose level and an infusion rather than a bolus injection 
of angiotensin II was used. An evaluation of reactivity to 
angiotensin requires full dose-response curves, but this type of 
study has the disadvantage that tachyphylaxis to angiotensin would 
make the construction of full dose-response curves very tedious. 
An infusion of angiotensin II amide potentiated noradrenaline 
responses. This potentiation, or sensitivity shift has been previously 
reported, and various mechanisms have been suggested. Palaic and 
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Khairallah (1967) have shown that angiotensin II inhibits the neuronal 
uptake of noradrenaline. Pals and Fulton (1968) have suggested that 
a synergism exists between the contractile effects of angiotensin II 
and noradrenaline. Baudouin, Meyer, Fermandjain and Norgat (1972) 
have proposed that angiotensin II increases the amount of free intra- 
cellular Ca 
++ in the vicinity of the contractile elements in smooth 
muscle, by releasing or loosening membrane bound Ca+ Day and Moore 
(1973) suggest that the enhancement of noradrenaline responses by angio- 
tensin II may be a consequence of an inhibition of the sodium pump. 
The results of the present study do not indicate which of these ex- 
planations is correct. An inhibition of the sodium pump by angio- 
tensin is, however, incompatible with the failure of angiotensin to 
potentiate KC1 induced responses. Panisset and Bourdois (1968) studied 
the interaction of angiotensin and noradrenaline on the perfused cat 
mesenteric vasculature preparation. Their results indicated that 
angiotensin potentiated noradrenaline responses by a combination of 
re-uptake blockade and a direct action on the smooth muscle cell. 
The attenuation of the noradrenaline potentiating actions of 
exogenous angiotensin at 1 and 2 weeks after contralateral nephrectomy 
could be a consequence of the "hypertensive" supersensitivity shift, 
which was maximal at these stages. In the early phases of renal/salt 
hypertension, the process causing supersensitivity could be stimulated 
by various factors, and exogenous angiotensin would be less effective 
in stimulating the already near maximally activated process. One of 
the factors which might stimulate the early supersensitivity could be 
endogenous angiotensin II. Plasma renin activity is elevated in the 
early stages of "Goldblatt clip" and aortic co-arctation hypertension 
(Brown, Davies, Olichney and Johnston, 1966., Carretero, Kuk, 
Piwonska, Houle and darin-Grez, 1971). Plasma renin levels are 
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normal or low in "Grollman hypertensive" rats (Vapaatalo, Lahovaara 
and Hackman, 1970., Menard, Alexandre, Giudicelli, Auzan and 
Chevillard, 1973). However, these levels were measured in the later 
stages of hypertension, and plasma renin activities in the early 
stages of this form of hypertension are unknown (Chap. 5). 
The "dummy" experiments using tissues from normotensive 
rats demonstrated that a previous exposure to a high level of angio- 
tensin would reduce or negate the potentiating effects of a further 
infusion. If the circulating levels of endogenous angiotensin in the 
acute renal hypertensive rat were high, one might expect a depression 
of the noradrenaline potentiating effects of an infusion of exogenous 
angiotensin, and a potentiation of noradrenaline induced responses. 
Potassium chloride induced responses were not significantly 
potentiated by 10-7M angiotensin II amide. The lack of "hypertensive" 
supersensitivity to potassium chloride at the 2 week stage adds further 
evidence to the hypothesis that elevated levels of endogenous angio- 
tensin II caused the specific noradrenaline supersensitivity in the 
early (1 and 2 week) stages of hypertension. 
The noradrenaline dose-response curve shift, induced by 10 
7M 
angiotensin II amide, ranged from 2.6-4.3, whilst the sensitivity shift 
demonstrated in tissues from 1 and 2 week hypertensive rats was 7.5-8.0. 
This quantitative discrepancy is evidence against the hypothesis that 
endogenous angiotensin II caused the "hypertensive" supersensitivity. 
A concentration of 10-? M angiotensin II would be unlikely in vivo, 
since the concentration in normal rat blood is around 2x 10 
1-M 
(Slack, Brown and Powell, personal communication). Angiotensin II 
levels in renal hypertensive rats are not available but Gocke, Gerten 
Sherwood and Laragh (1969) have measured levels of 10-10-1Ö 
9M 
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angiotensin II in plasma from humans with renal artery stenosis. 
However, endogenous 1-Asp-5-Ile angiotensin II is more potent 
in vivo than the synthetic 1-ß. s n-5-Val angiotensin II amide used in 
this study (Naka,; ima, Sakakibara, Sakuma and Sokabe, 1973) and a 
15 min in vitro exposure is not quantitatively comparable with an 
elevation of plasma levels over a period of several days. 
CHAPTER 4 
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STUDIES ON THE NECFU-iNISM or V,, 6CULkl ; ýb: E L: ýv ýIi, IVITý' IN N &ENTE1IC 
VASCULATURE Pf PAR', TIONS FRON iE NAL/. SALT RATS 
INTRODUCTION 
Increased vascular reactivity has been demonstrated in 
mesenteric vasculature preparations from renal/salt hypertensive rats 
(Chap. 3). The early phase of "true supersensitivity" exhibits the 
characteristics of an increased degree of smooth muscle shortening 
for a given sub-maximal dose of noradrenaline. in the later phase of 
increased reactivity, the vascular smooth muscle exhibits increased 
contractility, which might involve an increased 
wall/lumen ratio. In the later phases of hypertension there is a small 
persistent component of supersensitivity. 
This chapter describes experiments designed to investigate 
the mechanism of this supersensitivity. Two mechanisms are considered, 
a) changes in cellular calcium regulation, which might cause a non- 
specific supersensitivity, b) changes in the characteristics of the a- 
adrenoceptor, which might cause a specific noradrenaline supersensitivity. 
An impairment of neuronal noradrenaline re-uptake might also cause a 
specific supersensitivity. An investigation of noradrenaline re-uptake 
in vessels from hypertensive aniials was beyond the scope of the present 
study. 
1) THE INVOLVENE NT OF C,; LCIUM IN TF: ; INCid,:, SED SLINISITIVITY TO NCR- 
ADRENALINE OF MESENTERIC VESSELS Kil RI, T; AL/S, 'A.. LT INI PEt: TENSIVE RATS 
a) INTRODUCTION 
Calcium is essential for vascular smooth muscle contraction 
(Waugh, 1962., Bohr, 1964., Hinke, Wilson and Burnham, 1964). There is 
an increase in the amount of calcium or a change in the calcium 
dependance in vessels-from renal hypertensive rats (Tobian and Chesley, 
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1965., Grollman and Krishnamurty, 1973). The following experiments 
were designed to investigate whether a re-adjustment of intracellular 
calcium regulation is the cause of vascular supersensitivity. 
b) METHODS 
The induction of renal/salt hypertension (Grollman, 1944), 
the measurement of systolic blood pressure (Gerold and Tschirky, 1968) 
and the perfused mesenteric vasculature preparation 
(McGregor, 1965) have 
been described (Chap. 2). Mesenteric vessels supplying a standard 13 cm 
length of intestine, from the caecal end, were perfused. 
i) Perfusion solutions 
The normal Krebs solution previously described (Chap. 2) with 
the addition of Na2E. D. T. A. (0.026 mM) was used. When Ca 
++ 
- free Krebs 
solution was used, CaCl 2 and 
Na2E. D. T. A. were omitted, and E. G. T. A. 
(0.2 A) was added. 
ii) Experimental Procedure 
Mesenteric vasculature preparations from renal/salt hyper- 
tensive rats, 2 and 6 weeks after nephrectomy, and weight matched controls 
were perfused with normal Krebs solution (2 ml/min) for 1h at 37OC. 
The following procedure was used: - 
a) Krebs solution containing noradrenaline (1 ug/ml) was 
perfused for 5 min, during which time the evoked con- 
strictor response stabilized. 
b) Ca ++ -free Krebs solution containing noradrenaline (1 vg/ml) 
was perfused for 13 min, and the decay of the constrictor 
response observed. 
c) The tissue was perfused with normal Krebs solution for 
15 min. 
- 129 - 
d) Stages a) - c) were repeated until the decay pattern 
stabilized. 
e) Normal Krebs solution containing angiotensin II amide 
(10-7M) was perfused for 15 min. 
f) Stages a) - c) were repeated with angiotensin II amide 
(10-7M) in all Krebs solutions. 
An infusion of noradrenaline was used since preliminary 
experiments showed that the decay of responses to interm. ttent nor- 
adrenaline stimulation was :3h in 0.5 m14 E. G. T. A. Caý+ -free Krebs 
solution (n=5). A concentration of noradrenaline (1 iig/nl) which 
evoked a near maximum response was used. 
iii) Analysis of results 
The time taken for the noradrenaline evoked constrictor 
response to decay to 50;:, of the maximum response, for that tissue, was 
calculated and designated "decay half time". The "initial decay slope" 
of the noradrenaline response was evaluated by fitting regression lines 
to the decay pattern, plotted as a% reduction from the initial response, 
from 0.5 to 4.5 min in Ca 
++ 
-free Krebs solution. 
c) RESULTS 
The mean body weight, blood pressure and mesenteric vasculature 
noradrenaline evoked response amplitude for the hypertensive rats and 
their normotensive controls are given in Table 4: 1. . 
Noradrenaline responses in tissues from all hypertensive 
animals and those which had been exposed to angiotensin II developed 
more rapidly and with a shorter latency of onset than in control tissues 
(Fig. 4: 1). 
The initial'effect of exposure of the tissues to Ca ++ -free 
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Table 4: 1 
Body weight, systolic blood pressure and mesenteric vasculature nor- 
adrenaline response amplitudes for hypertensive and normotensive rats 
Parameter Normotensive 
Control Rats 
2 week Hyper- 
tensive Rats 
Normotený4; ve 
Control . '-, ts 
6 week Hyper- 
tensive Rats 
wt. (g) 206.1 9.6 202.3 5.5 273.0 10.2 289.0 7.7 
B. P. (mirdig) 105.9 4.4 178.6 ± 2.9* 121.4 3.7 172.8 8.2* 
Noradrenaline 
response (mmllg) 153.7 
+ 15.1 196.9 22.1 123.4 ± 8.9 206.9 ± 16.0* 
n 7 9 7 6 
*Significantly different from weight-matched normotensive 
controls. The noradrenaline response amplitudes were measured after 
5 min exposure to the agonist. 
Table 4: 2 
Decay half times and regression line data for tissues from 2 and 6 week 
renal/. alt hypertensive rats and normotensive controls, with and without 
angiotensin II treatment 
Group Angio- Abbrev- Decay Regression line data 
tensin iation time min 
treat- 
. 
y x Slope c C- 1-1I 
ment Sd. cef 
2 weeks 
Control - 2WC 2.9410.22 32.0 2.5 16.6±1.4 -9.5 0.9 
Control + 2WCA 4.1710.43* 28.3 2.5 13.7±1.2 -6.0 0.9 
Hypertensive - 21, JH 4.27±0.46* 20.6 2.5 12.2±1. O* -10.0 0.9 
Hypertensive + 2WHA 4.761o. 82* 29.5 2.5 12.9±0.9* -2.8 0.9 
6 weeks 
Control - 6wC 4.06±0.35 17.3 2.5 13.511.2 -16.3 0.9 
Control + 6WCA 6.7310.47* 18.0 2-. 5 9.2+0.6* -5.0 0.9 
Hypertensive - 6WH 4.04+0.34 25.3 2.5 11.010.8 -2.4 0.9 
Hypertensive + 6WHA 6.49-1.0* 23.2 2.5 9.0_0.9* 0.6 0.9 
*Significantly different from weight matched controls. 
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Fig. 4: 1 
Mean pressure records of typical noradrenaline (1 jig/ml) induced 
-constrictor responses of the perfused mesenteric vasculature pre- 
pa ration in the presence and absence of angiotensin II amide (10 
7M). 
After an initial 0.5 min time lag due to dead space in the apparatus, 
the tissue from the hypertensive rat (2 week stage) and tissues exposed 
to angiotensin respond immediately and the responses develop more 
rapidly than in control. 
d 
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Krebs solution (Fig. 4: 2) was often characterized by a small increase 
in response amplitude, probably due to the removal of membrane stabilizing 
calcium (Bohr, 1964). The response subsequently decayed to about 20% 
of its original amplitude in 12 min. A constrictor response occurred 
when normal Krebs perfusion wa's recommenced. This could have been due 
to residual noradrenaline, which would evoke a response as soon as 
activator Ca 
++ 
was available. 
i) Analysis of the noradrenaline decay curves of tissues from renal/salt 
hypertensive rats 2 and 6 weeks after ne hrectomy and weiht matched 
normotensive controls 
The decay patterns of tissues from 2 week control and 2 week 
hypertensive rats are shown in Fig. 4: 3, the effects of angiotensin II 
on the decay pattern of 6 week control tissues is shown in Fig. 4: 4. 
The decay half times and the regression line data computed from the nor- 
adrenaline decay curves are given in Table 
4: 2 (p 130). 
Exposure of normal tissues (2'wC, 6WC, see Table 4: 2) to 
angiotensin (2vJCA, 6ý"ýCý, ) caused significant prolongations of their 
noradrenaline decay half times. Tissues from 2 week hypertensive rats 
(21*H) had significantly longer decay half times than the controls (2WC), 
whereas decay half times, measured in tissues from 6/H rats did not 
differ from the controls (6wC). Exposure of tissues from hypertensive 
rats (2iIH, GifH) to angiotensin (2VAIA, 6WHA) caused a significant 
prolongation of the decay half time at the 6 week but not at the 2 week 
hypertensive stage. The initial slopes (Table 4: 2) derived from the 
decay of noradrenaline responses in Ca -free conditions showed an 
inverse relationship to decay half time. However, the initial decay 
slope of 641 tissues was less than control (6iIC) whereas the decay half 
times for the two groups were similar. 
E 
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Fig. 4: 2 
A typical mean pressure record of the decay of a noradrenaline induced 
contraction of the perfused mesenteric vasculature preparation in Ca++ 
-free conditions. An initial contraction is evoked b'; infusion of 
1 jig/ml of noradrenaline; transfer to Ca*+ -free Krebs solution causes 
the decay of the response after an initial small potentiation. A 
further constrictor response occurs on recommencing normal Krebs 
perfusion. 
.0 
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Fig. 4: 
The decay of noradrenaline (1,11g/ml) induced constrictor responses in 
calcium-free conditions, in mesenteric vasculature preparations from 
normotensive ( s-" )-and two week renal salt hypertensive (N. " - 4a) 
rats. The decay is expressed as the % reduction from the original 
response amplitude. 
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Fig, 4: 4 
The decay of noradrenaline (1 ug/ml) induced constrictor responses in 
calcium-free conditions in mesenteric vasculature preparations from 
normotensive rats (6 week control) in the absence ( S- s) and 
presence (u- -i) of angiotensin II amide 10-7H. The decay is 
expressed as the % reduction from the original response amplitude. 
Time in Cä free conditions (min). 
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d) DISCUSSION 
The results of this study confirm the previous observation 
that there is a difference between the behaviour of mesenteric arterioles 
from rats at the 2 and 6 week stages of renal/salt hypertension. The 
near maximum noradrenaline constrictor responses evokel in 6WHi tissues 
were significantly larger than controls (6: C), whereas the responses 
of 2WH and 2WC tissues were not significantly different. In contrast, 
the significant differences from controls of decay half time and slope 
in 2WH tissues were not observed in tissues from 6l"IH rats. Exposure 
of 2WH tissues to angiotensin II (2W1A) had no effect on the decay 
parameters, but tissues from normal (2WC, 6'ß. 'C) and 6`41 rats mimicked 
the behaviour of 241H tissues after exposure to angiotensin II (2ýiCA, 
6WCA, 6w11A). 
This study was designed to investigate the effects of angio- 
tensin II and hypertension on vascular calcium regulation. The decay 
of noradrenaline induced responses in calcium-free conditions was used 
as an indicator of calcium washout. The decay of noradrenaline evoked 
constrictor responses in Ca -free Krebs solution could have been due 
to distortion-or disruption of the ct-adrenoceptor (Tuttle and Moran, 
1969). This is unlikely because complete calcium depletion was not 
achieved, since the contraction was not totally abolished. In addition, 
the noradrenaline response decay rate was mainly dependant on the 
intensity of stimulation rather than, on the period of exposure to Ca ++ 
-free Krebs solution. An inhibition of membrane bound enzyme systems 
was also unlikely, since vascular responses to noradrenaline and 
potassium chloride are known to decay at different rates in Ca -free 
conditions (Hinke, Iilson and Burnham, 1964). Removal of "activator" 
calcium from the mesenteric arterioles is the most likely explanation 
of the noradrenaline response decay. 
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A reduction in noradrenaline response decay slope or a 
prolongation of decay half time is therefore interpreted as indicative 
of an increased intracellular calcium concentration [Ca++]. This could 
be achieved by an increased influx or a decreased efflux of the ion. 
The' passive influx of calcium is determined by the concentration 
gradient and the permeability of the cell membrane (Rasmussen, 1970). 
Holloway and Bohr (1973), have suggested that the cell membrane of the 
femoral artery smooth muscle in the renal hypertensive rat is more 
labile than normal. This is thought to be unlikely in the early renal/ 
salt hypertensive rat since mesenteric vasculature responses to 
potassium chloride have been shown to be normal (Chap. 3). An inhibition 
of the active efflux of Ca++ is the more probable explanation of the 
present results. 
Grollman and Krishnamurty, (1973) have reported similar results 
using aortae from acute and chronic renal hypertensive rats. The 
slower rate of relaxation of strips from acute hypertensive rats was 
interpreted as indicating an increased amount of available calcium which 
could cause supersensitivity of the aorta. Aortic strips from chronic 
renal hypertensive rats exhibited little change in sensitivity or in the 
rate of relaxation. An increased intracellular [Ca 
++] 
could be the 
cause of true vascular supersensitivity in the present study. Tissues 
which exhibited significantly reduced decay slopes and prolonged decay 
half times (214x, 2WCA, 6WCA) have previously been shorn to be super- 
sensitive to noradrenaline. Tissues from 6WH rats differed from controls 
by a small decrease in decay slope, and have a small degree of super- 
sensitivity (Chap. 3). 
An increased intracellular [Ca ], would also explain the 
difference in response profile between normal and hypertensive or 
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angiotensin-treated tissues. The early fast phase of arterial con- 
traction to noradrenaline is thought to be due to the release of intra- 
cellular calcium, whereas the later slow phase is caused by extra- 
cellular calcium (Sitrin and Bohr, 1971). All hypertensive (2wß, 6WH) 
and angiotensin treated tissues (2WCA, 6WC;; ) responded more rapidly 
to noradrenaline than controls indicating a greater release of intra- 
cellular calcium. Only in 6w11 tissues was the amplitude of the slow 
phase of the noradrenaline response significantly elevated (Table 4: 1). 
If an adaptive structural change in 6V1H tissues had occurred, as 
6 
suggested by Folkow, iiallbäck, Lundgren and Weiss (1970 c), it would 
account for the greater amplitude of both phases of the noradrenaline 
response observed in the present study. 
Angiotensin II prolonged the noradrenaline decay half time 
and reduced the decay slope. Several explanations could account for this 
action. Angiotensin II could stabilize the cell membrane so that Ca 
++ 
-free solutions would be less effective, but any stabilization would 
reduce reactivity. Angiotensin II might block the neuronal re-uptake 
of noradrenaline (Palaic and Khairallah, 1967), but this would have no 
effect in the, present experiments since noradrenaline was in excess, 
and neuronal re-uptake is calcium dependant (George and Leach, 1973)" 
Blockade of re-uptake by cocaine (Nicholas, 1970) or by desmethyl- 
imipramine at 10-6 M (preliminary observation, n=5) has no significant 
effect on the noradrenaline potentiating actions of angiotensin II. 
Inhibition of noradrenaline re-uptake by angiotensin II is therefore 
regarded as unlikely. 
Daniels, Severs and Buckley (1967) have shown that angiotensAn 
II stimulates the uptake of calcium into soft tissues. Long term in- 
fusion of angiotensin II increases the sodium and calcium content of 
dog arteries (Villamil, Nachev and Kleeman, 1970). Microsomal binding 
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of Ca is reduced by angiotensin Ti (Baudouin-Legros and Meyer, 1975) 
perhaps by reducing cyclic ANP levels (Angles D'Auriac, Baudouin and 
Meyer, 1972). These reports, together with the present data, support 
the hypothesis that angiotensin II reduces the active efflux of calcium. 
The results-of this study indicate that the vascular super- 
sensitivity of renal salt hypertension may involve an increase in available 
activator calcium. Angiotensin II also appears to stimulate this 
mechanism. 
2) THE CHARACTERISTICS OF THE a-ADRENOCEPTOR IN P: ESENTLRIC VASCULATURE 
PR ARATIGIJS FROM. RENAIýSIýLT rý. 'I'I; _; "'Tt iý? TVE t{Iý ' 11 2 AND 6 WEEKS AF1'L; RRs. 
CONTIRALtilUAL NEPH} EC1 N 
a) INTRODUCTION 
There is no reported ovidence of changes in the character- 
istics of the a-adrenoceptor in vessels from hypertensive humans or 
animals. The number of a-adrenoceptors-, and the pA2 and Kb values for 
phentolamine on these receptors, are normal in vessels from hypertensive 
humans and S. H. R. (Clineschmidt, Geller, Govier and Sjoerdsma, 1970., 
Janis and TriSCle, 1972., Horwitz, Clineschmidt, Van Burcn and Ommaya, 
, .. 1974). 
In the present study, phentolamine"and indoramin were used 
to investigate the characteristics of the x-adrenoceptors in mesenteric 
vasculature preparations from renal/salt hypertensive rats. Initial 
studies with indoramin revealed a difference between the pA2 value 
determined on the mesenteric vasculature preparation from the normo- 
tensive rat and the value previously reported for the guinea-pig aortic 
spiral preparation (Alps, Hill, Johnson and Wilson, 1972). This unusual. 
action of indoramin was investigated further using the guinea-pig mes- 
enteric vasculature preparation and the rat aortic spiral. 
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b) METHODS 
The measurement of conscious systolic blood pressure and the 
induction of renal/salt hypertension have been described (Chap. 2). 
i) The isolated rat mesenteric vasculature preparation 
The isolated rat mesenteric vasculature preparation has been 
described (Chap. 2). Preparations from normotensive and renal/salt 
hypertensive rats 2 and 6 weeks after contralateral nephrectomy were 
examined. 
ii) The normotensive guinea-pig isolated perfused mesenteric vasculature 
preparation 
Male guinea-pigs (500-750 g) were used, the general technique 
was similar to that described for the rat mesenteric preparation. The 
guinea-pigs were more difficult to anaesthetize with intraperitoneal 
pentobarbitone sodium than rats. The technique of intra-thoracic in- 
jection of the anaesthetic (30 mg/kg) proved to be efficient. A perfusion 
fluid flow rate of 2.6 ml/min and a perfusion cannula with a terminal o. d. 
of 1.02 mm were used. The perfusion rate and cannula size were necessarily 
larger than those used for the rat. 
iii) The normotensive rat or guinea-pig isolated aortic spiral preparation 
(Furchgott and Bhadrakom, 1953) 
Experiments on aortic spirals were made using Krebs solution 
at 370 and bubbled with 5% carbon dioxide in oxygen. Organ bath volumes 
" 
of 38 ml were used and ascorbic acid (10-4 M) was added to prevent 
oxidation of noradrenaline. This concentration of ascorbic acid was 
without effect on the contractile mechanism. of the tissues used. 
Contractions of the thoracic aorta were recorded by a variable 
inductance transducer (0.5 g load) connected to a phase discriminator and 
pen recorder. Cumulative dose-response curves were obtained for nor- 
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adrenaline, added to the bath every 5 min. 
iv) Experimental Procedure 
When the tissue had reached full sensitivity to noradrenaline, 
a control dose-response curve was made. The tissue was exposed to the 
antagonist drug phentolamine (5 x 10-8 - 10-51M1) or indoramin (5 x 10-8 - 
10 
5N) 
until antagonist equilibriums., as achieved i. e. when constant 
agonist responses were evoked. The noradrenaline dose-response curve was 
repeated in the presence of the antagonist. Usually, three concentrations 
of antagonist (in order of increasing concentration) were tested on each 
tissue. 
v) Analysis, of results 
In each experiment, the mean dose-ratio was calculated from 
measurements taken at points approximating to ED3MJ, EDSOr, and ED70rý on 
the log dose-response lines obtained in the presence and absence of the 
antagonist (Gaddum, Hameed, Hathway and Stephens, 1955). This ratio was 
subjected to the analysis described by Arunlakshana and Schild (1959) 
and the pA2 values were determined graphically (Fig. 4: 5). 
The apparent dissociation constants of the antagonists from 
11 
the a-adrenoceptors (K b) were calculated 
from the formula: - 
Kb = Molar concentration of antagonist 
Agonist dose-ratio -1 
or Kb =B mol/1. 
x-1) 
The noradrenaline dose-response curves made on mesenteric 
vasculature preparations from renal/salt hypertensive and normotensive 
rats, used for pA2 determinations, were compared and the reactivity and 
sensitivity shifts calculated as previously described (Chap. 3). 
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Fig. 4: 5 
The relation between the dose-ratios of noradrenaline and concentrations 
of indoramin hydrochloride on the mesenteric vasculature preparation 
of the normotensive rat, plotted by the method of Arunlakshana and 
Schild (1959). A calculated regression line was fitted to 21 points 
each of which represents a mean dose-ratio for one experiment. The 
slope function of the line was -. 1.06, which is close to the theoretical 
value of unity for competitive antagonism. The line intersects the 
abscissa at the pA2 value of 8.05, the pA10 value (where log dose-ratio 
-1 = 0.954) is 7.1.5. 
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c) RESULTS 
Using the calculated mean dose-ratio (x) of noradrenaline 
from each experiment, the log. (x-1) was plotted against the negative 
log. of the molar concentration of the antagonist. The calculated 
regression line intersected the abscissa at the pA2 value (Fig. 4: 5). 
i) Th va values for i ndoramin and phentolamine on tissues from 
normotensive rats and 
_E-pigs 
The pA2 value for indoramin of 8.05 on the normotensive 
rat mesenteric vasculature preparation was higher than the previously 
reported value on the guinea-pig aorta (7.38; Alps, Hill, Johnson and 
Wilson, 1972). The results of Arunlakshana and Schild (1959) analyses 
of phentolamine and indoramin on rat and guinea-pig mesenteric vasculature 
preparations and aortic spirals are given in Table 4: 3. 
The pA2 results indicated that indoramin was a more potent 
a-adrenoceptor blocking agent on the perfused mesenteric vasculature 
preparation than on the aorta, irrespective of the species used. In 
order to determine whether this difference was statistically significant, 
apparent Kb values were calculated, and are given in Table 4: 4. 
Indoramin at 10-5M was found to relax the rat aorta (n=2), 
but the height of the maximum noradrenaline induced contraction was un- 
changed. This result suggests a direct vasodilator action of indoramin 
at high concentration, perhaps because of its local anaesthetic activity 
(Alps, Hill, Johnson and Wilson, 1972). Phentolamine has been reported 
to have a direct action on blood vessels (Taylor, Dutherland, Mackenzie, 
Staunton and Donald, 1965) but in the experiments described in the present 
study, concentrations up to 10-5M did not cause any relaxation of the rat 
aorta. 
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Table 4: 
The results of Arunlakshana and Schild analyses of the a-block pA2 
values for indoramin & phentolanrme on the perfused mesenteric vessels 
of the rat and guinea-pipi and the rat and guinea-pig isolated aortic 
spiral preparations 
Drug Tissue Concentration n slope pA2 pA10 pA2-pA10 
used M. 
Indoramin A1esenteric 5x10 
8- 
5x10-6 21 -1.06 8.05 7.15 0.9 
Phentolamine 
vasculatur 
rat 5x10 -8 - 10 
5 
14 -0.91 7.84 6.80 1.04 
Indoramin Mesenteric 1Ö-8 - 5x10-6 17 -1.03 8.48 7.55 0.93 
Phentolamine 
vasculaturq 
guinea-pig 10 
?- 10 5 13 -0.93 ?. 51 6.49 1.02 
Indoramin Aortic 10-7 - 1075 13 -0.85 7.68 6.56 1.13 
Phentolamine 
spiral, 
rat 10 
7- 
10 
5 15 -0.91 8.29 7.25 1.04 
Indoramin Aortic 10-7 - 1Ö 
4 
16 -1.16 ?. 38 6.58 0.80 
Phentolamine 
spiral, 
guinea-pig 10 
7- 10-5 14 -0.90 7.64 6.58 1.06 
Note. The results for indoramin on the guinea-pig aorta were obtained 
from Alps, Hill, Johnson and Wilson (1972). The mean log (dose-ratio-1) 
values for each antagonist on each tissue lie on their respective 
regression lines. 
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ii) The pA2 values for indoramin and phentolamine on mesenteric 
Lyasýculature 
preparations from renal/salt hypertensive rats 
The mean noradrenaline dose-response curves from the mesenteric 
vasculature preparations from renal salt hypertensive and normotensive 
rats used to determine indoramin and phentolamine pA2 values are given 
in Fig. 4: 6. The mean Ell, dose, sensitivity and reactivity shifts of 
the "hypertensive" preparations are given in Table 4: 5. Body weights 
and systolic blood pressures are given in Table 4: 6. 
The results of Arunlakshana and Schild (1959) analyses of 
indoramin and phentolamine on rat mesenteric vasculature preparations 
from renal/salt hypertensive rats are given in Table 4: 7 and Kb values 
in Table 4: 6. 
It is evident that the difference in potency between indoramin 
and phentolamine on tissues from normotensive animals does not occur in 
tissues from hypertensive rats. 
d) DISCUSSION 
Indoramin and phentolamine were competitive a-adrenoceptor 
blocking agents on all the tissues used, as judged by the slope of the 
log. x-1/log. B lines approximating to unity and the pA2-pA10 values 
approximating to 0.95" 
The pA2 values determined on tissues from normotensive 
animals indicate that indoramin is a more potent a-adrenoceptor blocking 
agent on the mesenteric vasculature than on the aorta, irrespective of 
species. The significant differences between the apparent Kb values on 
the aorta and the mesenteric vasculature must reflect either a different 
a-adrenoceptor type in the mesenteric vasculature which has greater 
affinity for indoramin than for phentolamine, or that some action of 
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Table 4: 6 
Mean body weight and systolic blood pressure of normotensive and renal/ 
salt hypertensive rats, 2 and 6 weeks after nephrectomy. Apparent Kb 
values x 169moles/1 for indoramin. and phentolamine on the mesenteric 
vasculature preparations from these animals are also given 
Group Body Wt. 
go 
Blood 
pressure 
mmHg 
Kb 
Indoramin 
Kb 
Phentolamine 
n 
Control 262.0 ± 4.5 120.8 ± 3.3 9.1 1 1.4 26.0 ± 3.5 13 
2 week renal/ 
salt hyper- 217.2 - 6.7* 163.6 
± 2.6* 37.4 ± 11.1* 20.6 2.3 10 
tensive (<0.02) 
6 week renal/ 
salt hyper- 275.1 11.3 174.1 - 5.1* 23.4 
± 4.6* 20.4 ± 3.1 10 
tensive. (<0.01) 
s 
Significantly different from normotensive control 
Table 4: 
The results of Arunlakshana and Schild analyses of the a block px2 values 
for indoramin and phentolamine on the mesenteric vasculature preparation 
from renal/salt hypertensive rats 2 and 6 weeks after nephrectomy 
Drug Tissue Concentration n slope pA2 pA10 PA2-PA 1 
Indoramin 2 week 5x1Ö 
8- 
5x10 
6 
17 -1.06 7.58 6.68 0.9 
Phentolamine 
renal/salt 5x1Ö-8 - 5x1Ö-6 12 -1.02 7.68 
6.74 0.94 
Indoramin 6 week 5x10 
8- 
5x10 
6 
13 -1.07 7.75 6.86 0.89 
Phentolamine renal/salt 5x1Ö 
8- 
5x10 
6 
15 -0.99 7.76 6. "80 0.96 
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indoramin, unrelated to a-adrenoceptor blockade, renders it more potent 
on resistance vessels. 
With phentolamine, there was no significant difference 
between apparent Kb values on the guinea-pig aorta and mesenteric 
vasculature preparation. The apparent Kb value for phentolamine on 
the rat aorta was significantly different from the value on the rat 
mesentery. Phentolamine therefore appears to be more potent on the 
aorta than on the mesenteric vasculature from the rat. 
On mesenteric vasculature preparations from 2 week renal/ 
salt hypertensive rats which were supersensitive (sensitivity shift 
reactivity shift) the pA2 value of indoramin was similar to its value 
on aortic preparations. At the 6 week hypertensive stage (sensitivity 
shift < reactivity shift) the significant potency difference from the 
normotensive result was still evident but was reduced. The a-adreno- 
ceptor blocking potency of phentolamine was normal on mesenteric vas- 
culature preparations from hypertensive rats. 
Thus, indoramin appeared to reveal a change in the a-adreno- 
ceptor of the renal/salt hypertensive rat which was not shown by phentol- 
amine. The results could indicate that a subtle change in the a-adreno- 
ceptor does occur in supersensitive mesenteric vascular preparations 
from renal/salt hypertensive rats. An alternative explanation is that 
the lower pA2 value for indoramin on the mesenteric vasculature pre- 
paration from hypertensive rats is caused by the local anaesthetic 
activity of indoramin and the method used to measure response amplitude. 
There is evidence that the cell membranes of small blood 
vessels are more labile than those of larger arteries (Somlyo and Somlyo, 
1968). Indoramin is 3-4 times more potent than phentolamine as a local 
anaesthetic (preliminary observations n=5, guinea-pig weal test method, 
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Bulbring and Wajda, 1945). The mesenteric vasculature preparation from 
hypertensive rats responds in a biphasic manner when infused with nor- 
adrenaline (Fig. 4: 1). When a bolus of noradrenaline is injected into 
the mesenteric vasculature preparation the slow and fast phases of the 
response cannot be separated and the peak overall response amplitude is 
measured. In tissues from normotensive rats the peak amplitude will 
probably occur in the slow phase of the response, which is thought to 
be due to the entry of extracellular calcium (Sitrin and Bohr, 1971). 
In supersensitive tissues from hypertensive rats the peak amplitude will 
probably occur in the fast phase of the response, (Fig. 4: 1) which is 
thought to be caused by the release of intracellular calcium (Sitrin 
and Bohr, 1971). Both phases of the response are mediated by a-adreno- 
ceptors and are susceptible to blockade. The slow phase of the response 
is probably determined by membrane permeability and would therefore be 
susceptible to local anaesthesia. Both phentolamine and indoramin are 
a-adrenoceptor blocking agents but indoramin is also a local anaesthetic 
(Alps, Hill, Johnson and Wilson, 1972). Therefore, on tissues which are 
susceptible to local anaesthesia and whose responses are evaluated in the 
slow phase (i. e. the mesenteric vasculature preparation of the normotensive 
rat and guinea-pig) indoramin will appear more potent than on tissues 
which are less susceptible to local anaesthesia (i. e. the rat and guinea- 
pig aorta). However, on tissues which are supersensitive, and whose 
responses are evaluated in the fast phase, which is resistant to local 
anaesthesia, (mesenteric vasculature preparations from hypertensive 
rats) indoramin will only exhibit its a-blocking activity and the pA2 
value will be the same as that determined in local anaesthetic resistant 
preparations (i. e. the aorta). This explanation is dependant on the 
assumption that the local anaesthetic action of indoramin exhibits 
competitive kinetics. 
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The results of this investigation on the mechanism of 
vascular supersensitivity suggest that an increase in available 
activator calcium is probably involved. Changes in the characteristics 
of the a-adrenoceptor are unlikely as the pA2 value of phentolamine 
did not change. The differences in the pf: 2 value of -indoramin in 
tissues from hypertensive rats may reflect the unusual properties of 
this drug. 
1 
CHAPTER 5 
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FACTORS WHICH MIGHT STIMULATE VASCULAR SUPERSENSITIVITY IN MESENTERIC 
VASCULATURE PREPARATIONS FROM RENAL AND RENAL/SALT HYPERTENSIVE RATS 
INTRODUCTION 
Increased vascular sensitivity has been demonstrated in 
mesenteric vasculature preparations from renal/salt hypertensive rats 
(Chap 3). The mechanism of this supersensitivity might involve a change 
in cellular calcium regulation (Chap 4). This chapter describes exper- 
iments designed to investigate the factors which might stimulate the 
mechanism causing vascular supersensitivity. 
Two factors are considered, the effects of sodium-loading 
and of endogenous angiotensin II. There is evidence that sodium-loading 
can increase vascular reactivity (Vick, Ederstrom and Vergeer, 1956., 
Beilin, Wade, Honour and Cole, 1970., Vapaatalo, Lahovaara and Hackman, 
1970., Heistad, Abboud and Ballard, 1971., Harris and Palmer, 1972., 
Abboud, 1974). The renal/salt hypertensive rat is likely to be in 
positive sodium balance from an early stage because of the increased 
dietary sodium. In the renal hypertensive rat, with one remaining kidney, 
there is evidence of a positive sodium balance independant of dietary 
sodium-loading, (Tobian, Coffee and McCrea, 1969., 5wales, Thurston, 
Queiroz and Medina, 1972., Menard, Alexandre, Guidicelli, Auzan and 
Chevillard, 1973). 
Previous studies have demonstrated that exogenous angiotensin 
II can stimulate the process causing supersensitivity (Chaps 3& 4). 
The aim of the present investigation was to determine whether elevated 
endogenous angiotensin II could have caused the supersensitivity of 
isolated vascular preparations from renal/salt hypertensive rats. 
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1) STUDIES ON REACTIVITY IN THE PERFUSED MESENTERIC VASCULATURE 
PREPARATION FROM RENAL HYPERTENSIVE AND UNINEPHRECTOMIZED SALT- 
LOADED RATS 
a) INTRODUCTION 
Vascular reactivity is increased in mesenteric vasculature 
preparations from renal/salt hypertensive rats (Chap 3). Salt-loading 
these animals might affect vascular reactivity by, 1) an increase in 
vascular sensitivity per se, 2) an inhibition of the renin-angiotensin 
system (Gross, Brunner and Ziegler, 1965) which may be involved in 
vascular reactivity (Chap 3), 3) an increase in the vascular receptor 
affinity for angiotensin II (Brunner, Chang, Wallach, Sealey and Laragh, 
1972). 
Vascular reactivity was therefore studied in renal hyper- 
tensive rats without salt-loading and in normotensive uninephrectomized 
rats which were salt-loaded. 
b) METHODS 
i) Renal hypertensive rats 
Renal hypertensive and sham operated rats were prepared as 
described in Chap. 2. 
ii) Uninephrectcmized salt-loaded rats 
Female Charles River rats were uninephrectomized and given 
0.9% saline to drink. After 2 weeks of sodium-loading, the animals 
were killed and their mesenteric vasculatures perfused. 
The method of recording systolic blood pressure in conscious 
rats and the perfused mesenteric vasculature preparation have been 
described (Chap 2). The experimental procedure and analysis of results 
were as described in Chap 3. Dose-response curves to noradrenaline and 
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the influence of angiotensin II on noradrenaline responses'were in- 
vestigated. 
c) RESULTS 
i) Studies of vascular reactivity to noradrenaline in mesenteric 
preparations from renal hypertensive rats 
The mean body weights and systolic blood pressures of the 
renal hypertensive and sham operated rats are given in Table 5: 1. 
Temporal changes in vascular reactivity 
The noradrenaline dose-response curves of preparations from 
renal hypertensive rats were shifted to the left of the control curve 
at all time points investigated (Fig. 5: 1-4). At all the hypertensive 
stages (1,2,4 and 6 weeks after nephrectomy) the noradrenaline threshold 
dose was decreased, and at the 6 week stage, the maximum response was 
elevated (Table 5: 2, Fig. 5: 4). The regression line gradients of the 
noradrenaline dose-response curves of tissues from hypertensive rats 
were not different from control values (Table 5: 2). The reactivity 
shifts of the "hypertensive" dose-response curves were calculated, and 
are given in Table 5: 3. 
Temporal changes in vascular sensitivity 
The noradrenaline dose-response curves for tissues from renal 
hypertensive and sham operated rats, expressed as a percentage of the 
maximum response, are shown in Figs. 5: 5-8. All the "hypertensive" 
dose-response curves were shifted to the left of the control, but in 
contrast to the reactivity shifts (Fig. 5: 1-4, Table 5: 3) the sensitivity 
shifts declined at the 6 week hypertensive stage (Table 5: 4). 
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Table 5: 1 
The mean body weights and blood pressures of renal hypertensive and 
sham operated rats (*indicates significantly different from sham 
control). 
Weeks 
Sham Control Renal hypertensive 
after Body Wt. B. P. n Body Wt. B. P. n 
operation g. mmHg. g. mmHg. 
1 210.615.7 111.4± 5.2 5 183.019.1* 142.7± 1.5* 5 
2 218.4±4.0 117.0± 6.2 5 197.0121.8 162.6±9.7* 5 
4 263.0±8.1 114.5± 5.2 7 246.8± 9.5 173.2t13.4* 5 
6 263.0±8.1 114.5±5.2 7 251.2±17.7 163.4+ 6.0* 5 
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Fig. 5: 1 
Mean constrictor responses (mmHg) to noradrenaline of mes- 
enteric vasculature preparations from sham control (n=5) and renal 
hypertensive rats (n=5) 1 week post-operatively. Note the shift to 
the left and lower vasoconstrictor threshold of the "hypertensive" 
curve. 
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Fig. 5: 2 
Mean constrictor responses (mmHg) to noradrenaline of mes- 
enteric vasculature preparations from sham control (n=5) and renal 
hypertensive rats (n. 5) 2 weeks post-operatively. Note the shift to 
the left of the "hypertensive" curve. 
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10 
Mean constrictor responses (mmHg) to noradrenaline of mes- 
enteric vasculature preparations from sham control (n=7) and renal 
hypertensive rats (n=5), 4 weeks post-operatively. Note the shift to 
the left and the elevated maximum of the "hypertensive" curve. 
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Fig. :4 
Mean constrictor responses (mmHg) to noradrenaline of mes- 
enteric vasculature preparations from sham control (n=7) and renal 
hypertensive rats (n=5), 6 weeks post-operatively. Note the shift to 
the left and elevated maximum of the "hypertensive" curve. 
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Table 5: 3 
The mean noradrenaline reactivity shifts of mesenteric vasculature pre- 
parations from renal hypertensive rats. (* Indicates significantly 
different from sham operated control). 
Weeks 50°% hypertensive Sham Renal hyper. Reactivity 
after response amplitude Mean dose Mean dose Shift 
operation pg. + Lg. + 
1 69.5 mmHg 1.5910.4 0.42tO. 09* 5.1610.77* 
2 80.0 mmHg 1.1710.07 0.2510.08* 8.19±1.21* 
4 79.5 mmHg 1.18±0.16 0.28±0.08* 7.19±1.31* 
-6 99.0 mmHg 1.80±0.31 0.42±0.08* 5.25±0.61* 
Table 5: 4 
Mean noradrenaline ED P doses for tissues from sham operated and renal 
hypertensive rats and renal hyp ertensive sensitivity shifts (* Indicates 
significantly different from control), sensitivity shifts for tissues 
from renal/salt hypertensive rats (Chap 3) are included for comparison 
Weeks 
after 
operation 
Sham control 
EDSM , dose 
Renal hyper- 
tensive ED5 
dose 
Renal hyper- 
tensive sensi- 
tivity shift 
Renal/salt 
sensitivity 
shift 
1 1.28 ± 0.26 0.42 ± 0.09* 3.9 0.6 * 7.45 ± 0.82 
2 0.95 ± 0.07 0.25 ± 0.08* 6.6 ± 1.0 * 7.9 0.81 
4 0.74 ± 0.09 0.28 ± 0.08* 5.0 ± 0.8 * 4.18 ± 0.26 
6 0.74 0.09 0.42 ± 0.08* 2.2 0.2 * 3.1 ± 0.20 
t (Mean dose indicates the dose to evoke a 50% "hypertensive" response 
amplitude in individual sham control tissues). 
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Fig. 
1 Week. 
Mean constrictor responses to noradrenaline (% of maximum 
response) of mesenteric vasculature preparations from sham control 
(n=5) and renal hypertensive rats (n=5) one week post-operatively. Note 
that the shift to the left of the "hypertensive" dose-response curve 
is similar to the shift in Fig. 5: 1. 
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Fig. 5: 6 
Mean constrictor responses to noradrenaline (% of maximum 
response) of mesenteric vasculature preparations from sham control 
(n=5) and renal hypertensive rats (n=5), 2 weeks post-operatively. 
Note that the shift of the "hypertensive" dose-response curve is 
similar to the shift in Fig. 5: 2. 
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Fig. 5: 7 
Mean constrictor responses to noradrenaline (% of maximum 
response) of mesenteric vasculature preparations from sham control 
(n=7) and renal hypertensive rats (n=5), 4 weeks post-operatively. Note 
that the shift to the left of the "hypertensive" dose-response curve is 
less than the shift in Fig. 5: 3. 
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Fig. 5: 8 
Mean constrictor responses to noradrenaline (% of maximum 
response) of mesenteric vasculature preparations from sham control 
(n=7) and renal/salt hypertensive rats (n=5), 6 weeks post-operatively. 
Note that the shift to the left of the "hypertensive" dose-response curve 
is less than the shift in Fig. 5: 4. 
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ii) Vascular reactivity to anaiotensin II. The direct constrictor 
response and the angiotensin II induced noradrenaline sensitivity 
shift in mesenteric vessels from renal hypertensive and sham 
operated rats 
The mean angiotensin II induced constrictor responses and 
angiotensin II induced noradrenaline sensitivity shifts for mesenteric 
preparations from renal hypertensive and sham control animals are given 
in Table 5: 5. The direct constrictor responses to angiotensin were 
not significantly different from the sham operated control. The angio- 
tensin induced noradrenaline sensitivity shift was significantly reduced 
in tissues from 1 and 2 week hypertensive rats and reduced (but not 
significantly) in tissues from 4 week hypertensive rats. The angiotensin 
induced noradrenaline sensitivity shift was reduced in tissues whose 
increased reactivity was predominantly due to increased vascular 
sensitivity (Tables 5: 3 and 5: 4 ,p 165)" 
iii) Vascular reactivity to noradrenaline and angiotensin II in mesenteric 
prime arations from uninephrectomized, salt-loaded rats 
Salt-loading for two weeks in uninephrectomized rats did not 
significantly elevate the blood pressure (Table 5: 6). Mesenteric vas- 
culature preparations from salt-loaded rats exhibited increased reactivity 
to noradrenaline (Fig. 5: 9, Table 5: 6) with the dose-response curve shifted 
to the left. The increased reactivity was due to an increase in vascular 
sensitivity (Fig. 5: 10, Table 5: 6), which was markedly less than in 
tissues from renal and renal/salt hypertensive rats at the 2 week stage 
(Tables 5: 4,5: 6). 
Responses to angiotensin II were not significantly different 
in tissues from salt-loaded and sham operated rats. The angiotensin II 
induced noradrenaline sensitivity shift was reduced, though not to a 
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Table 5: 5 
Angiotensin induced constrictor response and angiotensin induced nor- 
adrenaline sensitivity shift in tissues from sham operated and renal 
hypertensive rats (*significantly different from sham control) 
Weeks post Angiotensin constrictor Angiotensin induced 
operative. response mmHg. sensitivity shift. 
Sham 
1 48.8 ± 8.3 3.34 ± 0.27 
2 57.8 ± 11.1 4.26 0.46 
4 40.7 ± 9.5 2.85 ± 0.47 
6 40.7 ± 9.5 2.85 ± 0.47 
Renal hyper- 
tensive 
1 87.0 ± 17.9 2.23 ± 0.29* 
2 80.0 ± 14.4 2.32 ± 0.4* 
4 62.0 ± 20.1 1.96 ± 0.39 
6 46.8 15.5 2.86 ± 0.36 
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Table 5: 6 
Mean body weight and blood pressure of salt-loaded and sham operated 
rats, with noradrenaline threshold, maximum response, EDS,,. dose, 
sensitivity and reactivity shifts, angiotensin induced response. angi. o- 
tensin induced noradrenaline sensitivity shift of mesenteric vasculature 
Preparations from these animals. (" Significantly different from sham 
control) 
Parameter Group 1 
2 week sham 
control 
Group 2 
2 week sodium load, 
unilateral nephrectomy 
n 5 5 
Body Wt. g. 218.4 4.0 224.4 8.6 
Blood pressure mmHg. 117.0 6.2 129.6 4.4 
Noradrenaline threshold jig. 0.024 
± 0.004 0.016 0.0024 
Max. Response mmHg. 139.2 16.0 127.0 4.6 
Noradrenaline ED5 dose pg. 0.95 ± 0.07 0.52 0.12* 
Noradrenaline sensitivity shift. - 2.14 
± 0.16* 
Noradrenaline, 50%% Group 2, dose jig. 0.9 0.005 0.52 0.12* 
Noradrenaline reactivity shift. - 2.02 0.15* 
gi p, g An otensin res onse mmH 57.8 11.1 40.0 10.6 
Angiotensin induced nor- 
adrenaline sensitivity shift. 4.26 0.46 3.02 0.7 
(Noradrenaline, 50% group 2, dose jig, indicates the dose of noradrenaline 
required by group 1 and 2 tissues to evoke a response of equal amplitude 
to 50% of the maximum response of group 2 tissues). 
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1 
Mean constrictor responses to noradrenaline (mmHg) of mes- 
enteric vasculature preparations from sham control (n=5) and uni- 
nephrectomized salt-loaded rats (h=5). Note the shift to the left of 
the "salt-load" dose-response curve. 
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Fig. 5: 10 
Mean constrictor responses to noradrenaline (% of maximum 
response) of mesenteric vasculature preparations from sham control 
(n=5) and uninephrectomized salt-loaded rats (n=5). Note that the 
shift of the "salt-load" dose-response curve is similar to that in 
Fig. 5: 9. 
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significant level, in tissues from the salt-loaded rats (Table 5: 6). 
d) DISCUSSION 
The increase in reactivity to noradrenaline of mesenteric 
vasculature preparations from renal hypertensive rats was qualitatively 
similar to the results of experiments using tissues from renal/salt 
hypertensive rats (Chap 3). During the early stages of renal hyper- 
tension (1-4 weeks after nephrectomy) the increased reactivity to 
noradrenaline of mesenteric preparations was predominantly due to an 
increase in vascular sensitivity (Tables 5: 3,5: 4, Figs. 5: 1-5: 3,5: 5- 
5: 7). At the 6 week stage, supersensitivity was not the major factor 
contributing to the increased reactivity (Tables 5: 3,5: 4, Figs. 5: 4, 
5: 8). The increase in the maximum response at the 6 week hypertensive 
stage could be interpreted as evidence of an increased contractility 
and wall/lumen ratio, but, as with the renal/salt hypertensive animals, 
there was no significant increase in the dose-response curve gradient. 
The noradrenaline threshold dose was reduced at all the time points in- 
vestigated, whereas it was only lower in the first two weeks of renal/ 
salt hypertension (Chap 3). The significant reduction of the angiotensin 
II induced noradrenaline sensitivity shift during the early (1-2 week) 
but not the later (4 -6 week) stages of renal hypertension was 
qualitatively similar to the reduction observed in tissues from renal/ 
salt hypertensive rats (Chap 3). 
Sodium-loading uninephrectomized rats caused an increase in 
vascular reactivity to noradrenaline which was due to an increased 
sensitivity (Table 5: 6). Sodium-loading for 2 weeks did not cause an 
increase in the affinity of the vascular angiotensin II receptor, as 
responses to this peptide were not elevated, and the angiotensin II 
induced noradrenaline sensitivity shift was slightly depressed (Table 
5: 6). 
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The increased vascular reactivity of tissues from salt-loaded 
uninephrectomized rats was probably due to"a direct influence of sodium 
on the vasculature. Arteries are rich in sodium and part of this is" 
thought to reside in a region in or near the cell membrane, called the 
paracellular matrix (Friedman and Friedman, 1964., 1967). Sodium trans- 
fer into this region may be a determinant of smooth muscle tension (Friedman, 
Friedman and Nakashima, 1957). Evidence for this hypothesis comes from 
experiments on the rabbit ear artery, where enzymic depolymerization of 
the matrix reduces both the sodium content and the reactivity (Harris 
and Palmer, 1971). An increased sodium content in the arterial wall 
could also increase reactivity by facilitating sympathetic transmission, 
by increasing wall thickness or by altering calcium mobilization (Tobian 
and Binion, 1952., Be Champlain, Krakoff and Axelrod, 1969., Sitrin and 
Bohr, 1971). 
An increase in the sodium and water content has been demon- 
strated in the blood vessels from hypertensive humans and animals (Tobian 
and Binion, 1952., Tobian, 1956., Jones, Feig! and Peterson, 1964). In 
the renal and renal/salt hypertensive rat the combination of a positive 
sodium balance (Chap 5 pt 2) with high blood pressure would increase the 
amount of sodium in the arteries (Hollander, Kramsch, Farmelant and 
Madoff, 1968). Salt-loading in the renal/salt hypertensive rat would 
promote this process more rapidly than in the renal hypertensive rat. 
Comparison of the present results with those from tissues of 
renal/salt hypertensive rats (Chap 3) reveals a marked difference in 
vascular sensitivity at the 1 week stage. The greater noradrenaline 
supersensitivity of the mesenteric vasculature preparations from the 
renal/salt hypertensive rat could be due to the additional influence 
of dietary salt-loading. In the later stages of renal hypertension a 
positive sodium balance is likely (Chap 5) and this would account for 
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the near equality of the noradrenaline sensitivity shifts in tissues 
from renal and renal/salt hypertensive rats (Table 5: 3). The greater 
sensitivity shift in tissues from renal. /salt hypertensive rats at the 
6 week stage could also be due to the additional sodium load. 
A positive sodium balance cannot cause all the early super- 
sensitivity to noradrenaline in either model of renal hypertension. In 
both the renal and the renal/salt hypertensive rat, the supersensitivity 
declines in the later stages of hypertension. This indicates that some 
evanescent sensitizing factor is present in the early stages of hyper- 
tension. The possibility that endogenous angiotensin II could be this 
factor is now investigated. 
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2) THE ACTIVITY OF THE RENIN-ANGIOTENSIN SYSTEM IN RENAL AND RENAL/SALT 
HYPERT: r; NSIVE RATS, AND ITS CONTRIBUTION TO INCREASED NORADRENALINE 
SENSITIVITY IN MESENTERIC VASCULATURE PREPARATIONS 
a) INTRODUCTION 
Exogenous angiotensin II can stimulate the process causing 
vascular supersensitivity in isolated mesenteric preparations from renal 
and renal/salt hypertensive rats (Chaps 3,4). In order to determine 
whether endogenous angiotensin II could stimulate this process in vivo 
the activity of the renin-angiotensin system in renal and renal/salt 
hypertensive rats was investigated. 
Plasma renin activity was used as an indicator of circulating 
angiotensin II levels since the development of a specific radioimmuno- 
assay for angiotensin II was beyond the scope of this study. 
Plasma renin activity may not correlate with local vascular 
activities, since Rosenthal and Hollander (1973) have demonstrated a 
three-fold increase in aortic renin activity in D. O. C. hypertensive rats 
with low plasma renin activity. Local generation of angiotensin II at 
vascular sites may play a role in the development of renal hypertension 
(Swales and Thurston, 1973) and the mesenteric vasculature has a 
significantly greater concentration of renin than other vascular beds 
(Genest, Simard, Rosenthal and Boucher, 1969). The possible contribution 
of vascular angiotensin II to the increased vascular sensitivity to nor- 
adrenaline in mesenteric preparations from renal/salt hypertensive rats 
was investigated with the specific angiotensin II antagonist Sar1 Ileu8 
angiotensin II. 
b) METHODS 
The induction of renal and renal/salt hypertension, the 
indirect measurement of systolic blood pressure in conscious rats, and 
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the perfused mesenteric vasculature preparation have been described 
(Chap 2). 
i) Radioimmunoassav of an iotensin I to determine plasma renin activity 
(PRA). 
The main steps of the radioimmunoassay procedure were: - 
1. Collection of plasma samples. 
2. Preparation of samples for the assay by generation of angio- 
tensin I. 
3. Preparation of the standard curve by dilution of known 
amounts of angiotensin I. 
1+. The assay, which involves competition of radio-active angio- 
tensin I for the antibody, and adsorption of free angiotensin 
I on charcoal-dextran. The bound radioactive angiotensin I 
was counted. 
The radioimmunoassay of angiotensin I was performed using the 
CEA-IRE-SORIN kit (RENK). 
Procedure 
1) Collection and storage of plaom same fs 
Norriotensive, srari operated, totally nephrectomized, renal 
and renal/salt hypertensive rats were anaesthetized by intra-peritoneal 
injection of pentobarbitone sodium (60 mg/kg). The abdomen was opened 
and clamps applied to the renal pedicles. The mesenteric artery was 
cannulated (Chap 2) in most of these rats and the mesenteric vein 
severed to prevent dilution of the blood with Krebs solution. The 
thorax was opened and blood taken by left ventricular puncture. Blood 
was collected into chilled syringes containing 10 egg of Na2EDTA. The 
0 blood was centrifuged (1000 g) at 4C for 15 min. The plasma was with- 
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drawn and stored in plastic vials at -20°C. 
2) Preparation of plasma samples for assay 
The following procedures were all performed at 2-4°C unless 
otherwise stated. The plasma samples were thawed and 0.5 ml added to 
0.5 ml of phosphate buffer containing the angiotensin converting enzyme 
and angiotensinace inhibitors, 2,3-dimercaptoproparol (3.5 m, M) and 8- 
hydroxyquico1ine sulphate (2mM) (Haber, Koerner, Page, Kliman and Purnode, 
1969). The final pH of the mixture was 5.6-5.8 which is the optimum for 
renin activity (Malvano, Zucchelli, Rosa and Salvetti, 1972). After 
mixing, the sample was divided into two 0.5 ml aliquots, one of which 
0 
was incubated at 370C for 1.5 h and the other at 4 C. 
j) Preparation of the standard curve. 
Synthetic Ileu5 angiotensin I (Schwarz/Mann) was diluted with 
0.025 mM Tris buffer (5.4 g Tris base, 14.92 g Na2EDTA, 2.5 g lysozyme 
in 11, pH 7.4) to give solutions of 16,8,4,2,1 and 0.5 ng/ml. 
4) The assay 
The assay was performed in duplicate and comprised of the 
samples given in Table 5: 7. 
The 1251 angiotensin I used had a specific activity of 1.5 mCi/ 
mg. The antiserum to angiotensin I was raised in rabbits and had a titre 
of 1: 150,000. 
After mixing, all samples were incubated for 24 h. After in- 
cubation, 0.1 ml of bovine serum was added to the tubes for the standard 
curve and 0.1 ml Tris buffer to all other tubes. Dextran charcoal (10: 1 
of charcoal, Norit, 211, F. Q. P. and Dextran T70) in Tris buffer was 
added to all tubes except those for total activity. When 10 min had 
elapsed all tubes were centrifuged at 1500-2000 g for 10 min. 0.5 ml 
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of supernatant was pipetted into counting vials and 10 ml of NE260 
scintillant (Nuclear Enterprises) added. Radioactivity was counted on 
a Packard Tricarb liquid scintillation spectrometer, model 3380 using 
the 
14C 
setting (counting efficiency = 32%) 
Samples were counted for 10 min or up to 10,000 disintegrations 
and the mean d. p. m. recorded. 
Analysis of results 
For each pair of duplicate tubes the mean net d. p. m. was cal- 
culated. The binding ability of the antibody was calculated from: - 
B/I = Zero standard mean d. p. m. x 100 
To Total activity mean d. p. m. 
For the standard and unknown samples: - 
$/ 
= Standard or sample mean d. p. m. x 100% Bo Zero standard mean d. p. m. 
Plotting B/Bo against pg of standard angiotensin I added on_ 
a logit-log. scale produces a straight line (Fig. 5: 11). B/Bo of the 
unknown samples can be read off as pg of angiotensin I using this graph. 
In order to determine the plasma renin activity (P. R. A. ) the angiotensin 
I in the non-incubated (4° C) plasma was subtracted from the angiotensin 
I in the incubated (37°C)sample: - 
P. R. A. = (Angiotensin I incubated - Angiotensin I non- 
incubated )X 20 
1.5 
= P6/ml/h. 
ii) Studies using the anEiotensin II antagonist Sar 
1 Ileu8 angiotensin II 
Mesenteric vasculature preparations from normotensive rats 
In order'to establish whether Sari Ileu8 angiotensin II would 
": . 
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Fig. : 11 
Typical standard line for radioimmunoassay of angiotensin I. 
B/Bo (see text) is plotted on a logit scale and pg of standard angio- 
tensin I added, on a log scale. Angiotensin I (pg) in an unknown sample 
can be read from where B/Bo lies on the calibration line. 
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reverse the noradrenaline potentiating action of angiotensin II amide, 
the following experiment was designed. 
Procedure 
1. Control noradrenaline dose-response curves were made in 
mesenteric vasculature preparations from normotensive rats. 
2. Perfusion with angiotensin II amide 10-7M for 15 min. 
3. The noradrenaline dose-response curve was repeated in the 
presence of angiotensin II amide. 
4. Perfusion with Sar1 Ileu8 angiotensin 11 (5 x 10-7M) for I h; 
Previous studies (Chap 3) have shown that 1j-2 h perfusion 
with normal Krebs solution does not reverse the noradrenaline 
potentiation induced by angiotensin II amide. 
5. The noradrenaline dose-response curve was repeated. 
In order to determine whether the angiotensin II antagonist 
would reverse the noradrenaline supersensitivity of mesenteric pre- 
parations from 1 and 2 week renal/salt hypertensive rats, the procedure 
was repeated, omitting stages 2 and 3. 
c) RESULTS 
i) Radioimmunoassay of anjiotensin I 
The binding ability of the antiserum used was 61.5 + 2.0% 
(six separate assays). The typical variation between test sample 
duplicates was 2.4 
t 0.8% (n=6). Plasma from two rats which had been 
totally nephrcctomized 24 h previously had a low renin activity (Table 
5: 8) indicating that the major component of the activity in plasma from 
normal rats (Table 5: 8) was of renal origin. 
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The mean systolic blood pressures and body weights of the 
rats which were used to obtain blood for the radioimmunoassay are given 
in Table 5: 9. The results of the radioimmunoassay are given in Table 
5: 8. Figure-of-eight ligation of one kidney before contralateral 
nephrectomy caused a significant rise in P. R. A. (compared with normo- 
tensive control). After contralateral nephrectomy, P. R. A. declined and 
reached low levels within 2 weeks (Table 5: 8). Renal hypertensive rats 
had a consistently higher P. R. A. than renal/salt hypertensive rats, 
particularly at the 1 week stage, but this difference was not statistically 
significant. The sham operations significantly increased P. R. A. (Table 
5: 8) probably because of the kidney manipulation involved. 
ii) The effects of Sar1 Ileu8 andotensin II on the noradrenaline 
sensitivity shift induced by an&iotensin II amide, and on the 
su ersensitive mesenteric vasculature preparation from renal/salt 
hypertensive rats 
The mean body weights and systolic blood pressures of the rats 
used in this study are given in Table 5: 10. 
Angiotensin II amide (10-7M) increased the noradrenaline 
sensitivity of mesenteric preparations from normotensive rats. Sari Ileu8 
angiotensin II (5 x 10 
7M) 
reversed this sensitivity shift (Fig. 5: 12). 
Mesenteric vasculature preparations from 2 week renal/salt hypertensive 
rats were supersensitive to noradrenaline, but Sar1 I1eu8 angiotensin 
II did not attenuate this. (Fig. 5: 12). The angiotensin antagonist 
also failed to reverse the noradrenaline supersensitivity of pre- 
parations from 1 week renal/salt hypertensive rats (n=3, preliminary 
studies). 
d) DISCUSSION 
The radioimmunoassay results demonstrate that renal hyper- 
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Table 5: 10 
Mean body weight and systolic blood pressure of renal/salt hypertensive 
and normotensive rats used in experiments with Sar 1 Ileu 
8 
angiotýn 
II. 
Group Wt. g. BP mmHg 
Normotensive n=5 261.8 11.5 117.4 ± 2.2 
2 week sham control n=5 218.4 4.0* 117.0 6.2 
2 week renal/salt n=5 181.8 6.4* 160.4 5.8* 
* Significantly different from control. 
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Fig. 5: 12 
The effects of Sar1 Ileu8 angiotensin II (5x10-7 M) on the 
noradrenaline supersensitivity of mesenteric preparations from renal/ 
salt hypertensive rats (n=5) 2 weeks after contralateral nephrectomy 
and tissues from normotensive rats (n=5) which have been treated with 
" angiotensin II amide (10-7, %1) * -----. control, for normotensive data 
(left side of figure) sham control for hypertensive rats (right side 
of figure). 
Control plus angiotensin II amide. 
Renal/salt hypertensive. 
Control, angiotensin II amide treated plus Sar1 
Ileu8 angiotensin II 
ý.. _ S Hypertensive plus 
Sari Ileu8 angiotensin II. 
Note the angiotensin II antagonist reverses the noradrenaline 
supersensitivity induced by exogenous angiotensin II amide, but does not 
reverse the supersensitivity of tissues from renal/salt hypertensive rats. 
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tension induced by "figure-of-eight" ligation of one kidney and contra- 
lateral nephrectomy is associated with a low P. R. A. The results are in 
qualitative agreement with previously reported bio-assay studies of 
P. R. A. in this type of hypertension, and extend the measurements to the 
early stages of hypertension (Vapaatalo, Lahovaara and Hackman, 1970., 
Menard, Alexandre, Guidicelli, Auzan and Chevillard, 1973)" 
Renin secretion is mainly controlled by two intrarenal re- 
ceptors, a vascular wall tension receptor and the sodium sensitive 
macula densa (Davis, 1973). The renal sympathetic nerves and humoral 
agents also exert a degree of control over renin secretion. In "Grollman" 
renal hypertension some of the renal arterioles will be overperfused 
because of the high blood pressure, resulting in an inhibition of renin 
release, and some will be underperfused, stimulating renin secretion. 
Plasma sodium is elevated in this type of hypertension (Menard, Alexandre, 
Guidicelli, Auzan and Chevillard, 1973) this is probably the major renin 
suppressing factor. The lower P. R. A. values found in renal/salt compared 
with those in renal hypertensive rats, particularly at the one week stage, 
support this suggestion. The P. R. A. of the renal hypertensive rats was 
markedly suppressed at the 2 week stage indicating a positive sodium 
balance. 
The P. R. A. values determined in this study for normotensive 
rats were higher than some previously reported values (1-3 ng/ml/h) using 
similar radioimmunoassay techniques (Forman and Mulrow, 1974., Susic and 
Sparks, 1974). This discrepancy probably arose because both laparotomy 
and anaesthesia stimulate renin release (McKenzie, Ryan and Lee, 1967., 
Campbell, 1974). In a recent study of P. R. A. in lightly anaesthetized 
rats, normal values of around 20 ng/ml/h have been reported (Gavras, 
Brunner, Laragh, Vaughan, Koss, Cote and Gavras, 1975). P. R. A. values 
obviously vary with the mode of collection of blood samples. Since the 
As 
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sampling technique was constant in the present study, comparative assess- 
ments are valid. 
The hypothesis that elevated plasma angiotensin II levels 
cause part of the early increa3c in vascular sensitivity to noradrenaline 
(Chaps 3 and 5) is not supported by the P. R. A. results. When the vascular 
sensitivity to noradrenaline was high (1,2 and 4 weeks after contra- 
lateral nephrectomy) the P. H. A. was low. The increase in P. R. A. after 
application of the figure-of-eight ligature could not have, any prolonged 
effect on the peripheral vasculature, since similar values were found 
throughout the study in the sham operated rats. 
Measurement of P. R. A. alone provides limited information about 
the levels of circulating angiotensin II. The plasma concentration of 
angiotensin II will also depend on the availability of renin substrate 
and on the rate of entry and clearance of angiotensin II from the plasma. 
The effects of circulating angiotensin II will depend on the affinity of 
the angiotensin II receptor. There is also the possibility that vascular, 
non-circulating, renin and angiotensin II may play a role in renal hyper- 
tension. The possibility that endogenous angiotensin II residing on the 
receptor sites was causing vascular supersensitivity in preparations from 
renal/salt hypertensive rats was investigated with a potent specific 
competitive angiotensin II antagonist. 
Sar1 Ileu8 angiotensin II completely reversed the noradrenaline 
sensitizing effects of exogenous angiotensin II. Angiotensin II antibodies 
and angiotensin II antagonists have previously been shown to attenuate the 
indirect effects of angiotensin II on noradrenaline and sympathetically 
mediated responses (Khairallah, Davila, Papanicolaou, Glende and Meyer, 
1971., Zimmerman, 1973). Previous experiments (Chap 3) have demonstrated 
that the noradrenaline sensitizing effects of angiotensin II amide persist 
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for more than 1-2 h of washing in normal Krebs solution. Tachyphylaxis 
to the direct constrictor effect of angiotensin II amide washes out in 
this time period, which suggests that the indirect effects of angiotensin 
II are inde-pendant of receptor occupancy. Both actions of angiotensin 
II are sensitive to receptor blockade (Fig. 5: 12 and Turker, Hall, Yamamoto, 
Sweet and Bumpus, 1972). An explanation of this apparent contradiction 
is that the angiotensin II receptors mediating the, two effects have 
different cellular locations or affinities for angiotensin II. 
The anCiotensin II antagonist did not attenuate the noradrenaline 
supersensitivity of mesenteric vasculature preparations from 1 and 2 week 
renal/salt hypertensive rats. This is strong evidence against the hypothesis 
that endogenous angiotensin II, whether of circulatöry or vascular origin, 
causes the increased noradrenaline sensitivity. 
/ 
CHAPTER 6 
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GENERAL DISCUSSION 
The initial aims of this study were to determine whether an 
increase in vascular reactivity occurs in arteriolar vezsels from renal 
and renal/salt hypertensive rats and whether this involved a true super- 
sensitivity or an apparent hyperreactivity. As the study progressed, the 
mechanism, the endogenous stimulants and the pathogenic significance of 
increased vascular reactivity were investigated. - 
An increase in vascular reactivity to noradrenaline was 
demonstrated throughout the development of renal and renal/salt hyper- 
tension. During the early (1 and 2 week) stages of hypertension, in- 
creased reactivity to noradrenaline was due to a supersensitivity of the 
mesenteric vessels (Fig. 6: 1). When the blood pressures of the rats had 
stabilized (4-6 weeks after contralateral nephrectomy) the increased 
reactivity was due to a combination of supersensitivity and another 
factor which involved an elevation of the maximum response. This factor, 
which is represented by the non-supersensitive shift remainder (Fig. 6: 1), 
was probably a consequence of hypertension since it appeared after the 
blood pressure had stabilized. 
The cause of the non-supersensitive shift remainder and the 
elevation of the maximum response might have been an increase in the 
wall/lumen ratio of the vessels. Evidence for such a structural change 
was unconvincing, possibly because the mesenteric vasculature preparation 
does not include the precapillary metarterioles which are most susceptible 
to medial hypertrophy (Folkow, Hallback, Lundgren, Weiss, Albrecht and 
Julius, 1974). 
A 
The major question about vascular reactivity in hypertension 
is whether the former precedes the latter, or vice versa. This question 
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Fig. 6: 1 
A comparison of the noradrenaline dose-response curve 
sensitivity and reactivity shifts and the effects of angiotensin II 
amide in mesenteric vasculature preparations from renal (R) and renal/ 
salt (R/S) hypertensive rats. Notation for the blood pressure and 
angiotensin induced noradrenaline sensitivity shifts traces: - 
®ýýý Renal/salt hypertensive. 
A-A Renal hypertensive. 
Sham Control. 
Notation for the histogram: - 
Noradrenalizie reactivity shift. 
a 
Noradrenaline sensitivity shift. 
Non-supersensitive shift remainder. 
Significantly different from renal. /salt data. 
Significantly different from reactivity shift. 
Sensitivity and reactivity shifts are equivalent at I and 2 
weeks (renal/salt)and at 1,2 and 4 weeks (renal) after contralateral 
nephrectomy. 
The noradrenaline potentiating effects of angiotensin II 
amide are attenuated at the 1 and 2 week stages (renal and renal/salt). 
Increased reactivity is due to a combination of increased sensitivity 
and some other factor at the 6 week stage (renal and renal/salt). 
4 
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can only be resolved by studies of vascular reactivity in tissues from 
animals in a pre-hypertensive phase. The Japanese S. H. R. goes through 
a pre-hypertensive phase (Albrecht, 1974) and would be eminently suitable 
for such an investigation if a valid control animal was available. A 
pre-hypertensive phase in renal hypertensive rats might be induced by 
antihypertensive drug treatment immediately after operative procedures. 
0 
The results of the present study demonstrate that the maximum 
increased reactivity to noradrenaline occurred at the 1 week stage in 
tissues from renal/salt hypertensive rats, while the blood pressure 
peaked at the 2 week stage (Fig. 6: 1). In the renal hypertensive rats, 
which had not been salt-loaded, the peak increased reactivity occurred 
at the 2 week stage and the maximum blood pressure at 
4 weeks. These 
results suggest that increased reactivity to noradrenaline, caused by 
vascular supersensitivity precedes the -increase in blood pressure. If 
the increase in vascular sensitivity caused an increase in peripheral 
resistance then the vascular supersensitivity could cause the hypertension. 
In order to prove this hypothesis, a direct comparison of peripheral 
resistance, vascular reactivity and the level of nervous and humoral. 
activation of the vascular smooth muscle during the development of hyper- 
tension is required. 
If the increased vascular sensitivity was causing the increase 
in blood pressure, then there should be a direct quantitative relationship 
0 between the two parameters. At the one week hypertensive stage the blood 
pressures of the renal and renal/salt hypertensive rats were the same, 
but the noradrenaline supersensitivity of mesenteric vasculature pre- 
parations from renal/salt and renal hypertensive rats were significantly 
different (Fig. 6: 1). This quantitative discrepancy could be interpreted 
as evidence against acausal link between supersensitivity and blood 
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pressure. Plasma renin activity was suppressed in the 1 week renal. /salt 
hypertensive rats, but similar values were found in normotensive and 1 
week renal hypertensive rats. Therefore in the 1 week renal/salt hyper- 
tensive rats, increased sensitivity combined with sympathetic activation 
could raise the blood pressure, while in the renal hypertensive. rat a 
smaller increase in sensitivity would be activated by both sympathetic 
nerves and circulating angiotensin II. Increased reactivity to angio- 
tensin II has not been demonstrated in this study since full dose-response 
curves to this agonist are technically difficult. 
The hypothesis that circulating angiotensin II provides the 
additional hypertensive stimulus in renal hypertensive rats could be 
tested with a specific angiotensin II antagonist. If the hypothesis 
is. correct, renal/salt hypertensive rats should be insensitive to the 
antihypertensive actions of the antagonist and the renal hypertensive 
rats sensitive. 
If it is assumed that the increased vascular sensitivity pre- 
cedes the increase in blood pressure, then the vascular reactivity at 
week "A" will determine the blood pressure level at week "A+111. The 
degree of supersensitivity of mesenteric vasculature preparations from 
the 1 week renal/salt hypertensive rats was approximately twice that of 
tissues from renal hypertensive rats at the same stage (Fig. 6: 1). The 
increase in blood pressure over the following week in the renal/salt 
hypertensive rats was twice that observed in the renal hypertensive rats 
(Fig. 6: 1). Vascular reactivity in tissues from rats 1 week after 
application of the figure-of-eight ligature has not been investigated. 
If there is an increase in vascular reactivity at this stage then it 
would be equal in renal and renal/salt hypertensive rats, since salt- 
loading was commenced after contralateral nephrectomy. The blood 
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pressure increase during the week following contralateral nephrectomy was 
the same in the renal and the renal/salt hypertensive rats (Fig. 6: 1). 
This interpretation of the results indicates a direct quantitative 
relationship between the increased vascular sensitivity and the increase 
in blood pressure during the following week. An investigation of vascular 
reactivity one week after application of the figure-of-eight ligature 
would confirm this interpretation. 
In the later stages of hypertension, the only significant 
difference between reactivity in tissues from renal/salt and renal 
hypertensive rats was at the 6 week stage. The lower overall reactivity 
in tissues from renal hypertensive rats, at this stage, was due to a 
smaller degree of supersensitivity in these preparations. The differenc; 
in sensitivity of mesenteric preparations from 6 week renal and renal/ 
salt hypertensive rats was probably due to the additional dietary salt 
load in the latter. Klore detailed studies of blood pressure and reactivity 
after the 6 week hypertensive stage would be necessary to determine 
whether this difference in reactivity has any long term effect on the 
blood pressure. 
The uninephrectomized rats which were salt-loaded did not be- 
come hypertensive. Mesenteric preparations from these animals were 
supersensitive to noradrenalire. This result appears to isolate in- 
creased vascular sensitivity from the development of high blood pressure. 
Salt-loading of the rats would, however, suppress the renin-angiotensin 
system (Davis, 973) so that the pro-hypertensive effects of increased 
vascular sensitivity could have been counteracted by the suppression of 
circulating pressor angiotensin II. It is likely that a longer period 
of salt-loading would cause an increase in blood pressure as salt-loading 
normal rats eventually causes hypertension (Meneely, Tucker, Darby and 
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Auerback, 1953) and this effect is exacerbated by unilateral nephrectomy 
(Koletsky, 1959, KolctAy and Goodsitt, 1960). 
The increased vascular reactivity which may precede the 
increase in blood pressurc was due to an increase in vascular sensitivity. 
The mechanism of this supersensitivity was investigated and appeared to 
involve an increase in the activator calcium available to the muscle 
myofibrils and not a change in the characteristics of the a-adrenoceptor. 
Whether thi:; 12; C:! 'oab, '. d ai'ai1abi3. it%, dte to increas3d levels or in- 
creased rel. e,; se of calcium could not be deteririhed with the method used. 
For the measurement of the amount of bound intracellular calcium in vessels 
from normotensive and hypertensive rats, the isolated vascular tissue could 
be loaded with 
45Ca 
. The loosley bound extracellular 
45Ca 
could be 
displaced with La+++ (Van Breeman and McNaughton, 1970) and the residual 
bound calcium 45 counted. In order to determine whether a greater release 
of calcium occurs in vascular tissues from hypertensive rats, microsomal 
fractions from the vessel walls could be loaded with 
45Ca 
and the rate 
of efflux followed with and without agonist stimulation. Alternatively the 
uptake of 
k5Ca 
into the microsomes could be inhibited by angiotensin or 
noradrenaline (Baudouin-Legros and Meyer, 1973)" 
A change in the characteristics of the a-adrenoceptor in mes- 
enteric vessels from hypertensive rats is unlikely. The results obtained 
with indoramin probably reflected a difference in the nature of the 
antagonist (compared with phentolamine) rather than a change in the 
a-adrenoceptor. Determination of the a-a. drenoceptor blocking potencies 
of indoramin and phentolamine on the fast and slow components of the 
mesenteric response to noradrenaline would confirm this. Tissues 
from normotensive rats which have been exposed to angiotensin II appear 
to mimic the behaviour of tissues from early renal/salt hypertensive 
rats. It would be interesting to determine whether the 
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a-adrenoceptor blocking potency of indoramin is reduced in angiotensin 
treated tissues. 
An impairment of noradrenaline re-uptake into sympathetic 
nerves may have contributed to the increased vascular sensitivity to 
this agonist. This possibility c. ould be investigated by loading mes- 
enteric preparations with tritiated noradrenaline and following the 
efflux after nerve stimulation. Additional evidence could be obtained 
by determining vascular sensitivity to an agonist, such as angiotensin 
II which is not taken up into the nerve terminal. 
The endogenous factors which might stimulate the early vas- 
cular supersensitivity in tissues from renal and renal/salt hypertensive 
rats have been investigated. Exogenous angiotensin II potentiated nor- 
adrenaline but r. ot KCl induced responses and the attenuation of these 
effects in the supersensitive Vascular preparations from early renal and 
renal/salt hypertensive rats were suggestive of an involvement of endo- 
genous angiotensin II. The reduction in the P. R. A. of the hypertensive 
animals and the inability of the angiotensin antagonist to reverse the 
- supersensitivity are strong evidence against endogenous angiotensin II 
stimulating vascular supersensitivity. 
The effects of the prostagl. ardins on blood vessel tone vary 
with tissue and species used and whether the experiment is performed in 
vivo or in vitro. Prostaglandins of renal origin are unlikely to be 
involved in arterial supersensitivity since they are metabolised in the 
pulmonary circulation (McGiff, Crowshaw and Itskovitz, 1974). Local 
vascular'prostaglandins are synthesized when sympathetic nerves are 
stimulated, and may blunt the noradrenergic constrictor response, in 
vivo (grody and Kadowitz, 1974), Conversely, in vitro, Prostaglandins 
c 
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E1 and E2 can constrict vascular smooth muscle by augmenting responses 
to both noradrenaline and KC1 (Greenberg and Long, 1973). The inhibition 
of prostaglandin synthesis by indomethacin depresses the responses of 
the isolated mesenteric vasculature preparation to noradrenaline (Malik 
and McGiff, 1975). An excess of certain prostaglandins or an imbalance 
between various types could produce vascular supersensitivity, although 
the profile of the supersensitivity caused by prostaglandin E1 and E2 
does not mimic that found in tissues from renal/salt hypertensive rats. 
The involvement of local prostaglandins in vascular reactivity is a 
complex problem and warrants further investigation. 
Nephrotensin, which is elevated in acute but not cironic renal 
hypertension, potentiates responses to noradrenaline and KC1 (Groliman 
and Krishnamurty, 1973), whereas the supersensitivity of tissues from 
renal/salt hypertensive rats was specific for noradrenaline. Similarly 
the plasma vasoactive factor (Bohr and Johansson, 1966) potentiates both 
noradrenaline and. KCl induced responses. 
The early rise and later decrease in vascular sensitivity to 
noradrenaline could indicate that a reduction of renal mass reduces the 
level of a desensitizing factor whose levels rise again as renal hyper- 
trophy occurs. If this were the case, the uninephrectomized salt/loaded 
rats should have exhibited a similar increase in vascular sensitivity to 
that found in tissues from renal/salt hypertensive rats. 
The effects of a positive sodium balance, which could be 
measured by metabolic or total exchangeable sodium studies, (Tobian, Coffee 
and McCrea, 1969) could not cause all of the early vascular supersensitivity 
since the rats had a low P. R. A. indicating a positive sodium balance, in 
the later stages of hypertension. 
The decline of vascular supersensitivity in the later stages 
of renal and renal/salt hypertension has been interpreted as indicating 
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that some sensitizing factor increases in the early stages but declines 
in the later stages of hypertension. An alternative possibility is that 
the sensitizing factor is elevated throughout the 6 week period but has 
different effects on the smooth muscle in the later stages of hyper- 
tension. If this factor affects calcium regulation, it could cause 
an increased availability of activator calcium in the early stages of 
hypertension. In the later stages the energetics of the cross-linking 
system of actin and myosin could change so that a greater contraction 
develops in response to a normal quantity of activator calcium. Such 
a change would shift the dose-response curve to the left of control, 
and elevate the maximum response to all agonists (Kalsner, 1974). 
The assumption on which all studies of vascular reactivity are 
based is that an increase in peripheral resistance causes or maintains 
hypertension. Guyton, Coleman and Granger (1972) have used the systems 
analysis approach in their computer simulation of the control of blood 
pressure. This analysis revealed two very important predictions, 
1) changes in peripheral resistance per se, play essentially no role in 
the long term regulation of arterial pressure, 2) arterial pressure can- 
not be changed chronically without either altering the function of the 
kidneys or changing the intake of water and electrolytes. This is because 
the renal body fluid mechanism for regulation of arterial pressure is the 
only control system with infinite gain. (Guyton, Coleman, Cowley, Scheel, 
Manning and Norman, 1972). Although the peripheral resistance will 
maintain the high blood pressure, this can only occur in the presence 
of an altered kidney function. This group of investigators also suggest 
that pretubular mechanisms i. e. an increase in resistance to blood flow 
in the afferent renal artery and arterioles, are more important than 
tubular mechanisms, i. e. sodium retention in pressure control (Guyton, 
Coleman, Cowley, Manning, Norman and Ferguson, 1974). Therefore an 
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increase in resistance of non-renal vascular beds, perhaps caused by 
increased vascular reactivity, could only, cause hypertension in the 
presence of an impaired or altered kidney function. If increased 
vascular reactivity also occurred in the renal afferent blood vessels 
then a causative link between reactivity and high blood pressure could 
be established. For this reason, future studies of vascular reactivity 
in hypertension should be directed towards the renal arterial-arteriolar 
vessels, an approach which has been neglected in previous studies. 
I 
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